##ANALYSISTYPE=CLINCNV_GERMLINE_MULTI
##GS140127_01 gender of sample: M
##GS140127_01 number of iterations: 1 , quality used at final iteration: 20
##GS140127_01 was it outlier after clustering? FALSE
##GS140127_01 fraction of outliers: 0.049
##GS140550_01 gender of sample: M
##GS140550_01 number of iterations: 1 , quality used at final iteration: 20
##GS140550_01 was it outlier after clustering? FALSE
##GS140550_01 fraction of outliers: 0.029
##GS140549_01 gender of sample: M
##GS140549_01 number of iterations: 1 , quality used at final iteration: 20
##GS140549_01 was it outlier after clustering? FALSE
##GS140549_01 fraction of outliers: 0.03
#chr	start	end	sample	size	CN_change	loglikelihood	qvalue	potential_AF	overlap af_genomes_imgag	cn_pathogenic	genes	gene_info	dosage_sensitive_disease_genes	clinvar_cnvs	omim
chr1	983382	983755	trio	373	1	6	0.01920	0.057	0.000	1p36 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/18]	AGRN	AGRN (oe_lof=0.32 region=exonic/splicing)	AGRN [HI=Gene associated with autosomal recessive phenotype PMIDS=]	144176 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144707 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144721 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145356 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147545 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148825 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148916 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149107 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149171 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149739 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150995 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151110 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151451 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152050 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152331 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152333 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152675 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152695 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152807 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152849 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153195 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154003 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154687 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253595 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253626 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393899 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394071 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396017 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396122 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396368 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396394 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],427642 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="Distal trisomy 1p36"],442107 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443012 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443237 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443250 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443771 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],565056 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57049 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57052 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57120 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57201 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57218 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58036 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58037 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58038 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58089 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58243 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58245 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58266 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58267 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58289 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58292 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58293 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58311 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58312 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58314 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58315 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58316 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],599663 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],599667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],612178 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625767 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 1p36 deletion syndrome"],625768 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 1p36 deletion syndrome"],625817 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814047 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814048 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816486 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980934 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],980935 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980936 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],988904 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	103320_[GENE=AGRN_PHENOS=Myasthenic_syndrome,congenital,8,with_pre-_and_postsynaptic_defects,615120,Autosomal_recessive]
chr1	1960540	1961211	trio	671	1	7	0.03429	0.025	0.000	1p36 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/18]	GABRD	GABRD (oe_lof=0.05 region=exonic/splicing)		144176 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144707 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144807 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145356 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147545 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148825 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148916 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149107 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149171 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149739 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150995 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151110 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151451 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152050 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152331 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152333 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152675 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152695 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152807 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152849 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153195 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154687 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253365 [CN_TYPE=gain CN=4 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253595 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253626 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393731 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],393899 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394071 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394133 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396017 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396122 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396368 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396394 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],427642 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="Distal trisomy 1p36"],442107 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443012 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443115 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443237 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443250 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443771 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],565057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565060 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57049 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57052 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57120 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57201 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57218 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58036 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58037 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58243 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58245 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58266 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58267 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58289 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58292 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58293 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58311 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58312 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58314 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58315 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58316 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58318 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58319 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],599667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],612178 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625765 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],625767 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 1p36 deletion syndrome"],625768 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 1p36 deletion syndrome"],666432 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Chromosome 1p36 deletion syndrome"],814047 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814048 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816486 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980935 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980936 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	137163_[GENE=GABRD_PHENOS=Epilepsy,idiopathic_generalized,10,613060,Autosomal_dominant/Epilepsy,juvenile_myoclonic,susceptibility_to,613060,Autosomal_dominant/Generalized_epilepsy_with_febrile_seizures_plus,type_5,susceptibility_to,613060,Autosomal_dominant]
chr1	2337913	2338068	trio	155	3	4	0.04650	0.140	0.000	1p36 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/18]	RER1,PEX10	RER1 (oe_lof=0.22 region=intronic/intergenic),PEX10 (oe_lof=0.48 region=exonic/splicing)		144176 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144707 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144807 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145356 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147545 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148825 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148916 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149107 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149171 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149739 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150995 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151110 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151451 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152050 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152331 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152333 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152675 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152695 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152807 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152849 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153195 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154687 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253595 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253626 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393899 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394071 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396017 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396122 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396368 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396394 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],427642 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="Distal trisomy 1p36"],442107 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443012 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443115 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443237 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443250 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],565058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565062 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57049 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57052 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57120 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57201 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57218 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58036 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58037 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58243 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58245 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58266 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58267 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58289 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58293 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58311 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58314 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58315 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58316 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58318 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58319 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],599667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],612178 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],612213 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625765 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],625767 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 1p36 deletion syndrome"],625768 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 1p36 deletion syndrome"],638130 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],666432 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Chromosome 1p36 deletion syndrome"],814047 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814048 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816486 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	602859_[GENE=PEX10_PHENOS=Peroxisome_biogenesis_disorder_6A_(Zellweger),614870,Autosomal_recessive/Peroxisome_biogenesis_disorder_6B,614871,Autosomal_recessive]
chr1	5987699	5987857	trio	158	3	8	0.01940	0.089	0.000	1p36 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/18]	NPHP4	NPHP4 (oe_lof=0.78 region=exonic/splicing)		152936 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442741 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58041 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59852 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],599730 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688495 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607215_[GENE=NPHP4_PHENOS=Senior-Loken_syndrome_4,606996,Autosomal_recessive/Nephronophthisis_4,606966,Autosomal_recessive]
chr1	6545886	6546024	trio	138	1	3	0.03925	0.083	0.000	1p36 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/18]	PLEKHG5	PLEKHG5 (oe_lof=0.38 region=intronic/intergenic)	PLEKHG5 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	152936 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442741 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59852 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],599730 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	611101_[GENE=PLEKHG5_PHENOS=Spinal_muscular_atrophy,distal,autosomal_recessive,4,611067,Autosomal_recessive/Charcot-Marie-Tooth_disease,recessive_intermediate_C,615376,Autosomal_recessive]
chr1	12066585	12066760	trio	175	1	6	0.01209	0.038	0.000	1p36 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/18]	MFN2	MFN2 (oe_lof=0.13 region=exonic/splicing)		144297 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146535 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153434 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253358 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],441991 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443150 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59887 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625539 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],638125 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth_disease,axonal,type_2A2A,609260,Autosomal_dominant/Charcot-Marie-Tooth_disease,axonal,type_2A2B,617087,Autosomal_recessive/Hereditary_motor_and_sensory_neuropathy_VIA,601152,Autosomal_dominant]
chr1	17312948	17314739	trio	1791	1	3	0.05003	0.064	0.000		ATP13A2	ATP13A2 (oe_lof=0.42 region=exonic/splicing)		149010 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58056 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59900 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980391 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	610513_[GENE=ATP13A2_PHENOS=Spastic_paraplegia_78,autosomal_recessive,617225,Autosomal_recessive/Kufor-Rakeb_syndrome,606693,Autosomal_recessive]
chr1	17326731	17327039	trio	308	1	3	0.14065	0.210	0.000		ATP13A2	ATP13A2 (oe_lof=0.42 region=exonic/splicing)		149010 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58056 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59900 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980391 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	610513_[GENE=ATP13A2_PHENOS=Spastic_paraplegia_78,autosomal_recessive,617225,Autosomal_recessive/Kufor-Rakeb_syndrome,606693,Autosomal_recessive]
chr1	19205784	19205877	trio	93	1	6	0.01277	0.057	0.000		ALDH4A1,MIR4695	ALDH4A1 (oe_lof=0.45 region=exonic/splicing),MIR4695 (oe_lof=n/a region=intronic/intergenic)	ALDH4A1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	149010 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59918 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980391 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia,type_II,239510,Autosomal_recessive]
chr1	22157946	22158065	trio	119	1	6	0.01367	0.057	0.000		HSPG2	HSPG2 (oe_lof=0.34 region=exonic/splicing)	HSPG2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	397403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59918 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	142461_[GENE=HSPG2_PHENOS=Dyssegmental_dysplasia,Silverman-Handmaker_type,224410,Autosomal_recessive/Schwartz-Jampel_syndrome,type_1,255800,Autosomal_recessive]
chr1	22176524	22178736	trio	2212	1	4	0.07866	0.076	0.000		HSPG2	HSPG2 (oe_lof=0.34 region=exonic/splicing)	HSPG2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	397403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59918 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	142461_[GENE=HSPG2_PHENOS=Dyssegmental_dysplasia,Silverman-Handmaker_type,224410,Autosomal_recessive/Schwartz-Jampel_syndrome,type_1,255800,Autosomal_recessive]
chr1	22214421	22214569	trio	148	1	4	0.01713	0.038	0.000		HSPG2	HSPG2 (oe_lof=0.34 region=exonic/splicing)	HSPG2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	397403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59918 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	142461_[GENE=HSPG2_PHENOS=Dyssegmental_dysplasia,Silverman-Handmaker_type,224410,Autosomal_recessive/Schwartz-Jampel_syndrome,type_1,255800,Autosomal_recessive]
chr1	22979672	22979806	trio	134	3	3	0.06690	0.261	0.000		C1QB	C1QB (oe_lof=0.33 region=intronic/intergenic)	C1QB [HI=Gene associated with autosomal recessive phenotype PMIDS=]		120570_[GENE=C1QB_PHENOS=C1q_deficiency,613652,Autosomal_recessive]
chr1	24122631	24122765	trio	134	1	4	0.03623	0.057	0.000		LYPLA2,GALE	LYPLA2 (oe_lof=0.07 region=intronic/intergenic),GALE (oe_lof=0.91 region=exonic/splicing)			606953_[GENE=GALE_PHENOS=Galactose_epimerase_deficiency,230350,Autosomal_recessive]
chr1	24124175	24124371	trio	196	3	5	0.04793	0.210	0.000		LYPLA2,GALE,HMGCL	LYPLA2 (oe_lof=0.07 region=intronic/intergenic),GALE (oe_lof=0.91 region=exonic/splicing),HMGCL (oe_lof=0.67 region=intronic/intergenic)			606953_[GENE=GALE_PHENOS=Galactose_epimerase_deficiency,230350,Autosomal_recessive],613898_[GENE=HMGCL_PHENOS=HMG-CoA_lyase_deficiency,246450,Autosomal_recessive]
chr1	24151836	24151959	trio	123	4	10	0.00238	0.197	0.000		HMGCL	HMGCL (oe_lof=0.67 region=exonic/splicing)			613898_[GENE=HMGCL_PHENOS=HMG-CoA_lyase_deficiency,246450,Autosomal_recessive]
chr1	24172554	24172673	trio	119	3	6	0.02518	0.153	0.000		FUCA1	FUCA1 (oe_lof=0.62 region=exonic/splicing)			612280_[GENE=FUCA1_PHENOS=Fucosidosis,230000,Autosomal_recessive]
chr1	33282779	33283643	trio	864	3	4	0.03097	0.166	0.000		YARS1,S100PBP	YARS1 (oe_lof=0.37 region=exonic/splicing),S100PBP (oe_lof=0.11 region=intronic/intergenic)		146124 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59931 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625764 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],814067 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	603623_[GENE=YARS1_PHENOS=Infantile-onset_multisystem_neurologic,endocrine,and_pancreatic_disease_2,619418,Autosomal_recessive/Charcot-Marie-Tooth_disease,dominant_intermediate_C,608323,Autosomal_dominant]
chr1	33480113	33487072	trio	6959	3	4	0.18139	0.134	0.000		AK2	AK2 (oe_lof=0.68 region=exonic/splicing)		146124 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59931 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625764 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],814067 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	103020_[GENE=AK2_PHENOS=Reticular_dysgenesis,267500,Autosomal_recessive]
chr1	33502327	33502522	trio	195	3	5	0.03348	0.134	0.000		AK2	AK2 (oe_lof=0.68 region=exonic/splicing)		146124 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59931 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625764 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],814067 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	103020_[GENE=AK2_PHENOS=Reticular_dysgenesis,267500,Autosomal_recessive]
chr1	40562777	40724076	trio	161299	3	7	0.00964	0.096	0.000		PPT1,RLF,RNU6-1237P,TMCO2,ZMPSTE24	PPT1 (oe_lof=0.52 region=exonic/splicing),RLF (oe_lof=0.00 region=complete),RNU6-1237P (oe_lof=n/a region=complete),TMCO2 (oe_lof=0.85 region=complete),ZMPSTE24 (oe_lof=0.94 region=exonic/splicing)	PPT1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	58072 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59934 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600722_[GENE=PPT1_PHENOS=Ceroid_lipofuscinosis,neuronal,1,256730,Autosomal_recessive],606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral_dysplasia_with_type_B_lipodystrophy,608612,Autosomal_recessive/Restrictive_dermopathy,lethal,275210,Autosomal_recessive]
chr1	43203890	43203994	trio	104	1	3	0.07361	0.089	0.000		CLDN19	CLDN19 (oe_lof=0.51 region=exonic/splicing)		152832 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154142 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395212 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57093 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia_5,renal,with_ocular_involvement,248190,Autosomal_recessive]
chr1	43205502	43205935	trio	433	1	5	0.01336	0.070	0.000		CLDN19	CLDN19 (oe_lof=0.51 region=exonic/splicing)		152832 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154142 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395212 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57093 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia_5,renal,with_ocular_involvement,248190,Autosomal_recessive]
chr1	43224513	43225071	trio	558	3	4	0.02994	0.083	0.000		P3H1	P3H1 (oe_lof=0.91 region=exonic/splicing)	P3H1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	152832 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154142 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395212 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57093 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610339_[GENE=P3H1_PHENOS=Osteogenesis_imperfecta,type_VIII,610915,Autosomal_recessive]
chr1	43396707	43396887	trio	180	3	14	0.00123	0.070	0.000		SLC2A1	SLC2A1 (oe_lof=0.05 region=exonic/splicing)	SLC2A1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=10980529,25532859,25564316]	152832 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154142 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395212 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57093 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],689310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	138140_[GENE=SLC2A1_PHENOS=Dystonia_9,601042,Autosomal_dominant/GLUT1_deficiency_syndrome_1,infantile_onset,severe,606777,Autosomal_dominant,Autosomal_recessive/Stomatin-deficient_cryohydrocytosis_with_neurologic_defects,608885,Autosomal_dominant/Epilepsy,idiopathic_generalized,susceptibility_to,12,614847,Autosomal_dominant/GLUT1_deficiency_syndrome_2,childhood_onset,612126,Autosomal_dominant]
chr1	45392290	45392421	trio	131	3	4	0.07668	0.242	0.000		EIF2B3	EIF2B3 (oe_lof=0.21 region=exonic/splicing)	EIF2B3 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy_with_vanishing_white_matter,603896,Autosomal_recessive]
chr1	46663364	46663553	trio	189	3	3	0.08833	0.236	0.000		POMGNT1	POMGNT1 (oe_lof=0.79 region=exonic/splicing)			606822_[GENE=POMGNT1_PHENOS=Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,3,613151,Autosomal_recessive/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,3,613157,Autosomal_recessive/Retinitis_pigmentosa_76,617123,Autosomal_recessive/Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,3,253280,Autosomal_recessive]
chr1	53662091	53662777	trio	686	3	5	0.02796	0.178	0.000		CPT2	CPT2 (oe_lof=0.78 region=exonic/splicing)		1047872 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Abnormality of the kidney;Transverse facial cleft"],394094 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600650_[GENE=CPT2_PHENOS=Encephalopathy,acute,infection-induced,4,susceptibility_to,614212,Autosomal_dominant,Autosomal_recessive/CPT_II_deficiency,infantile,600649,Autosomal_recessive/CPT_II_deficiency,lethal_neonatal,608836,Autosomal_recessive/CPT_II_deficiency,myopathic,stress-induced,255110,Autosomal_dominant,Autosomal_recessive]
chr1	92949282	92949366	trio	84	4	5	0.02479	0.357	0.000		GFI1	GFI1 (oe_lof=0.25 region=intronic/intergenic)		981207 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Diamond-Blackfan anemia 6"]	600871_[GENE=GFI1_PHENOS=Neutropenia,nonimmune_chronic_idiopathic,of_adults,607847,Autosomal_dominant/Neutropenia,severe_congenital_2,autosomal_dominant,613107,Autosomal_dominant]
chr1	98386430	98386625	trio	195	3	4	0.03106	0.166	0.000		DPYD	DPYD (oe_lof=0.77 region=exonic/splicing)	DPYD [HI=Gene associated with autosomal recessive phenotype PMIDS=]		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine_dehydrogenase_deficiency,274270,Autosomal_recessive/5-fluorouracil_toxicity,274270,Autosomal_recessive]
chr1	100315630	100315981	trio	351	3	6	0.01932	0.146	0.000		AGL	AGL (oe_lof=0.64 region=intronic/intergenic)		685074 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	610860_[GENE=AGL_PHENOS=Glycogen_storage_disease_IIIa,232400,Autosomal_recessive/Glycogen_storage_disease_IIIb,232400,Autosomal_recessive]
chr1	100381956	100382063	trio	107	3	5	0.02613	0.076	0.000		AGL	AGL (oe_lof=0.64 region=exonic/splicing)			610860_[GENE=AGL_PHENOS=Glycogen_storage_disease_IIIa,232400,Autosomal_recessive/Glycogen_storage_disease_IIIb,232400,Autosomal_recessive]
chr1	100671776	100671867	trio	91	3	3	0.07509	0.121	0.000		DBT	DBT (oe_lof=0.50 region=exonic/splicing)			248610_[GENE=DBT_PHENOS=Maple_syrup_urine_disease,type_II,248600,Autosomal_recessive]
chr1	100715316	109756760	trio	9041444	3	6	0.01022	0.159	0.044 (0.05,0.05,0.02,0.16,0.16,0.16,0.16,0.90,0.90,0.90,0.90,0.21,0.21,0.21,0.21,0.21,0.21,0.21,0.21,0.21,0.21,0.21,0.21,0.21,0.21,0.07,0.07,0.07,0.07,0.97,0.97,0.97,0.97,0.97,0.97,0.98,0.98,0.97,0.97,0.97,0.97,0.97,0.97,0.62,0.62,0.61,0.61,0.63,0.62,0.62,0.63,0.63,0.63,0.63,0.63,0.61,0.55,0.55,0.65,0.63,0.63,0.47,0.47,0.55,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.65,0.65,0.90,0.90,0.90,0.90,0.58,0.58,0.65,0.65,0.54,0.54,0.66,0.66,0.64,0.53,0.53,0.67,0.67,0.56,0.56,0.63,0.63,0.63,0.64,0.64,0.62,0.62,0.62,0.90,0.90,0.90,0.90,0.97,0.97,0.68,0.68,0.30,0.30,0.90,0.90,0.97,0.97,0.98,0.97,0.97,0.97,0.97,0.97,0.97,0.56,0.56,0.63,0.63,0.61,0.60,0.60,0.63,0.64,0.64,0.61,0.62,0.62,0.38,0.38,0.62,0.50,0.50,0.43,0.99,0.99,0.99,0.99,0.10,0.99,0.99,1.00,0.14,0.61,0.61,0.61,0.61,0.61,0.02,0.02,0.03,0.04,0.04,0.05,0.41,0.41,0.41,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,1.00,1.00,1.00,1.00,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.99,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.07,0.02,0.04,0.02,0.97,0.97,0.97,0.04,0.05,0.42,0.42,0.42,0.02)		DBT,RTCA,MIR553,CDC14A,BCAS2P2,GPR88,VCAM1,EXTL2,SLC30A7,HNRNPA1P68,DPH5,SCARNA16,S1PR1,PPIAP7,LINC01307,RNU6-965P,OLFM3,RNU6-352P,DNAJA1P5,COL11A1,SOD2P1,RN7SKP285,RNPC3,AMY2B,ACTG1P4,AMY2A,AMY1A,AMY1B,AMYP1,AMY1C,FTLP17,SEPTIN2P1,PRMT6,NTNG1,VAV3,VAV3-AS1,SLC25A24,NBPF4,SLC25A24P1,NBPF6,NBPF5P,SLC25A24P2,ST13P21,FAM102B,HENMT1,PRPF38B,FNDC7,STXBP3,AKNAD1,SPATA42,GPSM2,CLCC1,WDR47,RANP5,TAF13,TMEM167B,SCARNA2,C1ORF194,ELAPOR1,SARS1	DBT (oe_lof=0.50 region=exonic/splicing),RTCA (oe_lof=0.74 region=complete),MIR553 (oe_lof=n/a region=complete),CDC14A (oe_lof=0.51 region=complete),BCAS2P2 (oe_lof=n/a region=complete),GPR88 (oe_lof=0.11 region=complete),VCAM1 (oe_lof=0.18 region=complete),EXTL2 (oe_lof=0.57 region=complete),SLC30A7 (oe_lof=0.64 region=complete),HNRNPA1P68 (oe_lof=n/a region=complete),DPH5 (oe_lof=0.77 region=complete),SCARNA16 (oe_lof=n/a region=complete),S1PR1 (oe_lof=0.12 region=complete),PPIAP7 (oe_lof=n/a region=complete),LINC01307 (oe_lof=n/a region=complete),RNU6-965P (oe_lof=n/a region=complete),OLFM3 (oe_lof=0.39 region=complete),RNU6-352P (oe_lof=n/a region=complete),DNAJA1P5 (oe_lof=n/a region=complete),COL11A1 (oe_lof=0.14 region=complete),SOD2P1 (oe_lof=n/a region=complete),RN7SKP285 (oe_lof=n/a region=complete),RNPC3 (oe_lof=0.44 region=complete),AMY2B (oe_lof=1.33 region=complete),ACTG1P4 (oe_lof=n/a region=complete),AMY2A (oe_lof=1.12 region=complete),AMY1A (oe_lof=1.06 region=complete),AMY1B (oe_lof=1.54 region=complete),AMYP1 (oe_lof=n/a region=complete),AMY1C (oe_lof=0.77 region=complete),FTLP17 (oe_lof=n/a region=complete),SEPTIN2P1 (oe_lof=n/a region=complete),PRMT6 (oe_lof=0.47 region=complete),NTNG1 (oe_lof=0.16 region=complete),VAV3 (oe_lof=0.54 region=complete),VAV3-AS1 (oe_lof=n/a region=complete),SLC25A24 (oe_lof=0.78 region=complete),NBPF4 (oe_lof=0.65 region=complete),SLC25A24P1 (oe_lof=n/a region=complete),NBPF6 (oe_lof=0.67 region=complete),NBPF5P (oe_lof=n/a region=complete),SLC25A24P2 (oe_lof=n/a region=complete),ST13P21 (oe_lof=n/a region=complete),FAM102B (oe_lof=0.44 region=complete),HENMT1 (oe_lof=1.01 region=complete),PRPF38B (oe_lof=0.20 region=complete),FNDC7 (oe_lof=0.67 region=complete),STXBP3 (oe_lof=0.38 region=complete),AKNAD1 (oe_lof=0.93 region=complete),SPATA42 (oe_lof=n/a region=complete),GPSM2 (oe_lof=0.60 region=complete),CLCC1 (oe_lof=0.33 region=complete),WDR47 (oe_lof=0.23 region=complete),RANP5 (oe_lof=n/a region=complete),TAF13 (oe_lof=0.47 region=complete),TMEM167B (oe_lof=0.00 region=complete),SCARNA2 (oe_lof=n/a region=complete),C1ORF194 (oe_lof=1.05 region=complete),ELAPOR1 (oe_lof=0.53 region=complete),SARS1 (oe_lof=0.07 region=exonic/splicing)	COL11A1 [HI=Little evidence for dosage pathogenicity PMIDS=21035103],GPSM2 [HI=Gene associated with autosomal recessive phenotype PMIDS=],TAF13 [HI=Little evidence for dosage pathogenicity PMIDS=24463507]	60008 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60009 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814113 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	120280_[GENE=COL11A1_PHENOS=Fibrochondrogenesis_1,228520,Autosomal_recessive/Stickler_syndrome,type_II,604841,Autosomal_dominant/Marshall_syndrome,154780,Autosomal_dominant/Deafness,autosomal_dominant_37,618533,Autosomal_dominant/Lumbar_disc_herniation,susceptibility_to,603932],248610_[GENE=DBT_PHENOS=Maple_syrup_urine_disease,type_II,248600,Autosomal_recessive],600774_[GENE=TAF13_PHENOS=Mental_retardation,autosomal_recessive_60,617432,Autosomal_recessive],603504_[GENE=CDC14A_PHENOS=Deafness,autosomal_recessive_32,with_or_without_immotile_sperm,608653,Autosomal_recessive],607468_[GENE=GPR88_PHENOS=Chorea,childhood-onset,with_psychomotor_retardation,616939,Autosomal_recessive],607529_[GENE=SARS1_PHENOS=Neurodevelopmental_disorder_with_microcephaly,ataxia,and_seizures,617709,Autosomal_recessive],608744_[GENE=SLC25A24_PHENOS=Fontaine_progeroid_syndrome,612289,Autosomal_dominant],609245_[GENE=GPSM2_PHENOS=Chudley-McCullough_syndrome,604213,Autosomal_recessive],617539_[GENE=CLCC1_PHENOS=Retinitis_pigmentosa_32,609913,Autosomal_recessive],618016_[GENE=RNPC3_PHENOS=Growth_hormone_deficiency,isolated,type_V,618160,Autosomal_recessive]
chr1	115259269	115259525	trio	256	4	6	0.02518	0.236	0.000		NRAS,CSDE1	NRAS (oe_lof=0.19 region=intronic/intergenic),CSDE1 (oe_lof=0.05 region=intronic/intergenic)		814118 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	164790_[GENE=NRAS_PHENOS=Noonan_syndrome_6,613224,Autosomal_dominant/RAS-associated_autoimmune_lymphoproliferative_syndrome_type_IV,somatic,614470/Melanocytic_nevus_syndrome,congenital,somatic,137550/Epidermal_nevus,somatic,162900/Schimmelpenning-Feuerstein-Mims_syndrome,somatic_mosaic,163200/Thyroid_carcinoma,follicular,somatic,188470/Neurocutaneous_melanosis,somatic,249400/Colorectal_cancer,somatic,114500]
chr1	149804211	149832735	trio	28524	3	17	0.00331	0.153	0.000		H4C14,H3C14,H2AC18,H2BC19P,H2BC20P,H2AC19,H3C15,H4C15	H4C14 (oe_lof=n/a region=exonic/splicing),H3C14 (oe_lof=n/a region=complete),H2AC18 (oe_lof=n/a region=complete),H2BC19P (oe_lof=n/a region=complete),H2BC20P (oe_lof=n/a region=complete),H2AC19 (oe_lof=n/a region=complete),H3C15 (oe_lof=n/a region=complete),H4C15 (oe_lof=n/a region=exonic/splicing)		58105 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr1	154143115	154143197	trio	82	3	7	0.01385	0.089	0.000		TPM3,RN7SL431P	TPM3 (oe_lof=0.37 region=exonic/splicing),RN7SL431P (oe_lof=n/a region=intronic/intergenic)		493594 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],565180 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60011 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625770 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Mental retardation, autosomal dominant 18"]	191030_[GENE=TPM3_PHENOS=CAP_myopathy_1,609284,Autosomal_dominant,Autosomal_recessive/Myopathy,congenital,with_fiber-type_disproportion,255310,Autosomal_dominant,Autosomal_recessive/Nemaline_myopathy_1,autosomal_dominant_or_recessive,609284,Autosomal_dominant,Autosomal_recessive]
chr1	154245029	154246447	trio	1418	3	4	0.06625	0.153	0.000		UBAP2L,HAX1	UBAP2L (oe_lof=0.03 region=intronic/intergenic),HAX1 (oe_lof=0.85 region=exonic/splicing)		493594 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],565180 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605998_[GENE=HAX1_PHENOS=Neutropenia,severe_congenital_3,autosomal_recessive,610738,Autosomal_recessive]
chr1	155262958	155263144	trio	186	3	4	0.04262	0.070	0.000		HCN3,PKLR	HCN3 (oe_lof=0.46 region=intronic/intergenic),PKLR (oe_lof=0.59 region=exonic/splicing)		151159 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],493594 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	609712_[GENE=PKLR_PHENOS=Adenosine_triphosphate,elevated,of_erythrocytes,102900,Autosomal_dominant/Pyruvate_kinase_deficiency,266200,Autosomal_recessive]
chr1	156024507	156024758	trio	251	5	9	0.02518	0.293	0.000		UBQLN4,LAMTOR2	UBQLN4 (oe_lof=0.12 region=intronic/intergenic),LAMTOR2 (oe_lof=0.30 region=exonic/splicing)		151159 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],493594 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],565183 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	610389_[GENE=LAMTOR2_PHENOS=Immunodeficiency_due_to_defect_in_MAPBP-interacting_protein,610798,Autosomal_recessive]
chr1	160251819	160252000	trio	181	3	6	0.02064	0.032	0.000		DCAF8,PEX19	DCAF8 (oe_lof=0.14 region=exonic/splicing),PEX19 (oe_lof=0.52 region=exonic/splicing)			600279_[GENE=PEX19_PHENOS=Peroxisome_biogenesis_disorder_12A_(Zellweger),614886,Autosomal_recessive],615820_[GENE=DCAF8_PHENOS=Giant_axonal_neuropathy_2,autosomal_dominant,610100,Autosomal_dominant]
chr1	160254835	161136472	trio	881637	3	17	0.01463	0.229	0.006 (0.04,0.04)		DCAF8,PEX19,COPA,SUMO1P3,NCSTN,NHLH1,RNU4-42P,VANGL2,SLAMF6,CD84,SLAMF1,SETP9,CD48,SLAMF7,LY9,CD244,ITLN1,ITLN2,F11R,TSTD1,USF1,ARHGAP30,NECTIN4,KLHDC9,PFDN2,NIT1,DEDD,SNORA78,UFC1,USP21,PPOX,B4GALT3	DCAF8 (oe_lof=0.14 region=intronic/intergenic),PEX19 (oe_lof=0.52 region=exonic/splicing),COPA (oe_lof=0.04 region=exonic/splicing),SUMO1P3 (oe_lof=n/a region=complete),NCSTN (oe_lof=0.10 region=complete),NHLH1 (oe_lof=0.29 region=complete),RNU4-42P (oe_lof=n/a region=complete),VANGL2 (oe_lof=0.17 region=complete),SLAMF6 (oe_lof=0.34 region=complete),CD84 (oe_lof=0.84 region=complete),SLAMF1 (oe_lof=0.41 region=complete),SETP9 (oe_lof=n/a region=complete),CD48 (oe_lof=0.83 region=complete),SLAMF7 (oe_lof=0.34 region=complete),LY9 (oe_lof=0.78 region=complete),CD244 (oe_lof=0.29 region=complete),ITLN1 (oe_lof=0.65 region=complete),ITLN2 (oe_lof=0.68 region=complete),F11R (oe_lof=0.60 region=complete),TSTD1 (oe_lof=0.21 region=complete),USF1 (oe_lof=0.31 region=complete),ARHGAP30 (oe_lof=0.09 region=complete),NECTIN4 (oe_lof=0.17 region=complete),KLHDC9 (oe_lof=0.98 region=complete),PFDN2 (oe_lof=0.23 region=complete),NIT1 (oe_lof=0.67 region=complete),DEDD (oe_lof=0.07 region=complete),SNORA78 (oe_lof=n/a region=complete),UFC1 (oe_lof=0.46 region=complete),USP21 (oe_lof=0.31 region=exonic/splicing),PPOX (oe_lof=0.30 region=intronic/intergenic),B4GALT3 (oe_lof=0.34 region=intronic/intergenic)			191523_[GENE=USF1_PHENOS=Hyperlipidemia,familial_combined,susceptibility_to,602491],600279_[GENE=PEX19_PHENOS=Peroxisome_biogenesis_disorder_12A_(Zellweger),614886,Autosomal_recessive],600533_[GENE=VANGL2_PHENOS=Neural_tube_defects,182940,Autosomal_dominant],600923_[GENE=PPOX_PHENOS=Porphyria_variegata,176200,Autosomal_dominant],601924_[GENE=COPA_PHENOS=Autoimmune_interstitial_lung,joint,and_kidney_disease,616414,Autosomal_dominant],605254_[GENE=NCSTN_PHENOS=Acne_inversa,familial,1,142690,Autosomal_dominant],605554_[GENE=CD244_PHENOS=Rheumatoid_arthritis,susceptibility_to,180300],609607_[GENE=NECTIN4_PHENOS=Ectodermal_dysplasia-syndactyly_syndrome_1,613573,Autosomal_recessive],610554_[GENE=UFC1_PHENOS=Neurodevelopmental_disorder_with_spasticity_and_poor_growth,618076,Autosomal_recessive],615820_[GENE=DCAF8_PHENOS=Giant_axonal_neuropathy_2,autosomal_dominant,610100,Autosomal_dominant]
chr1	161277038	161277224	trio	186	3	4	0.04579	0.159	0.000		MPZ	MPZ (oe_lof=0.25 region=exonic/splicing)			159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth_disease,type_2I,607677,Autosomal_dominant/Dejerine-Sottas_disease,145900,Autosomal_dominant,Autosomal_recessive/Charcot-Marie-Tooth_disease,type_1B,118200,Autosomal_dominant/Roussy-Levy_syndrome,180800,Autosomal_dominant/Charcot-Marie-Tooth_disease,dominant_intermediate_D,607791,Autosomal_dominant/Hypomyelinating_neuropathy,congenital,2,618184,Autosomal_dominant/Charcot-Marie-Tooth_disease,type_2J,607736,Autosomal_dominant]
chr1	167487635	173794504	trio	6306869	3	6	0.01685	0.108	0.005 (0.07,0.02,0.98,0.98,0.55,0.55,0.55,0.55,0.55,0.55,0.55,0.55,0.55,0.55,0.04)		CD247,AKR1D1P1,CREG1,RCSD1,MPZL1,ADCY10,MPC2,DCAF6,MIR1255B2,GCSHP5,GPR161,TIPRL,RPL34P1,SFT2D2,ANKRD36BP1,RNU6-1310P,TBX19,MIR557,QRSL1P1,XCL2,XCL1,DPT,LINC00626,SUMO1P2,LINC00970,RPL29P7,RNA5SP66,ATP1B1,NME7,BLZF1,CCDC181,SLC19A2,F5,SELP,SELL,SELE,METTL18,C1ORF112,SCYL3,RN7SL333P,KIFAP3,RN7SL269P,MRPS10P1,SIGLEC30P,METTL11B,MIR3119-1,ISCUP1,LINC01142,HAUS4P1,GORAB,PRRX1,MROH9,FMO3,MIR1295A,FMO6P,FMO2,FMO1,HMGB1P11,FMO4,TOP1P1,GM2AP2,RNU6-290P,CYCSP53,PRRC2C,RN7SL425P,MYOC,PFN1P1,RPL4P3,VAMP4,SCARNA20,EEF1AKNMT,DNM3,DNM3-IT1,MIR214,DNM3OS,MIR199A2,SNORD112,RNU6-157P,C1ORF105,PIGC,SUCO,RNU6-693P,FASLG,SLC25A38P1,AIMP1P2,TNFSF18,GOT2P2,TNFSF4,PRDX6,SLC9C2,ANKRD45,KLHL20,RN7SKP160,CENPL,DARS2	CD247 (oe_lof=0.39 region=exonic/splicing),AKR1D1P1 (oe_lof=n/a region=exonic/splicing),CREG1 (oe_lof=0.73 region=complete),RCSD1 (oe_lof=0.31 region=complete),MPZL1 (oe_lof=0.29 region=complete),ADCY10 (oe_lof=0.85 region=complete),MPC2 (oe_lof=0.13 region=complete),DCAF6 (oe_lof=0.25 region=complete),MIR1255B2 (oe_lof=n/a region=complete),GCSHP5 (oe_lof=n/a region=complete),GPR161 (oe_lof=0.45 region=complete),TIPRL (oe_lof=0.07 region=complete),RPL34P1 (oe_lof=n/a region=complete),SFT2D2 (oe_lof=0.43 region=complete),ANKRD36BP1 (oe_lof=n/a region=complete),RNU6-1310P (oe_lof=n/a region=complete),TBX19 (oe_lof=0.59 region=complete),MIR557 (oe_lof=n/a region=complete),QRSL1P1 (oe_lof=n/a region=complete),XCL2 (oe_lof=0.84 region=complete),XCL1 (oe_lof=1.09 region=complete),DPT (oe_lof=0.72 region=complete),LINC00626 (oe_lof=n/a region=complete),SUMO1P2 (oe_lof=n/a region=complete),LINC00970 (oe_lof=n/a region=complete),RPL29P7 (oe_lof=n/a region=complete),RNA5SP66 (oe_lof=n/a region=complete),ATP1B1 (oe_lof=0.00 region=complete),NME7 (oe_lof=0.56 region=complete),BLZF1 (oe_lof=0.63 region=complete),CCDC181 (oe_lof=0.71 region=complete),SLC19A2 (oe_lof=0.44 region=complete),F5 (oe_lof=0.43 region=complete),SELP (oe_lof=1.03 region=complete),SELL (oe_lof=0.64 region=complete),SELE (oe_lof=0.59 region=complete),METTL18 (oe_lof=0.77 region=complete),C1ORF112 (oe_lof=0.52 region=complete),SCYL3 (oe_lof=0.23 region=complete),RN7SL333P (oe_lof=n/a region=complete),KIFAP3 (oe_lof=0.36 region=complete),RN7SL269P (oe_lof=n/a region=complete),MRPS10P1 (oe_lof=n/a region=complete),SIGLEC30P (oe_lof=n/a region=complete),METTL11B (oe_lof=0.53 region=complete),MIR3119-1 (oe_lof=n/a region=complete),ISCUP1 (oe_lof=n/a region=complete),LINC01142 (oe_lof=n/a region=complete),HAUS4P1 (oe_lof=n/a region=complete),GORAB (oe_lof=0.60 region=complete),PRRX1 (oe_lof=0.26 region=complete),MROH9 (oe_lof=0.72 region=complete),FMO3 (oe_lof=1.11 region=complete),MIR1295A (oe_lof=n/a region=complete),FMO6P (oe_lof=0.63 region=complete),FMO2 (oe_lof=0.67 region=complete),FMO1 (oe_lof=0.74 region=complete),HMGB1P11 (oe_lof=n/a region=complete),FMO4 (oe_lof=0.79 region=complete),TOP1P1 (oe_lof=n/a region=complete),GM2AP2 (oe_lof=n/a region=complete),RNU6-290P (oe_lof=n/a region=complete),CYCSP53 (oe_lof=n/a region=complete),PRRC2C (oe_lof=0.07 region=complete),RN7SL425P (oe_lof=n/a region=complete),MYOC (oe_lof=0.85 region=complete),PFN1P1 (oe_lof=n/a region=complete),RPL4P3 (oe_lof=n/a region=complete),VAMP4 (oe_lof=0.30 region=complete),SCARNA20 (oe_lof=n/a region=complete),EEF1AKNMT (oe_lof=0.61 region=complete),DNM3 (oe_lof=0.30 region=complete),DNM3-IT1 (oe_lof=n/a region=complete),MIR214 (oe_lof=n/a region=complete),DNM3OS (oe_lof=n/a region=complete),MIR199A2 (oe_lof=n/a region=complete),SNORD112 (oe_lof=n/a region=complete),RNU6-157P (oe_lof=n/a region=complete),C1ORF105 (oe_lof=0.89 region=complete),PIGC (oe_lof=0.50 region=complete),SUCO (oe_lof=0.19 region=complete),RNU6-693P (oe_lof=n/a region=complete),FASLG (oe_lof=0.28 region=complete),SLC25A38P1 (oe_lof=n/a region=complete),AIMP1P2 (oe_lof=n/a region=complete),TNFSF18 (oe_lof=0.86 region=complete),GOT2P2 (oe_lof=n/a region=complete),TNFSF4 (oe_lof=0.61 region=complete),PRDX6 (oe_lof=0.87 region=complete),SLC9C2 (oe_lof=0.31 region=complete),ANKRD45 (oe_lof=0.55 region=complete),KLHL20 (oe_lof=0.30 region=complete),RN7SKP160 (oe_lof=n/a region=complete),CENPL (oe_lof=0.30 region=exonic/splicing),DARS2 (oe_lof=0.66 region=exonic/splicing)	DARS2 [HI=Gene associated with autosomal recessive phenotype PMIDS=],F5 [HI=Gene associated with autosomal recessive phenotype PMIDS=11435304,19598066],FASLG [HI=Gene associated with autosomal recessive phenotype PMIDS=],GORAB [HI=Gene associated with autosomal recessive phenotype PMIDS=]	60047 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],979302 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],997045 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Intrauterine growth retardation"]	134638_[GENE=FASLG_PHENOS=Autoimmune_lymphoproliferative_syndrome,type_IB,601859,Autosomal_dominant/Lung_cancer,susceptibility_to,211980,Autosomal_dominant,Somatic_mutation],136132_[GENE=FMO3_PHENOS=Trimethylaminuria,602079,Autosomal_recessive],167420_[GENE=PRRX1_PHENOS=Agnathia-otocephaly_complex,202650,Autosomal_dominant,Autosomal_recessive],182330_[GENE=ATP1B1_PHENOS=Blood_pressure_regulation_QTL,145500,Multifactorial],186780_[GENE=CD247_PHENOS=Immunodeficiency_25,610163,Autosomal_recessive],601652_[GENE=MYOC_PHENOS=Glaucoma_1A,primary_open_angle,137750,Autosomal_dominant],601730_[GENE=PIGC_PHENOS=Glycosylphosphatidylinositol_biosynthesis_defect_16,617816,Autosomal_recessive],603594_[GENE=TNFSF4_PHENOS=Myocardial_infarction,susceptibility_to,608446],603941_[GENE=SLC19A2_PHENOS=Thiamine-responsive_megaloblastic_anemia_syndrome,249270,Autosomal_recessive],604614_[GENE=TBX19_PHENOS=Adrenocorticotropic_hormone_deficiency,201400,Autosomal_recessive],605205_[GENE=ADCY10_PHENOS=Hypercalciuria,absorptive,susceptibility_to,143870,Autosomal_dominant],607983_[GENE=GORAB_PHENOS=Geroderma_osteodysplasticum,231070,Autosomal_recessive],610956_[GENE=DARS2_PHENOS=Leukoencephalopathy_with_brain_stem_and_spinal_cord_involvement_and_lactate_elevation,611105,Autosomal_recessive],612309_[GENE=F5_PHENOS=Pregnancy_loss,recurrent,susceptibility_to,1,614389,Autosomal_dominant/Thrombophilia,susceptibility_to,due_to_factor_V_Leiden,188055,Autosomal_dominant/Budd-Chiari_syndrome,600880,Autosomal_recessive/Thrombophilia_due_to_activated_protein_C_resistance,188055,Autosomal_dominant/Stroke,ischemic,susceptibility_to,601367,Multifactorial/Factor_V_deficiency,227400,Autosomal_recessive],617987_[GENE=EEF1AKNMT_PHENOS=Deafness,autosomal_recessive_26,modifier_of,605429,Autosomal_dominant]
chr1	183187515	183187633	trio	118	3	5	0.02862	0.083	0.000		LAMC2	LAMC2 (oe_lof=0.48 region=exonic/splicing)		393869 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60077 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	150292_[GENE=LAMC2_PHENOS=Epidermolysis_bullosa,junctional,non-Herlitz_type,226650,Autosomal_recessive/Epidermolysis_bullosa,junctional,Herlitz_type,226700,Autosomal_recessive]
chr1	183556020	183559749	trio	3729	3	3	0.12274	0.166	0.000		NCF2	NCF2 (oe_lof=0.49 region=exonic/splicing)	NCF2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	393869 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60077 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608515_[GENE=NCF2_PHENOS=Chronic_granulomatous_disease_2,autosomal_recessive,233710,Autosomal_recessive]
chr1	197113077	197115834	trio	2757	3	4	0.14065	0.217	0.000		ASPM	ASPM (oe_lof=0.63 region=exonic/splicing)	ASPM [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146109 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],565208 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	605481_[GENE=ASPM_PHENOS=Microcephaly_5,primary,autosomal_recessive,608716,Autosomal_recessive]
chr1	198691535	198691615	trio	80	1	3	0.59336	0.580	0.000		PTPRC	PTPRC (oe_lof=0.11 region=exonic/splicing)		60079 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	151460_[GENE=PTPRC_PHENOS=Severe_combined_immunodeficiency,T_cell-negative,B-cell/natural_killer-cell_positive,608971,Autosomal_recessive/Hepatitis_C_virus,susceptibility_to,609532]
chr1	201022327	201022412	trio	85	1	3	0.04961	0.089	0.000		CACNA1S	CACNA1S (oe_lof=0.39 region=exonic/splicing)		144143 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	114208_[GENE=CACNA1S_PHENOS=Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580,Autosomal_dominant/Hypokalemic_periodic_paralysis,type_1,170400,Autosomal_dominant/Malignant_hyperthermia_susceptibility_5,601887,Autosomal_dominant]
chr1	201054554	201054719	trio	165	0	14	0.01144	0.433	0.000		CACNA1S	CACNA1S (oe_lof=0.39 region=exonic/splicing)		144143 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	114208_[GENE=CACNA1S_PHENOS=Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580,Autosomal_dominant/Hypokalemic_periodic_paralysis,type_1,170400,Autosomal_dominant/Malignant_hyperthermia_susceptibility_5,601887,Autosomal_dominant]
chr1	201061090	201061252	trio	162	3	4	0.07527	0.121	0.000		CACNA1S	CACNA1S (oe_lof=0.39 region=exonic/splicing)		144143 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	114208_[GENE=CACNA1S_PHENOS=Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580,Autosomal_dominant/Hypokalemic_periodic_paralysis,type_1,170400,Autosomal_dominant/Malignant_hyperthermia_susceptibility_5,601887,Autosomal_dominant]
chr1	215813890	215814086	trio	196	3	3	0.06675	0.197	0.000		USH2A	USH2A (oe_lof=0.76 region=exonic/splicing)			608400_[GENE=USH2A_PHENOS=Usher_syndrome,type_2A,276901,Autosomal_recessive/Retinitis_pigmentosa_39,613809]
chr1	220330602	220330840	trio	238	3	4	0.01707	0.025	0.000		RAB3GAP2	RAB3GAP2 (oe_lof=0.19 region=exonic/splicing)	RAB3GAP2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	814162 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	609275_[GENE=RAB3GAP2_PHENOS=Martsolf_syndrome_1,212720,Autosomal_recessive/Warburg_micro_syndrome_2,614225,Autosomal_recessive]
chr1	220368630	220368729	trio	99	3	4	0.03348	0.025	0.000		RAB3GAP2	RAB3GAP2 (oe_lof=0.19 region=exonic/splicing)	RAB3GAP2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	814162 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	609275_[GENE=RAB3GAP2_PHENOS=Martsolf_syndrome_1,212720,Autosomal_recessive/Warburg_micro_syndrome_2,614225,Autosomal_recessive]
chr1	220445555	222988523	trio	2542968	3	10	0.00856	0.166	0.004 (0.03,0.03,0.51,0.51,0.51)		RAB3GAP2,AURKAP1,XRCC6P3,PRELID3BP1,MARK1,RN7SL464P,HDAC1P2,C1ORF115,MTARC2,MTARC1,RNU6ATAC35P,HLX-AS1,HLX,DUSP10,RNU6-403P,LINC02474,LINC01705,QRSL1P2,CICP13,RNU6-791P,HHIPL2,TAF1A,MIA3,AIDA,BROX,FAM177B	RAB3GAP2 (oe_lof=0.19 region=exonic/splicing),AURKAP1 (oe_lof=n/a region=intronic/intergenic),XRCC6P3 (oe_lof=n/a region=complete),PRELID3BP1 (oe_lof=n/a region=complete),MARK1 (oe_lof=0.21 region=complete),RN7SL464P (oe_lof=n/a region=complete),HDAC1P2 (oe_lof=n/a region=complete),C1ORF115 (oe_lof=0.69 region=complete),MTARC2 (oe_lof=0.55 region=complete),MTARC1 (oe_lof=0.80 region=complete),RNU6ATAC35P (oe_lof=n/a region=complete),HLX-AS1 (oe_lof=n/a region=complete),HLX (oe_lof=0.13 region=complete),DUSP10 (oe_lof=0.14 region=complete),RNU6-403P (oe_lof=n/a region=complete),LINC02474 (oe_lof=n/a region=complete),LINC01705 (oe_lof=n/a region=complete),QRSL1P2 (oe_lof=n/a region=complete),CICP13 (oe_lof=n/a region=complete),RNU6-791P (oe_lof=n/a region=complete),HHIPL2 (oe_lof=1.12 region=complete),TAF1A (oe_lof=0.67 region=complete),MIA3 (oe_lof=0.25 region=complete),AIDA (oe_lof=0.50 region=complete),BROX (oe_lof=0.73 region=complete),FAM177B (oe_lof=0.88 region=complete)	RAB3GAP2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146329 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],146516 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],687736 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814162 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979934 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	609275_[GENE=RAB3GAP2_PHENOS=Martsolf_syndrome_1,212720,Autosomal_recessive/Warburg_micro_syndrome_2,614225,Autosomal_recessive],613455_[GENE=MIA3_PHENOS=Ondontochondrodysplasia_2_with_hearing_loss_and_diabetes,619269,Autosomal_recessive]
chr1	225609769	225616567	trio	6798	3	9	0.00888	0.102	0.000		LBR	LBR (oe_lof=0.24 region=exonic/splicing)	LBR [HI=Gene associated with autosomal recessive phenotype PMIDS=]	155156 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58542 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600024_[GENE=LBR_PHENOS=Pelger-Huet_anomaly,169400,Autosomal_dominant/Pelger-Huet_anomaly_with_mild_skeletal_anomalies,618019/Reynolds_syndrome,613471,Autosomal_dominant/Greenberg_skeletal_dysplasia,215140,Autosomal_recessive]
chr1	231376909	231377212	trio	303	4	25	0.00000	0.178	0.000		C1ORF131,GNPAT	C1ORF131 (oe_lof=1.12 region=intronic/intergenic),GNPAT (oe_lof=0.23 region=exonic/splicing)			602744_[GENE=GNPAT_PHENOS=Rhizomelic_chondrodysplasia_punctata,type_2,222765,Autosomal_recessive]
chr1	235530718	235530877	trio	159	4	12	0.00107	0.146	0.000		TBCE	TBCE (oe_lof=0.54 region=intronic/intergenic)	TBCE [HI=Gene associated with autosomal recessive phenotype PMIDS=]	625533 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],625534 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814181 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	604934_[GENE=TBCE_PHENOS=Kenny-Caffey_syndrome,type_1,244460,Autosomal_recessive/Hypoparathyroidism-retardation-dysmorphism_syndrome,241410,Autosomal_recessive/Encephalopathy,progressive,with_amyotrophy_and_optic_atrophy,617207,Autosomal_recessive]
chr1	235964161	235964407	trio	246	3	4	0.02753	0.013	0.000		LYST	LYST (oe_lof=0.24 region=exonic/splicing)	LYST [HI=Gene associated with autosomal recessive phenotype PMIDS=]	147606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625533 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],625534 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814181 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	606897_[GENE=LYST_PHENOS=Chediak-Higashi_syndrome,214500,Autosomal_recessive]
chr1	235967794	235967975	trio	181	3	4	0.05685	0.178	0.000		LYST	LYST (oe_lof=0.24 region=exonic/splicing)	LYST [HI=Gene associated with autosomal recessive phenotype PMIDS=]	147606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625533 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],625534 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814181 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	606897_[GENE=LYST_PHENOS=Chediak-Higashi_syndrome,214500,Autosomal_recessive]
chr1	236958571	236959047	trio	476	3	7	0.01665	0.146	0.000		MTR	MTR (oe_lof=0.46 region=exonic/splicing)	MTR [HI=Gene associated with autosomal recessive phenotype PMIDS=]	147606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625533 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],625534 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814181 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	156570_[GENE=MTR_PHENOS=Neural_tube_defects,folate-sensitive,susceptibility_to,601634,Autosomal_recessive/Homocystinuria-megaloblastic_anemia,cblG_complementation_type,250940,Autosomal_recessive]
chr2	1520645	1520764	trio	119	3	5	0.02540	0.140	0.000		TPO	TPO (oe_lof=0.84 region=exonic/splicing)		144454 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146223 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146260 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147583 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148175 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148892 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],152339 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],152440 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],152888 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153475 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154668 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154817 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396625 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Mental retardation, autosomal dominant 39"],562667 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60104 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],686001 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688279 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814206 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979986 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	606765_[GENE=TPO_PHENOS=Thyroid_dyshormonogenesis_2A,274500,Autosomal_recessive]
chr2	25391357	25391569	trio	212	1	6	0.01768	0.102	0.000		POMC	POMC (oe_lof=0.74 region=intronic/intergenic)			176830_[GENE=POMC_PHENOS=Obesity,early-onset,susceptibility_to,601665,Autosomal_dominant,Autosomal_recessive,Multifactorial/Obesity,adrenal_insufficiency,and_red_hair_due_to_POMC_deficiency,609734,Autosomal_recessive]
chr2	26507741	26507835	trio	94	1	3	0.02518	0.032	0.000		HADHB	HADHB (oe_lof=0.72 region=exonic/splicing)			143450_[GENE=HADHB_PHENOS=Trifunctional_protein_deficiency,609015,Autosomal_recessive]
chr2	26508265	26508449	trio	184	3	4	0.04952	0.236	0.000		HADHB	HADHB (oe_lof=0.72 region=exonic/splicing)			143450_[GENE=HADHB_PHENOS=Trifunctional_protein_deficiency,609015,Autosomal_recessive]
chr2	27535851	27545399	trio	9548	3	7	0.01920	0.115	0.000		UCN,MPV17,GTF3C2	UCN (oe_lof=0.00 region=intronic/intergenic),MPV17 (oe_lof=1.20 region=exonic/splicing),GTF3C2 (oe_lof=0.17 region=intronic/intergenic)			137960_[GENE=MPV17_PHENOS=Charcot-Marie-Tooth_disease,axonal,type_2EE,618400,Autosomal_recessive/Mitochondrial_DNA_depletion_syndrome_6_(hepatocerebral_type),256810,Autosomal_recessive]
chr2	27590603	27591016	trio	413	3	7	0.00780	0.038	0.000		EIF2B4,SNX17	EIF2B4 (oe_lof=0.14 region=exonic/splicing),SNX17 (oe_lof=0.34 region=intronic/intergenic)			606687_[GENE=EIF2B4_PHENOS=Ovarioleukodystrophy,603896,Autosomal_recessive/Leukoencephalopathy_with_vanishing_white_matter,603896,Autosomal_recessive]
chr2	27591863	27593334	trio	1471	4	4	0.10112	0.210	0.000		EIF2B4,SNX17	EIF2B4 (oe_lof=0.14 region=exonic/splicing),SNX17 (oe_lof=0.34 region=intronic/intergenic)			606687_[GENE=EIF2B4_PHENOS=Ovarioleukodystrophy,603896,Autosomal_recessive/Leukoencephalopathy_with_vanishing_white_matter,603896,Autosomal_recessive]
chr2	31805680	31806050	trio	370	1	6	0.02829	0.140	0.000		SRD5A2	SRD5A2 (oe_lof=n/a region=exonic/splicing)	SRD5A2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	562660 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60107 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60108 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625673 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency"]	607306_[GENE=SRD5A2_PHENOS=Pseudovaginal_perineoscrotal_hypospadias,264600,Autosomal_recessive]
chr2	32361936	32362267	trio	331	3	2	0.07551	0.045	0.000		SPAST	SPAST (oe_lof=0.09 region=exonic/splicing)	SPAST [HI=Sufficient evidence for dosage pathogenicity PMIDS=24690193,28572275,15667412]	562660 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60108 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625542 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],685336 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979970 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	604277_[GENE=SPAST_PHENOS=Spastic_paraplegia_4,autosomal_dominant,182601,Autosomal_dominant]
chr2	44139561	44139707	trio	146	3	3	0.07178	0.191	0.000		LRPPRC	LRPPRC (oe_lof=0.39 region=exonic/splicing)	LRPPRC [HI=Gene associated with autosomal recessive phenotype PMIDS=]	442534 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	607544_[GENE=LRPPRC_PHENOS=Mitochondrial_complex_IV_deficiency,nuclear_type_5,(French-Canadian),220111,Autosomal_recessive]
chr2	45169027	45170059	trio	1032	1	4	0.03262	0.025	0.000		SIX3-AS1,SIX3	SIX3-AS1 (oe_lof=n/a region=exonic/splicing),SIX3 (oe_lof=0.00 region=exonic/splicing)	SIX3 [HI=Sufficient evidence for dosage pathogenicity PMIDS=19346217,20157829,20531442]	393873 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	603714_[GENE=SIX3_PHENOS=Schizencephaly,269160/Holoprosencephaly_2,157170,Autosomal_dominant]
chr2	58456939	61244996	trio	2788057	3	8	0.02479	0.217	0.003 (0.10,0.10)	2p15-16.1 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/70]	FANCL,EIF3FP3,LINC01122,RNU6-508P,RNA5SP94,RNU1-32P,MIR4432,BCL11A,RN7SL361P,RNU6-612P,ATP1B3P1,PAPOLG,RN7SL632P,REL,RNU4-51P,NONOP2,PUS10,RNA5SP95,PEX13	FANCL (oe_lof=1.20 region=exonic/splicing),EIF3FP3 (oe_lof=n/a region=complete),LINC01122 (oe_lof=n/a region=complete),RNU6-508P (oe_lof=n/a region=complete),RNA5SP94 (oe_lof=n/a region=complete),RNU1-32P (oe_lof=n/a region=complete),MIR4432 (oe_lof=n/a region=complete),BCL11A (oe_lof=0.12 region=complete),RN7SL361P (oe_lof=n/a region=complete),RNU6-612P (oe_lof=n/a region=complete),ATP1B3P1 (oe_lof=n/a region=complete),PAPOLG (oe_lof=0.13 region=complete),RN7SL632P (oe_lof=n/a region=complete),REL (oe_lof=0.07 region=complete),RNU4-51P (oe_lof=n/a region=complete),NONOP2 (oe_lof=n/a region=complete),PUS10 (oe_lof=0.74 region=exonic/splicing),RNA5SP95 (oe_lof=n/a region=complete),PEX13 (oe_lof=0.58 region=exonic/splicing)	BCL11A [HI=Sufficient evidence for dosage pathogenicity PMIDS=27453576,25938782,25979662]	1220531 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Intellectual developmental disorder with persistence of fetal hemoglobin"],1220532 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Intellectual developmental disorder with persistence of fetal hemoglobin"],147996 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150334 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155243 [CN_TYPE=loss CN=0 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396354 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],523277 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Global developmental delay;Generalized hypotonia;Macrocephalus"],562595 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57148 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60147 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60178 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],689038 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	601789_[GENE=PEX13_PHENOS=Peroxisome_biogenesis_disorder_11A_(Zellweger),614883,Autosomal_recessive/Peroxisome_biogenesis_disorder_11B,614885,Autosomal_recessive],606557_[GENE=BCL11A_PHENOS=Dias-Logan_syndrome,617101,Autosomal_dominant],608111_[GENE=FANCL_PHENOS=Fanconi_anemia,complementation_group_L,614083,Autosomal_recessive]
chr2	69581611	69581710	trio	99	3	4	0.01920	0.019	0.000		GFPT1	GFPT1 (oe_lof=0.19 region=exonic/splicing)		625545 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	138292_[GENE=GFPT1_PHENOS=Myasthenia,congenital,12,with_tubular_aggregates,610542,Autosomal_recessive]
chr2	71801318	71801511	trio	193	1	5	0.00964	0.051	0.000		DYSF	DYSF (oe_lof=0.60 region=exonic/splicing)			603009_[GENE=DYSF_PHENOS=Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601,Autosomal_recessive/Miyoshi_muscular_dystrophy_1,254130,Autosomal_recessive/Myopathy,distal,with_anterior_tibial_onset,606768,Autosomal_recessive]
chr2	74153943	74154189	trio	246	3	5	0.02450	0.197	0.000		DGUOK	DGUOK (oe_lof=0.74 region=exonic/splicing)			601465_[GENE=DGUOK_PHENOS=Portal_hypertension,noncirrhotic,1,617068,Autosomal_recessive/Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_recessive_4,617070,Autosomal_recessive/Mitochondrial_DNA_depletion_syndrome_3_(hepatocerebral_type),251880,Autosomal_recessive]
chr2	74589767	74590564	trio	797	3	5	0.08600	0.038	0.000		DCTN1	DCTN1 (oe_lof=0.24 region=exonic/splicing)			601143_[GENE=DCTN1_PHENOS=Neuronopathy,distal_hereditary_motor,type_VIIB,607641,Autosomal_dominant/Perry_syndrome,168605,Autosomal_dominant/Amyotrophic_lateral_sclerosis,susceptibility_to,105400,Autosomal_dominant,Autosomal_recessive]
chr2	74691613	74691859	trio	246	3	4	0.04254	0.076	0.000		WBP1,MOGS	WBP1 (oe_lof=0.87 region=intronic/intergenic),MOGS (oe_lof=0.66 region=exonic/splicing)		155389 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	601336_[GENE=MOGS_PHENOS=Congenital_disorder_of_glycosylation,type_IIb,606056,Autosomal_recessive]
chr2	84676763	84686596	trio	9833	3	7	0.10226	0.096	0.000		SUCLG1	SUCLG1 (oe_lof=0.49 region=exonic/splicing)	SUCLG1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		611224_[GENE=SUCLG1_PHENOS=Mitochondrial_DNA_depletion_syndrome_9_(encephalomyopathic_type_with_methylmalonic_aciduria),245400,Autosomal_recessive]
chr2	97213129	97213264	trio	135	3	17	0.00039	0.096	0.000		ARID5A	ARID5A (oe_lof=0.11 region=exonic/splicing)		1047904 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Cleft lip;Intrauterine growth retardation"],144712 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146017 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154733 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394206 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="See cases"],443435 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],562641 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57434 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57543 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],638119 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],687873 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],929311 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	
chr2	99179918	99181236	trio	1318	3	8	0.03283	0.083	0.000		INPP4A	INPP4A (oe_lof=0.13 region=exonic/splicing)		150339 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],394206 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr2	109367710	109368169	trio	459	3	7	0.02518	0.153	0.000		RANBP2	RANBP2 (oe_lof=0.09 region=exonic/splicing)		562633 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],562663 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57544 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625546 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814292 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	601181_[GENE=RANBP2_PHENOS=Encephalopathy,acute,infection-induced,3,susceptibility_to,608033,Autosomal_dominant]
chr2	109522754	109527316	trio	4562	1	3	0.04579	0.089	0.000		EDAR	EDAR (oe_lof=0.57 region=exonic/splicing)		1012467 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],562633 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],562663 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57544 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625546 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814292 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	604095_[GENE=EDAR_PHENOS=Hair_morphology_1,hair_thickness,612630/Ectodermal_dysplasia_10A,hypohidrotic/hair/nail_type,autosomal_dominant,129490,Autosomal_dominant/Ectodermal_dysplasia_10B,hypohidrotic/hair/tooth_type,autosomal_recessive,224900,Autosomal_recessive]
chr2	110926019	110926140	trio	121	3	4	0.04579	0.217	0.000		NPHP1	NPHP1 (oe_lof=0.73 region=exonic/splicing)	NPHP1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	1179110 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Senior-Loken syndrome 1;Joubert syndrome 4;Nephronophthisis 1"],1179212 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Senior-Loken syndrome 1;Joubert syndrome 4;Nephronophthisis 1"],152160 [CN_TYPE=loss CN=0 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253441 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32789 [CN_TYPE=loss CN=0 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395867 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],431747 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Bardet-Biedl syndrome"],562663 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57545 [CN_TYPE=loss CN=0 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625547 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Hereditary liability to pressure palsies"],625824 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Nephronophthisis 1"],684897 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684918 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684957 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684959 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684979 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684994 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685019 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685033 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685081 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685113 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685227 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685287 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685293 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685377 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685385 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685550 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685660 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685776 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685780 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686045 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686159 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686284 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686286 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686491 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686519 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686535 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686693 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686694 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686788 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686813 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686846 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686879 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687024 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687266 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687438 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687693 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687719 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687838 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688040 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688048 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688135 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688273 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688339 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688420 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688437 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688488 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688532 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688679 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688757 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688818 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688863 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688954 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689037 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689104 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689116 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689121 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689185 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689227 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689233 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689244 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689300 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689331 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607100_[GENE=NPHP1_PHENOS=Joubert_syndrome_4,609583,Autosomal_recessive/Nephronophthisis_1,juvenile,256100,Autosomal_recessive/Senior-Loken_syndrome-1,266900,Autosomal_recessive]
chr2	110962467	110962649	trio	182	4	8	0.01429	0.236	0.000		NPHP1	NPHP1 (oe_lof=0.73 region=exonic/splicing)	NPHP1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	1179110 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Senior-Loken syndrome 1;Joubert syndrome 4;Nephronophthisis 1"],1179212 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Senior-Loken syndrome 1;Joubert syndrome 4;Nephronophthisis 1"],152160 [CN_TYPE=loss CN=0 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253441 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32789 [CN_TYPE=loss CN=0 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395867 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],431747 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Bardet-Biedl syndrome"],562663 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57545 [CN_TYPE=loss CN=0 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625547 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Hereditary liability to pressure palsies"],625824 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Nephronophthisis 1"],684897 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684918 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684957 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684959 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684979 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684994 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685019 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685033 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685081 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685113 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685227 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685287 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685293 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685377 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685385 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685550 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685660 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685776 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685780 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686045 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686159 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686284 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686286 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686491 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686519 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686535 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686693 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686694 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686788 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686813 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686846 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686879 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687024 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687266 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687438 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687693 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687719 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687838 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688040 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688048 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688135 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688273 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688339 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688420 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688437 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688488 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688532 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688679 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688757 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688818 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688863 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688954 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689037 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689104 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689116 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689121 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689185 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689227 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689233 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689244 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689300 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689331 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607100_[GENE=NPHP1_PHENOS=Joubert_syndrome_4,609583,Autosomal_recessive/Nephronophthisis_1,juvenile,256100,Autosomal_recessive/Senior-Loken_syndrome-1,266900,Autosomal_recessive]
chr2	113885128	113887251	trio	2123	3	3	0.09143	0.191	0.000		IL1RN	IL1RN (oe_lof=0.40 region=exonic/splicing)		686299 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980470 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	147679_[GENE=IL1RN_PHENOS=Gastric_cancer_risk_after_H._pylori_infection,137215,Autosomal_dominant/Microvascular_complications_of_diabetes_4,612628/Interleukin_1_receptor_antagonist_deficiency,612852,Autosomal_recessive]
chr2	152422220	152422344	trio	124	3	3	0.03908	0.006	0.000		NEB	NEB (oe_lof=0.37 region=exonic/splicing)		396507 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],562665 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	161650_[GENE=NEB_PHENOS=Nemaline_myopathy_2,autosomal_recessive,256030,Autosomal_recessive/Arthrogryposis_multiplex_congenita_6,619334,Autosomal_recessive]
chr2	152437301	152437428	trio	127	3	5	0.03348	0.268	0.000		NEB	NEB (oe_lof=0.37 region=exonic/splicing)		396507 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],562665 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],688549 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	161650_[GENE=NEB_PHENOS=Nemaline_myopathy_2,autosomal_recessive,256030,Autosomal_recessive/Arthrogryposis_multiplex_congenita_6,619334,Autosomal_recessive]
chr2	152458405	152458532	trio	127	3	5	0.03429	0.261	0.000		NEB	NEB (oe_lof=0.37 region=exonic/splicing)		396507 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],562665 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],688549 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	161650_[GENE=NEB_PHENOS=Nemaline_myopathy_2,autosomal_recessive,256030,Autosomal_recessive/Arthrogryposis_multiplex_congenita_6,619334,Autosomal_recessive]
chr2	152463110	152464132	trio	1022	3	3	0.16914	0.280	1.000 (0.29,0.29)		NEB	NEB (oe_lof=0.37 region=exonic/splicing)		396507 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],562665 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],688549 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	161650_[GENE=NEB_PHENOS=Nemaline_myopathy_2,autosomal_recessive,256030,Autosomal_recessive/Arthrogryposis_multiplex_congenita_6,619334,Autosomal_recessive]
chr2	152521837	152522063	trio	226	1	5	0.03700	0.331	0.000		NEB	NEB (oe_lof=0.37 region=exonic/splicing)		396507 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],562665 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	161650_[GENE=NEB_PHENOS=Nemaline_myopathy_2,autosomal_recessive,256030,Autosomal_recessive/Arthrogryposis_multiplex_congenita_6,619334,Autosomal_recessive]
chr2	152590902	152591011	trio	109	3	5	0.03052	0.172	0.000		NEB	NEB (oe_lof=0.37 region=intronic/intergenic)		396507 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],562665 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	161650_[GENE=NEB_PHENOS=Nemaline_myopathy_2,autosomal_recessive,256030,Autosomal_recessive/Arthrogryposis_multiplex_congenita_6,619334,Autosomal_recessive]
chr2	152739755	152739894	trio	139	3	4	0.02613	0.032	0.000		CACNB4	CACNB4 (oe_lof=0.28 region=exonic/splicing)		396507 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],562665 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	601949_[GENE=CACNB4_PHENOS=Epilepsy,juvenile_myoclonic,susceptibility_to,6,607682,Autosomal_dominant/Episodic_ataxia,type_5,613855,Autosomal_dominant/Epilepsy,idiopathic_generalized,susceptibility_to,9,607682,Autosomal_dominant]
chr2	166854538	166854695	trio	157	1	4	0.03109	0.344	0.000		SCN1A	SCN1A (oe_lof=0.02 region=exonic/splicing)	SCN1A [HI=Sufficient evidence for dosage pathogenicity PMIDS=11359211,11940708,18930999]	144471 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153359 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154605 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155321 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253421 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253464 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253660 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395863 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442396 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442551 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442768 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],493569 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],60245 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685770 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],813324 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Severe myoclonic epilepsy in infancy"],813715 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Microcephaly"],814342 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	182389_[GENE=SCN1A_PHENOS=Developmental_and_epileptic_encephalopathy_6B,non-Dravet,619317,Autosomal_dominant/Migraine,familial_hemiplegic,3,609634,Autosomal_dominant/Dravet_syndrome,607208,Autosomal_dominant/Febrile_seizures,familial,3A,604403,Autosomal_dominant/Generalized_epilepsy_with_febrile_seizures_plus,type_2,604403,Autosomal_dominant]
chr2	167232197	167232507	trio	310	3	8	0.00816	0.102	0.000		SCN9A	SCN9A (oe_lof=0.55 region=intronic/intergenic)		144471 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154605 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155321 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395863 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442396 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442551 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442768 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],493569 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],60245 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],813324 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Severe myoclonic epilepsy in infancy"],814342 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	603415_[GENE=SCN9A_PHENOS=Erythermalgia,primary,133020,Autosomal_dominant/Insensitivity_to_pain,congenital,243000,Autosomal_recessive/Small_fiber_neuropathy,133020,Autosomal_dominant/Paroxysmal_extreme_pain_disorder,167400,Autosomal_dominant/Neuropathy,hereditary_sensory_and_autonomic,type_IID,243000,Autosomal_recessive]
chr2	170151100	170151230	trio	130	3	4	0.03272	0.121	0.000		LRP2	LRP2 (oe_lof=0.20 region=exonic/splicing)	LRP2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	187824 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	600073_[GENE=LRP2_PHENOS=Donnai-Barrow_syndrome,222448,Autosomal_recessive]
chr2	173330257	173330401	trio	144	3	6	0.02334	0.178	0.000		ITGA6,ITGA6-AS1	ITGA6 (oe_lof=0.37 region=exonic/splicing),ITGA6-AS1 (oe_lof=n/a region=exonic/splicing)		58766 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	147556_[GENE=ITGA6_PHENOS=Epidermolysis_bullosa,junctional,with_pyloric_stenosis,226730,Autosomal_recessive]
chr2	179484705	179484849	trio	144	3	7	0.01240	0.045	0.000		TTN-AS1,TTN	TTN-AS1 (oe_lof=n/a region=exonic/splicing),TTN (oe_lof=0.33 region=exonic/splicing)		625774 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Myopathy, myofibrillar, 9, with early respiratory failure"]	188840_[GENE=TTN_PHENOS=Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807,Autosomal_recessive/Cardiomyopathy,familial_hypertrophic,9,613765,Autosomal_dominant/Tibial_muscular_dystrophy,tardive,600334,Autosomal_dominant/Salih_myopathy,611705,Autosomal_recessive/Cardiomyopathy,dilated,1G,604145/Myopathy,myofibrillar,9,with_early_respiratory_failure,603689,Autosomal_dominant]
chr2	179546093	179546475	trio	382	3	3	0.12474	0.242	0.000		TTN-AS1,TTN	TTN-AS1 (oe_lof=n/a region=intronic/intergenic),TTN (oe_lof=0.33 region=exonic/splicing)		625774 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Myopathy, myofibrillar, 9, with early respiratory failure"]	188840_[GENE=TTN_PHENOS=Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807,Autosomal_recessive/Cardiomyopathy,familial_hypertrophic,9,613765,Autosomal_dominant/Tibial_muscular_dystrophy,tardive,600334,Autosomal_dominant/Salih_myopathy,611705,Autosomal_recessive/Cardiomyopathy,dilated,1G,604145/Myopathy,myofibrillar,9,with_early_respiratory_failure,603689,Autosomal_dominant]
chr2	179548716	179549486	trio	770	3	4	0.07967	0.108	0.000		TTN-AS1,TTN	TTN-AS1 (oe_lof=n/a region=intronic/intergenic),TTN (oe_lof=0.33 region=exonic/splicing)		625774 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Myopathy, myofibrillar, 9, with early respiratory failure"]	188840_[GENE=TTN_PHENOS=Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807,Autosomal_recessive/Cardiomyopathy,familial_hypertrophic,9,613765,Autosomal_dominant/Tibial_muscular_dystrophy,tardive,600334,Autosomal_dominant/Salih_myopathy,611705,Autosomal_recessive/Cardiomyopathy,dilated,1G,604145/Myopathy,myofibrillar,9,with_early_respiratory_failure,603689,Autosomal_dominant]
chr2	179556733	179558745	trio	2012	3	7	0.10082	0.229	0.000		TTN-AS1,TTN	TTN-AS1 (oe_lof=n/a region=intronic/intergenic),TTN (oe_lof=0.33 region=exonic/splicing)		625774 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Myopathy, myofibrillar, 9, with early respiratory failure"]	188840_[GENE=TTN_PHENOS=Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807,Autosomal_recessive/Cardiomyopathy,familial_hypertrophic,9,613765,Autosomal_dominant/Tibial_muscular_dystrophy,tardive,600334,Autosomal_dominant/Salih_myopathy,611705,Autosomal_recessive/Cardiomyopathy,dilated,1G,604145/Myopathy,myofibrillar,9,with_early_respiratory_failure,603689,Autosomal_dominant]
chr2	179566885	179566982	trio	97	3	4	0.04030	0.057	0.000		TTN-AS1,TTN	TTN-AS1 (oe_lof=n/a region=intronic/intergenic),TTN (oe_lof=0.33 region=exonic/splicing)		625774 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Myopathy, myofibrillar, 9, with early respiratory failure"]	188840_[GENE=TTN_PHENOS=Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807,Autosomal_recessive/Cardiomyopathy,familial_hypertrophic,9,613765,Autosomal_dominant/Tibial_muscular_dystrophy,tardive,600334,Autosomal_dominant/Salih_myopathy,611705,Autosomal_recessive/Cardiomyopathy,dilated,1G,604145/Myopathy,myofibrillar,9,with_early_respiratory_failure,603689,Autosomal_dominant]
chr2	179571579	179571691	trio	112	3	4	0.03360	0.032	0.000		TTN-AS1,TTN	TTN-AS1 (oe_lof=n/a region=intronic/intergenic),TTN (oe_lof=0.33 region=exonic/splicing)		625774 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Myopathy, myofibrillar, 9, with early respiratory failure"]	188840_[GENE=TTN_PHENOS=Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807,Autosomal_recessive/Cardiomyopathy,familial_hypertrophic,9,613765,Autosomal_dominant/Tibial_muscular_dystrophy,tardive,600334,Autosomal_dominant/Salih_myopathy,611705,Autosomal_recessive/Cardiomyopathy,dilated,1G,604145/Myopathy,myofibrillar,9,with_early_respiratory_failure,603689,Autosomal_dominant]
chr2	179584271	179584569	trio	298	3	4	0.03391	0.045	0.000		TTN-AS1,TTN	TTN-AS1 (oe_lof=n/a region=intronic/intergenic),TTN (oe_lof=0.33 region=exonic/splicing)		625774 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Myopathy, myofibrillar, 9, with early respiratory failure"]	188840_[GENE=TTN_PHENOS=Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807,Autosomal_recessive/Cardiomyopathy,familial_hypertrophic,9,613765,Autosomal_dominant/Tibial_muscular_dystrophy,tardive,600334,Autosomal_dominant/Salih_myopathy,611705,Autosomal_recessive/Cardiomyopathy,dilated,1G,604145/Myopathy,myofibrillar,9,with_early_respiratory_failure,603689,Autosomal_dominant]
chr2	190444529	190445547	trio	1018	3	9	0.00856	0.127	0.000		SLC40A1	SLC40A1 (oe_lof=0.11 region=exonic/splicing)		146486 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604653_[GENE=SLC40A1_PHENOS=Hemochromatosis,type_4,606069,Autosomal_dominant]
chr2	191843572	191843737	trio	165	3	3	0.10493	0.191	0.000		STAT1	STAT1 (oe_lof=0.08 region=exonic/splicing)			600555_[GENE=STAT1_PHENOS=Immunodeficiency_31C,chronic_mucocutaneous_candidiasis,autosomal_dominant,614162,Autosomal_dominant/Immunodeficiency_31A,mycobacteriosis,autosomal_dominant,614892,Autosomal_dominant/Immunodeficiency_31B,mycobacterial_and_viral_infections,autosomal_recessive,613796,Autosomal_recessive]
chr2	191848358	191849129	trio	771	3	3	0.07551	0.153	0.000		STAT1	STAT1 (oe_lof=0.08 region=exonic/splicing)			600555_[GENE=STAT1_PHENOS=Immunodeficiency_31C,chronic_mucocutaneous_candidiasis,autosomal_dominant,614162,Autosomal_dominant/Immunodeficiency_31A,mycobacteriosis,autosomal_dominant,614892,Autosomal_dominant/Immunodeficiency_31B,mycobacterial_and_viral_infections,autosomal_recessive,613796,Autosomal_recessive]
chr2	198363389	198363584	trio	195	3	3	0.09902	0.236	0.000	2q33.1 deletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/51]	HSPD1,HSPE1,HSPE1-MOB4	HSPD1 (oe_lof=0.09 region=exonic/splicing),HSPE1 (oe_lof=0.00 region=intronic/intergenic),HSPE1-MOB4 (oe_lof=0.07 region=intronic/intergenic)		146362 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154446 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253668 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57395 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],689171 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Chromosome 2q32-q33 deletion syndrome"]	118190_[GENE=HSPD1_PHENOS=Spastic_paraplegia_13,autosomal_dominant,605280,Autosomal_dominant/Leukodystrophy,hypomyelinating,4,612233,Autosomal_recessive]
chr2	202568835	202569336	trio	501	3	3	0.08833	0.076	0.000	2q33.1 deletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/51]	ALS2	ALS2 (oe_lof=0.39 region=exonic/splicing)	ALS2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146362 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],147402 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58816 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58817 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	606352_[GENE=ALS2_PHENOS=Primary_lateral_sclerosis,juvenile,606353,Autosomal_recessive/Spastic_paralysis,infantile_onset_ascending,607225,Autosomal_recessive/Amyotrophic_lateral_sclerosis_2,juvenile,205100,Autosomal_recessive]
chr2	204822512	204822616	trio	104	3	4	0.02287	0.051	0.000	2q33.1 deletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/51]	ICOS	ICOS (oe_lof=0.40 region=exonic/splicing)		147740 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],187825 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	604558_[GENE=ICOS_PHENOS=Immunodeficiency,common_variable,1,607594,Autosomal_recessive]
chr2	207023810	207024253	trio	443	3	6	0.01152	0.146	0.000		NDUFS1,EEF1B2,SNORD51,SNORA41	NDUFS1 (oe_lof=0.57 region=exonic/splicing),EEF1B2 (oe_lof=0.33 region=intronic/intergenic),SNORD51 (oe_lof=n/a region=intronic/intergenic),SNORA41 (oe_lof=n/a region=intronic/intergenic)		150331 [CN_TYPE=gain CN=4 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	157655_[GENE=NDUFS1_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_5,618226,Autosomal_recessive]
chr2	207636895	207637054	trio	159	3	3	0.03215	0.032	0.000		FASTKD2	FASTKD2 (oe_lof=0.48 region=exonic/splicing)		59163 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	612322_[GENE=FASTKD2_PHENOS=Combined_oxidative_phosphorylation_deficiency_44,618855,Autosomal_recessive]
chr2	211057518	211060072	trio	2554	3	8	0.05752	0.134	0.000		ACADL	ACADL (oe_lof=0.81 region=exonic/splicing)		150477 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr2	211069295	211069416	trio	121	3	3	0.07659	0.134	0.000		ACADL	ACADL (oe_lof=0.81 region=exonic/splicing)		150477 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr2	211085361	211090225	trio	4864	3	4	0.07833	0.146	0.000		ACADL	ACADL (oe_lof=0.81 region=exonic/splicing)		150477 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr2	217339982	217340184	trio	202	3	7	0.01282	0.108	0.000		SMARCAL1	SMARCAL1 (oe_lof=0.41 region=exonic/splicing)		816573 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	606622_[GENE=SMARCAL1_PHENOS=Schimke_immunoosseous_dysplasia,242900,Autosomal_recessive]
chr2	227896854	227912275	trio	15421	3	12	0.15389	0.261	0.000		COL4A4	COL4A4 (oe_lof=0.47 region=exonic/splicing)		980012 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120131_[GENE=COL4A4_PHENOS=Hematuria,familial_benign,141200,Autosomal_dominant/Alport_syndrome_2,autosomal_recessive,203780,Autosomal_recessive]
chr2	227920651	227924969	trio	4318	3	8	0.14491	0.248	0.000		COL4A4	COL4A4 (oe_lof=0.47 region=exonic/splicing)		980012 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120131_[GENE=COL4A4_PHENOS=Hematuria,familial_benign,141200,Autosomal_dominant/Alport_syndrome_2,autosomal_recessive,203780,Autosomal_recessive]
chr2	227973930	227983487	trio	9557	3	10	0.03626	0.146	0.000		COL4A4	COL4A4 (oe_lof=0.47 region=exonic/splicing)		980012 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120131_[GENE=COL4A4_PHENOS=Hematuria,familial_benign,141200,Autosomal_dominant/Alport_syndrome_2,autosomal_recessive,203780,Autosomal_recessive]
chr2	228135476	228137843	trio	2367	3	5	0.11354	0.223	0.000		COL4A3	COL4A3 (oe_lof=0.40 region=exonic/splicing)	COL4A3 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	980012 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120070_[GENE=COL4A3_PHENOS=Hematuria,benign_familial,141200,Autosomal_dominant/Alport_syndrome_3,autosomal_dominant,104200,Autosomal_dominant/Alport_syndrome_2,autosomal_recessive,203780,Autosomal_recessive]
chr2	233398631	233398855	trio	224	3	5	0.02442	0.083	0.000		CHRND	CHRND (oe_lof=0.65 region=exonic/splicing)		144230 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395854 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	100720_[GENE=CHRND_PHENOS=Myasthenic_syndrome,congenital,3C,associated_with_acetylcholine_receptor_deficiency,616323,Autosomal_recessive/Multiple_pterygium_syndrome,lethal_type,253290,Autosomal_recessive/Myasthenic_syndrome,congenital,3B,fast-channel,616322,Autosomal_recessive/Myasthenic_syndrome,congenital,3A,slow-channel,616321,Autosomal_dominant]
chr2	238261155	238262056	trio	901	3	8	0.02968	0.229	0.000		COL6A3	COL6A3 (oe_lof=0.45 region=exonic/splicing)		147368 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148764 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397079 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562662 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	120250_[GENE=COL6A3_PHENOS=Ullrich_congenital_muscular_dystrophy_1,254090,Autosomal_dominant,Autosomal_recessive/Dystonia_27,616411,Autosomal_recessive/Bethlem_myopathy_1,158810,Autosomal_dominant,Autosomal_recessive]
chr2	240024462	240024602	trio	140	3	7	0.01571	0.191	0.000	2q37 monosomy [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/44]	HDAC4	HDAC4 (oe_lof=0.00 region=exonic/splicing)	HDAC4 [HI=Little evidence for dosage pathogenicity PMIDS=20691407]	144177 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147368 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148764 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151032 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],187820 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397079 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442661 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562659 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562662 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57432 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58885 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59178 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625780 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Chromosome 2q37 deletion syndrome"],625781 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 2q37 deletion syndrome"],638101 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814377 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],997054 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Poland anomaly"]	
chr2	240048142	240048385	trio	243	1	6	0.01757	0.070	0.000	2q37 monosomy [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/44]	HDAC4	HDAC4 (oe_lof=0.00 region=exonic/splicing)	HDAC4 [HI=Little evidence for dosage pathogenicity PMIDS=20691407]	144177 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147368 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148764 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151032 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],187820 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397079 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442661 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562659 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562662 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57432 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58885 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59178 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625780 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Chromosome 2q37 deletion syndrome"],625781 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 2q37 deletion syndrome"],638101 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814377 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],997054 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Poland anomaly"]	
chr2	240098099	240111783	trio	13684	1	13	0.01330	0.070	0.000	2q37 monosomy [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/44]	HDAC4	HDAC4 (oe_lof=0.00 region=exonic/splicing)	HDAC4 [HI=Little evidence for dosage pathogenicity PMIDS=20691407]	144177 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147368 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148764 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151032 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],187820 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397079 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442661 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562657 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562659 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562662 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57432 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58885 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59178 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625780 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Chromosome 2q37 deletion syndrome"],625781 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 2q37 deletion syndrome"],638101 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814377 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],997054 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Poland anomaly"]	
chr2	241528750	241528901	trio	151	3	5	0.02829	0.045	0.000		CAPN10-DT,CAPN10	CAPN10-DT (oe_lof=n/a region=intronic/intergenic),CAPN10 (oe_lof=0.71 region=exonic/splicing)		144177 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146232 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],146578 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147368 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147508 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149568 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],151032 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153228 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155356 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],187820 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397079 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441642 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442496 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442540 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442661 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443364 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],562656 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562657 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562659 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562662 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57432 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58885 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58910 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58911 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58912 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625780 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Chromosome 2q37 deletion syndrome"],625781 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 2q37 deletion syndrome"],638101 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814379 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605286_[GENE=CAPN10_PHENOS=Diabetes_mellitus,noninsulin-dependent_1,601283]
chr3	4535022	4536200	trio	1178	3	19	0.00156	0.172	0.000		ITPR1-DT,ITPR1	ITPR1-DT (oe_lof=n/a region=intronic/intergenic),ITPR1 (oe_lof=0.08 region=intronic/intergenic)		147406 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153151 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154669 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155690 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443797 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57172 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57737 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],605501 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687590 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687697 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	147265_[GENE=ITPR1_PHENOS=Gillespie_syndrome,206700,Autosomal_dominant,Autosomal_recessive/Spinocerebellar_ataxia_29,congenital_nonprogressive,117360,Autosomal_dominant/Spinocerebellar_ataxia_15,606658,Autosomal_dominant]
chr3	4687256	4687422	trio	166	3	4	0.04030	0.038	0.000		ITPR1	ITPR1 (oe_lof=0.08 region=exonic/splicing)		147406 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153151 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154669 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443797 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57172 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57737 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],605501 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	147265_[GENE=ITPR1_PHENOS=Gillespie_syndrome,206700,Autosomal_dominant,Autosomal_recessive/Spinocerebellar_ataxia_29,congenital_nonprogressive,117360,Autosomal_dominant/Spinocerebellar_ataxia_15,606658,Autosomal_dominant]
chr3	4725060	4725245	trio	185	3	5	0.03611	0.076	0.000		ITPR1	ITPR1 (oe_lof=0.08 region=exonic/splicing)		147406 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153151 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154669 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443797 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57172 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57737 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],605501 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	147265_[GENE=ITPR1_PHENOS=Gillespie_syndrome,206700,Autosomal_dominant,Autosomal_recessive/Spinocerebellar_ataxia_29,congenital_nonprogressive,117360,Autosomal_dominant/Spinocerebellar_ataxia_15,606658,Autosomal_dominant]
chr3	12705302	12705710	trio	408	3	6	0.02602	0.115	0.000		RAF1	RAF1 (oe_lof=0.19 region=intronic/intergenic)		395579 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	164760_[GENE=RAF1_PHENOS=Cardiomyopathy,dilated,1NN,615916,Autosomal_dominant/Noonan_syndrome_5,611553,Autosomal_dominant/LEOPARD_syndrome_2,611554]
chr3	24536133	24536323	trio	190	1	7	0.01571	0.102	0.000		THRB,THRB-AS1	THRB (oe_lof=0.05 region=intronic/intergenic),THRB-AS1 (oe_lof=n/a region=intronic/intergenic)			190160_[GENE=THRB_PHENOS=Thyroid_hormone_resistance,autosomal_recessive,274300,Autosomal_recessive/Thyroid_hormone_resistance,188570,Autosomal_dominant/Thyroid_hormone_resistance,selective_pituitary,145650,Autosomal_dominant]
chr3	30715587	30730013	trio	14426	3	9	0.01277	0.102	0.000		TGFBR2	TGFBR2 (oe_lof=0.26 region=exonic/splicing)	TGFBR2 [HI=Some evidence for dosage pathogenicity PMIDS=18781618,15235604,15731757]	253599 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	190182_[GENE=TGFBR2_PHENOS=Loeys-Dietz_syndrome_2,610168,Autosomal_dominant/Colorectal_cancer,hereditary_nonpolyposis,type_6,614331/Esophageal_cancer,somatic,133239]
chr3	38179959	38181499	trio	1540	3	5	0.00082	0.051	0.000		ACAA1,MYD88	ACAA1 (oe_lof=0.74 region=intronic/intergenic),MYD88 (oe_lof=0.29 region=exonic/splicing)			602170_[GENE=MYD88_PHENOS=Macroglobulinemia,Waldenstrom,somatic,153600/Immunodeficiency_68,612260,Autosomal_recessive]
chr3	46620712	46620866	trio	154	3	7	0.01940	0.102	0.000		LRRC2,TDGF1	LRRC2 (oe_lof=0.71 region=intronic/intergenic),TDGF1 (oe_lof=1.46 region=exonic/splicing)	TDGF1 [HI=Little evidence for dosage pathogenicity PMIDS=12073012]	144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	187395_[GENE=TDGF1_PHENOS=Forebrain_defects]
chr3	48604330	48604633	trio	303	3	3	0.04262	0.070	0.000		UCN2,COL7A1	UCN2 (oe_lof=0.73 region=intronic/intergenic),COL7A1 (oe_lof=0.50 region=exonic/splicing)		144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	120120_[GENE=COL7A1_PHENOS=EBD,localisata_variant/Epidermolysis_bullosa,pretibial,131850,Autosomal_dominant,Autosomal_recessive/Transient_bullous_of_the_newborn,131705,Autosomal_dominant,Autosomal_recessive/EBD,Bart_type,132000,Autosomal_dominant/Epidermolysis_bullosa_dystrophica,AD,131750,Autosomal_dominant/Epidermolysis_bullosa_pruriginosa,604129,Autosomal_dominant,Autosomal_recessive/EBD_inversa,226600,Autosomal_recessive/Epidermolysis_bullosa_dystrophica,AR,226600,Autosomal_recessive/Toenail_dystrophy,isolated,607523,Autosomal_dominant]
chr3	48610597	48610679	trio	82	3	4	0.03758	0.115	0.000		COL7A1	COL7A1 (oe_lof=0.50 region=exonic/splicing)		144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	120120_[GENE=COL7A1_PHENOS=EBD,localisata_variant/Epidermolysis_bullosa,pretibial,131850,Autosomal_dominant,Autosomal_recessive/Transient_bullous_of_the_newborn,131705,Autosomal_dominant,Autosomal_recessive/EBD,Bart_type,132000,Autosomal_dominant/Epidermolysis_bullosa_dystrophica,AD,131750,Autosomal_dominant/Epidermolysis_bullosa_pruriginosa,604129,Autosomal_dominant,Autosomal_recessive/EBD_inversa,226600,Autosomal_recessive/Epidermolysis_bullosa_dystrophica,AR,226600,Autosomal_recessive/Toenail_dystrophy,isolated,607523,Autosomal_dominant]
chr3	48613049	48616720	trio	3671	3	7	0.05561	0.057	0.000		COL7A1,MIR711	COL7A1 (oe_lof=0.50 region=exonic/splicing),MIR711 (oe_lof=n/a region=exonic/splicing)		144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	120120_[GENE=COL7A1_PHENOS=EBD,localisata_variant/Epidermolysis_bullosa,pretibial,131850,Autosomal_dominant,Autosomal_recessive/Transient_bullous_of_the_newborn,131705,Autosomal_dominant,Autosomal_recessive/EBD,Bart_type,132000,Autosomal_dominant/Epidermolysis_bullosa_dystrophica,AD,131750,Autosomal_dominant/Epidermolysis_bullosa_pruriginosa,604129,Autosomal_dominant,Autosomal_recessive/EBD_inversa,226600,Autosomal_recessive/Epidermolysis_bullosa_dystrophica,AR,226600,Autosomal_recessive/Toenail_dystrophy,isolated,607523,Autosomal_dominant]
chr3	48618683	48618783	trio	100	3	3	0.05414	0.159	0.000		COL7A1,MIR711	COL7A1 (oe_lof=0.50 region=exonic/splicing),MIR711 (oe_lof=n/a region=intronic/intergenic)		144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	120120_[GENE=COL7A1_PHENOS=EBD,localisata_variant/Epidermolysis_bullosa,pretibial,131850,Autosomal_dominant,Autosomal_recessive/Transient_bullous_of_the_newborn,131705,Autosomal_dominant,Autosomal_recessive/EBD,Bart_type,132000,Autosomal_dominant/Epidermolysis_bullosa_dystrophica,AD,131750,Autosomal_dominant/Epidermolysis_bullosa_pruriginosa,604129,Autosomal_dominant,Autosomal_recessive/EBD_inversa,226600,Autosomal_recessive/Epidermolysis_bullosa_dystrophica,AR,226600,Autosomal_recessive/Toenail_dystrophy,isolated,607523,Autosomal_dominant]
chr3	48625216	48625847	trio	631	3	7	0.03967	0.197	0.000		COL7A1	COL7A1 (oe_lof=0.50 region=exonic/splicing)		144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	120120_[GENE=COL7A1_PHENOS=EBD,localisata_variant/Epidermolysis_bullosa,pretibial,131850,Autosomal_dominant,Autosomal_recessive/Transient_bullous_of_the_newborn,131705,Autosomal_dominant,Autosomal_recessive/EBD,Bart_type,132000,Autosomal_dominant/Epidermolysis_bullosa_dystrophica,AD,131750,Autosomal_dominant/Epidermolysis_bullosa_pruriginosa,604129,Autosomal_dominant,Autosomal_recessive/EBD_inversa,226600,Autosomal_recessive/Epidermolysis_bullosa_dystrophica,AR,226600,Autosomal_recessive/Toenail_dystrophy,isolated,607523,Autosomal_dominant]
chr3	48630525	48630706	trio	181	3	5	0.02112	0.051	0.000		COL7A1	COL7A1 (oe_lof=0.50 region=exonic/splicing)		144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	120120_[GENE=COL7A1_PHENOS=EBD,localisata_variant/Epidermolysis_bullosa,pretibial,131850,Autosomal_dominant,Autosomal_recessive/Transient_bullous_of_the_newborn,131705,Autosomal_dominant,Autosomal_recessive/EBD,Bart_type,132000,Autosomal_dominant/Epidermolysis_bullosa_dystrophica,AD,131750,Autosomal_dominant/Epidermolysis_bullosa_pruriginosa,604129,Autosomal_dominant,Autosomal_recessive/EBD_inversa,226600,Autosomal_recessive/Epidermolysis_bullosa_dystrophica,AR,226600,Autosomal_recessive/Toenail_dystrophy,isolated,607523,Autosomal_dominant]
chr3	48936113	48936436	trio	323	3	7	0.01367	0.166	0.000		SLC25A20	SLC25A20 (oe_lof=0.73 region=exonic/splicing)		144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980510 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	613698_[GENE=SLC25A20_PHENOS=Carnitine-acylcarnitine_translocase_deficiency,212138,Autosomal_recessive]
chr3	49058608	49058842	trio	234	3	4	0.04189	0.185	0.000		DALRD3,MIR425,NDUFAF3,MIR191,IMPDH2	DALRD3 (oe_lof=0.77 region=intronic/intergenic),MIR425 (oe_lof=n/a region=intronic/intergenic),NDUFAF3 (oe_lof=0.51 region=intronic/intergenic),MIR191 (oe_lof=n/a region=intronic/intergenic),IMPDH2 (oe_lof=0.50 region=intronic/intergenic)		144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980510 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	146691_[GENE=IMPDH2_PHENOS=IMPDH2_enzyme_activity,variation_in,617995],612911_[GENE=NDUFAF3_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_18,618240,Autosomal_recessive],618904_[GENE=DALRD3_PHENOS=Developmental_and_epileptic_encephalopathy_86,618910,Autosomal_recessive]
chr3	49459527	49459714	trio	187	3	4	0.01195	0.038	0.000		AMT,NICN1	AMT (oe_lof=0.42 region=exonic/splicing),NICN1 (oe_lof=0.37 region=intronic/intergenic)		144168 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980510 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	238310_[GENE=AMT_PHENOS=Glycine_encephalopathy,605899,Autosomal_recessive]
chr3	58062763	58063031	trio	268	0	9	0.01920	0.369	0.000		FLNB	FLNB (oe_lof=0.34 region=exonic/splicing)			603381_[GENE=FLNB_PHENOS=Larsen_syndrome,150250,Autosomal_dominant/Atelosteogenesis,type_I,108720,Autosomal_dominant/Atelosteogenesis,type_III,108721,Autosomal_dominant/Spondylocarpotarsal_synostosis_syndrome,272460,Autosomal_recessive/Boomerang_dysplasia,112310,Autosomal_dominant]
chr3	58110049	58111480	trio	1431	3	3	0.12418	0.242	0.000		FLNB	FLNB (oe_lof=0.34 region=exonic/splicing)			603381_[GENE=FLNB_PHENOS=Larsen_syndrome,150250,Autosomal_dominant/Atelosteogenesis,type_I,108720,Autosomal_dominant/Atelosteogenesis,type_III,108721,Autosomal_dominant/Spondylocarpotarsal_synostosis_syndrome,272460,Autosomal_recessive/Boomerang_dysplasia,112310,Autosomal_dominant]
chr3	63953410	63968131	trio	14721	3	6	0.03360	0.070	0.000		ATXN7	ATXN7 (oe_lof=0.16 region=exonic/splicing)			607640_[GENE=ATXN7_PHENOS=Spinocerebellar_ataxia_7,164500,Autosomal_dominant]
chr3	121553228	121553936	trio	708	3	6	0.03360	0.210	0.000		IQCB1,EAF2	IQCB1 (oe_lof=0.64 region=intronic/intergenic),EAF2 (oe_lof=0.88 region=intronic/intergenic)		253332 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57829 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	609237_[GENE=IQCB1_PHENOS=Senior-Loken_syndrome_5,609254,Autosomal_recessive]
chr3	128621386	128621481	trio	95	1	7	0.01385	0.032	0.000		ACAD9	ACAD9 (oe_lof=0.54 region=exonic/splicing)		148370 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	611103_[GENE=ACAD9_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_20,611126,Autosomal_recessive]
chr3	128629574	128629666	trio	92	1	4	0.03058	0.121	0.000		ACAD9,CFAP92	ACAD9 (oe_lof=0.54 region=exonic/splicing),CFAP92 (oe_lof=0.87 region=intronic/intergenic)		148370 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	611103_[GENE=ACAD9_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_20,611126,Autosomal_recessive]
chr3	135969157	135969410	trio	253	3	5	0.01449	0.185	0.000		PCCB	PCCB (oe_lof=0.60 region=exonic/splicing)		523197 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="Intellectual disability, autosomal dominant 47"],523198 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="Intellectual disability, autosomal dominant 47"],523199 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="Intellectual disability, autosomal dominant 47"],57831 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	232050_[GENE=PCCB_PHENOS=Propionicacidemia,606054,Autosomal_recessive]
chr3	139062851	139063050	trio	199	5	19	0.00008	0.217	0.000		MRPS22	MRPS22 (oe_lof=0.54 region=exonic/splicing)		147602 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562821 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980063 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605810_[GENE=MRPS22_PHENOS=Ovarian_dysgenesis_7,618117,Autosomal_recessive/Combined_oxidative_phosphorylation_deficiency_5,611719,Autosomal_recessive]
chr3	142297478	142297678	trio	200	4	11	0.00223	0.185	0.000		ATR,RPL6P9	ATR (oe_lof=0.31 region=exonic/splicing),RPL6P9 (oe_lof=n/a region=intronic/intergenic)	ATR [HI=Little evidence for dosage pathogenicity PMIDS=30159786,26556299,29439820]		601215_[GENE=ATR_PHENOS=Seckel_syndrome_1,210600,Autosomal_recessive/Cutaneous_telangiectasia_and_cancer_syndrome,familial,614564,Autosomal_dominant]
chr3	155571002	158362514	trio	2791512	3	9	0.00506	0.159	0.003 (0.37,0.37,0.37,0.03,0.03,0.04,0.07)		SLC33A1,GMPS,SETP14,VN2R1P,ALG1L15P,KCNAB1,KCNAB1-AS2,KCNAB1-AS1,SSR3,TIPARP-AS1,TIPARP,METTL15P1,LINC00886,PA2G4P4,LEKR1,KLF3P2,RN7SKP177,LINC00880,LINC00881,CCNL1,KRT18P34,RNA5SP146,VEPH1,PTX3,SLC66A1L,RN7SKP46,SHOX2,RSRC1,MLF1,MTAPP1,GFM1	SLC33A1 (oe_lof=0.48 region=exonic/splicing),GMPS (oe_lof=0.09 region=complete),SETP14 (oe_lof=n/a region=complete),VN2R1P (oe_lof=n/a region=complete),ALG1L15P (oe_lof=n/a region=complete),KCNAB1 (oe_lof=0.28 region=complete),KCNAB1-AS2 (oe_lof=n/a region=complete),KCNAB1-AS1 (oe_lof=n/a region=complete),SSR3 (oe_lof=0.11 region=complete),TIPARP-AS1 (oe_lof=n/a region=complete),TIPARP (oe_lof=0.00 region=complete),METTL15P1 (oe_lof=n/a region=complete),LINC00886 (oe_lof=n/a region=complete),PA2G4P4 (oe_lof=n/a region=complete),LEKR1 (oe_lof=0.36 region=complete),KLF3P2 (oe_lof=n/a region=complete),RN7SKP177 (oe_lof=n/a region=complete),LINC00880 (oe_lof=n/a region=complete),LINC00881 (oe_lof=n/a region=complete),CCNL1 (oe_lof=0.10 region=complete),KRT18P34 (oe_lof=n/a region=complete),RNA5SP146 (oe_lof=n/a region=complete),VEPH1 (oe_lof=0.92 region=complete),PTX3 (oe_lof=0.67 region=complete),SLC66A1L (oe_lof=0.86 region=complete),RN7SKP46 (oe_lof=n/a region=complete),SHOX2 (oe_lof=0.40 region=complete),RSRC1 (oe_lof=0.49 region=complete),MLF1 (oe_lof=0.79 region=complete),MTAPP1 (oe_lof=n/a region=complete),GFM1 (oe_lof=0.58 region=exonic/splicing)	GFM1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		603690_[GENE=SLC33A1_PHENOS=Spastic_paraplegia_42,autosomal_dominant,612539,Autosomal_dominant/Congenital_cataracts,hearing_loss,and_neurodegeneration,614482,Autosomal_recessive],606639_[GENE=GFM1_PHENOS=Combined_oxidative_phosphorylation_deficiency_1,609060,Autosomal_recessive],613352_[GENE=RSRC1_PHENOS=Intellectual_developmental_disorder,autosomal_recessive_70,618402,Autosomal_recessive]
chr3	180707110	180707572	trio	462	3	14	0.00123	0.159	0.000		DNAJC19	DNAJC19 (oe_lof=0.66 region=exonic/splicing)		814502 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980553 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],986754 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Anophthalmia/microphthalmia-esophageal atresia syndrome"]	608977_[GENE=DNAJC19_PHENOS=3-methylglutaconic_aciduria,type_V,610198,Autosomal_recessive]
chr3	184072326	184072771	trio	445	1	3	0.04062	0.127	0.000		EIF2B5,CLCN2	EIF2B5 (oe_lof=0.26 region=intronic/intergenic),CLCN2 (oe_lof=0.55 region=exonic/splicing)		151178 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153971 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155230 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396282 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57995 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814505 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],980554 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],986756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Anophthalmia/microphthalmia-esophageal atresia syndrome"]	600570_[GENE=CLCN2_PHENOS=Leukoencephalopathy_with_ataxia,615651,Autosomal_recessive/Hyperaldosteronism,familial,type_II,605635,Autosomal_dominant/Epilepsy,juvenile_myoclonic,susceptibility_to,8,607628,Autosomal_dominant/Epilepsy,juvenile_absence,susceptibility_to,2,607628,Autosomal_dominant/Epilepsy,idiopathic_generalized,susceptibility_to,11,607628,Autosomal_dominant],603945_[GENE=EIF2B5_PHENOS=Ovarioleukodystrophy,603896,Autosomal_recessive/Leukoencephalopathy_with_vanishing_white_matter,603896,Autosomal_recessive]
chr3	184074771	184074892	trio	121	3	3	0.04282	0.070	0.000		EIF2B5,CLCN2,POLR2H	EIF2B5 (oe_lof=0.26 region=intronic/intergenic),CLCN2 (oe_lof=0.55 region=exonic/splicing),POLR2H (oe_lof=0.13 region=intronic/intergenic)		151178 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153971 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155230 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396282 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57995 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],814505 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],980554 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],986756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Anophthalmia/microphthalmia-esophageal atresia syndrome"]	600570_[GENE=CLCN2_PHENOS=Leukoencephalopathy_with_ataxia,615651,Autosomal_recessive/Hyperaldosteronism,familial,type_II,605635,Autosomal_dominant/Epilepsy,juvenile_myoclonic,susceptibility_to,8,607628,Autosomal_dominant/Epilepsy,juvenile_absence,susceptibility_to,2,607628,Autosomal_dominant/Epilepsy,idiopathic_generalized,susceptibility_to,11,607628,Autosomal_dominant],603945_[GENE=EIF2B5_PHENOS=Ovarioleukodystrophy,603896,Autosomal_recessive/Leukoencephalopathy_with_vanishing_white_matter,603896,Autosomal_recessive]
chr3	190039763	190040245	trio	482	3	7	0.01440	0.121	0.000		CLDN1	CLDN1 (oe_lof=0.60 region=exonic/splicing)		155397 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253655 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57871 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625822 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Neonatal ichthyosis-sclerosing cholangitis syndrome"]	603718_[GENE=CLDN1_PHENOS=Ichthyosis,leukocyte_vacuoles,alopecia,and_sclerosing_cholangitis,607626,Autosomal_recessive]
chr3	197025279	197025457	trio	178	3	4	0.03978	0.248	0.000	3q29 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/37],3q29 microduplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/77]	DLG1,MIR4797,DLG1-AS1	DLG1 (oe_lof=0.17 region=intronic/intergenic),MIR4797 (oe_lof=n/a region=intronic/intergenic),DLG1-AS1 (oe_lof=n/a region=exonic/splicing)		147306 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148016 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148628 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149477 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149940 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153972 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154986 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155434 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160885 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160933 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253357 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253577 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],267260 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="3q29 microdeletion syndrome"],34369 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394253 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396780 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397198 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397455 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397468 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443234 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443988 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562864 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562865 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562867 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],562868 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57328 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57999 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58000 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59288 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59289 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59981 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59982 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59983 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59984 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59985 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59986 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],606470 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],606472 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],606473 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686054 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686190 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816511 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980655 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],997046 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Motor delay;Delayed speech and language development"],997056 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Behavioral abnormality;Delayed speech and language development"]	
chr3	197403746	197404422	trio	676	3	2	0.01940	0.140	0.000		RUBCN,MIR922	RUBCN (oe_lof=0.58 region=exonic/splicing),MIR922 (oe_lof=n/a region=intronic/intergenic)		147306 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148016 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149477 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155434 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253357 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396780 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57999 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58000 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980655 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	613516_[GENE=RUBCN_PHENOS=Spinocerebellar_ataxia,autosomal_recessive_15,615705,Autosomal_recessive]
chr3	197410168	197410320	trio	152	4	4	0.05410	0.229	0.000		RUBCN	RUBCN (oe_lof=0.58 region=exonic/splicing)		147306 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148016 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149477 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155434 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253357 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396780 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57999 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58000 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980655 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	613516_[GENE=RUBCN_PHENOS=Spinocerebellar_ataxia,autosomal_recessive_15,615705,Autosomal_recessive]
chr3	197444838	197476578	trio	31740	3	7	0.02366	0.121	0.000		RUBCN,FYTTD1	RUBCN (oe_lof=0.58 region=exonic/splicing),FYTTD1 (oe_lof=0.22 region=intronic/intergenic)		148016 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149477 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155434 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253357 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396780 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57999 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58000 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980655 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	613516_[GENE=RUBCN_PHENOS=Spinocerebellar_ataxia,autosomal_recessive_15,615705,Autosomal_recessive]
chr4	994390	997910	trio	3520	1	11	0.09196	0.038	0.000		IDUA	IDUA (oe_lof=0.82 region=exonic/splicing)		1047903 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized hypotonia;Renal hypoplasia;Intrauterine growth retardation"],145401 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145991 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146279 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147562 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147744 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147791 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148311 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150122 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150615 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153530 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155105 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155180 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155257 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],161057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395188 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396062 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396557 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442291 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443042 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57159 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57182 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57275 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57873 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57900 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57903 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57904 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57905 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57929 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57933 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57939 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58014 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59417 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59418 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59419 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],606517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686294 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814518 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979456 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979458 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979459 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	252800_[GENE=IDUA_PHENOS=Mucopolysaccharidosis_Is,607016,Autosomal_recessive/Mucopolysaccharidosis_Ih/s,607015,Autosomal_recessive/Mucopolysaccharidosis_Ih,607014,Autosomal_recessive]
chr4	1803084	1804801	trio	1717	1	2	0.21328	0.083	0.000	Wolf-Hirschhorn Syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/1]	FGFR3	FGFR3 (oe_lof=0.39 region=exonic/splicing)		1047903 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized hypotonia;Renal hypoplasia;Intrauterine growth retardation"],145401 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145991 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146279 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147562 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147791 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150122 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150615 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153530 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155105 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155180 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155257 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155481 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],161057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253474 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395188 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396062 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396557 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442291 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443042 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562877 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],562878 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57159 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57182 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57275 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57873 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57900 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57903 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57904 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57905 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57929 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57933 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57939 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58014 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59417 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59418 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59419 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],606517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625700 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="4p partial monosomy syndrome"],686294 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814518 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979458 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979459 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983182 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	134934_[GENE=FGFR3_PHENOS=Muenke_syndrome,602849,Autosomal_dominant/SADDAN,616482,Autosomal_dominant/Hypochondroplasia,146000,Autosomal_dominant/LADD_syndrome,149730,Autosomal_dominant/Thanatophoric_dysplasia,type_II,187601,Autosomal_dominant/Nevus,epidermal,somatic,162900/CATSHL_syndrome,610474,Autosomal_dominant,Autosomal_recessive/Thanatophoric_dysplasia,type_I,187600,Autosomal_dominant/Spermatocytic_seminoma,somatic,273300/Bladder_cancer,somatic,109800/Achondroplasia,100800,Autosomal_dominant/Cervical_cancer,somatic,603956/Colorectal_cancer,somatic,114500/Crouzon_syndrome_with_acanthosis_nigricans,612247,Autosomal_dominant]
chr4	1807072	1807406	trio	334	1	3	0.16031	0.338	0.000	Wolf-Hirschhorn Syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/1]	FGFR3	FGFR3 (oe_lof=0.39 region=exonic/splicing)		1047903 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized hypotonia;Renal hypoplasia;Intrauterine growth retardation"],145401 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145991 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146279 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147562 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147791 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150122 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150615 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153530 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155105 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155180 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155257 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155481 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],161057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253474 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395188 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396062 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396557 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442291 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443042 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562877 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],562878 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57159 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57182 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57275 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57873 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57900 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57903 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57904 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57905 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57929 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57933 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57939 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58014 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59417 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59418 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59419 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],606517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625700 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="4p partial monosomy syndrome"],686294 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814518 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979458 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979459 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983182 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	134934_[GENE=FGFR3_PHENOS=Muenke_syndrome,602849,Autosomal_dominant/SADDAN,616482,Autosomal_dominant/Hypochondroplasia,146000,Autosomal_dominant/LADD_syndrome,149730,Autosomal_dominant/Thanatophoric_dysplasia,type_II,187601,Autosomal_dominant/Nevus,epidermal,somatic,162900/CATSHL_syndrome,610474,Autosomal_dominant,Autosomal_recessive/Thanatophoric_dysplasia,type_I,187600,Autosomal_dominant/Spermatocytic_seminoma,somatic,273300/Bladder_cancer,somatic,109800/Achondroplasia,100800,Autosomal_dominant/Cervical_cancer,somatic,603956/Colorectal_cancer,somatic,114500/Crouzon_syndrome_with_acanthosis_nigricans,612247,Autosomal_dominant]
chr4	1900938	1901132	trio	194	3	6	0.02387	0.166	0.000	Wolf-Hirschhorn Syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/1]	NSD2	NSD2 (oe_lof=0.05 region=intronic/intergenic)		1047903 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized hypotonia;Renal hypoplasia;Intrauterine growth retardation"],145401 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145991 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146279 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147562 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147791 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150122 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150615 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153530 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155105 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155180 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155257 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155481 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],161057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253474 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395188 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396062 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396557 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442291 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443042 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562877 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],562878 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57159 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57182 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57275 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57873 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57900 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57903 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57904 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57905 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57929 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57933 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57939 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58014 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59417 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59418 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59419 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],606517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625700 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="4p partial monosomy syndrome"],686294 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814518 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979458 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979459 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	
chr4	1953825	1953968	trio	143	3	4	0.05775	0.159	0.000	Wolf-Hirschhorn Syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/1]	NSD2	NSD2 (oe_lof=0.05 region=exonic/splicing)		1047903 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized hypotonia;Renal hypoplasia;Intrauterine growth retardation"],145401 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145991 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146279 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147562 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147791 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150122 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150615 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153530 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155105 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155180 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155257 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155481 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],161057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253474 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396062 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396557 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442291 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443042 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562877 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57159 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57182 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57275 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57873 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57900 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57903 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57904 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57905 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57929 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57933 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57939 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58014 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59418 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59419 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],606517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625700 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="4p partial monosomy syndrome"],686294 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814518 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979457 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979458 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979459 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	
chr4	1957410	1957586	trio	176	3	4	0.07382	0.204	0.000	Wolf-Hirschhorn Syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/1]	NSD2	NSD2 (oe_lof=0.05 region=exonic/splicing)		1047903 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized hypotonia;Renal hypoplasia;Intrauterine growth retardation"],145401 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145991 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146279 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147562 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147791 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150122 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150615 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153530 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155105 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155180 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155257 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155481 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],161057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253474 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396062 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396557 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442291 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443042 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],562877 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57159 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57182 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57275 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57873 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57900 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57903 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57904 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57905 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57929 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57933 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57939 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58014 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59418 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59419 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],606517 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625700 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="4p partial monosomy syndrome"],686294 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814518 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979457 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979458 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979459 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	
chr4	15471479	15471691	trio	212	3	6	0.01642	0.166	0.000		CC2D2A	CC2D2A (oe_lof=0.63 region=intronic/intergenic)	CC2D2A [HI=Gene associated with autosomal recessive phenotype PMIDS=]	58026 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	612013_[GENE=CC2D2A_PHENOS=COACH_syndrome_2,619111/Meckel_syndrome_6,612284,Autosomal_recessive/Joubert_syndrome_9,612285,Autosomal_recessive]
chr4	79207549	79207703	trio	154	3	3	0.03700	0.064	0.000		FRAS1	FRAS1 (oe_lof=0.56 region=exonic/splicing)		152987 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	607830_[GENE=FRAS1_PHENOS=Fraser_syndrome_1,219000,Autosomal_recessive]
chr4	79440475	79440645	trio	170	3	4	0.06827	0.204	0.000		FRAS1	FRAS1 (oe_lof=0.56 region=exonic/splicing)		152987 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	607830_[GENE=FRAS1_PHENOS=Fraser_syndrome_1,219000,Autosomal_recessive]
chr4	87653543	87653637	trio	94	3	4	0.03000	0.019	0.000		PTPN13	PTPN13 (oe_lof=0.52 region=exonic/splicing)		147434 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152920 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr4	87679821	87679948	trio	127	3	4	0.06009	0.172	0.000		PTPN13	PTPN13 (oe_lof=0.52 region=exonic/splicing)		147434 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152920 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr4	87696314	87696505	trio	191	3	6	0.02934	0.166	0.000		PTPN13	PTPN13 (oe_lof=0.52 region=exonic/splicing)		147434 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152920 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr4	103681865	107237761	trio	3555896	3	16	0.01450	0.153	0.004 (0.03,0.03,0.03,0.75,0.53,0.53)		MANBA,UBE2D3,RNU7-151P,CISD2,SLC9B1,PABPC1P7,ACTR3BP4,SLC9B2,BDH2,CENPE,DDX3P3,TACR3,RNU6-635P,CXXC4,RNU6-351P,SNORA31,TET2,TET2-AS1,RN7SL89P,PPA2,RNU6-553P,EEF1A1P9,ATP5F1EP1,ARHGEF38,ARHGEF38-IT1,INTS12,GSTCD,NPNT,TBCK,AIMP1	MANBA (oe_lof=0.73 region=exonic/splicing),UBE2D3 (oe_lof=0.21 region=complete),RNU7-151P (oe_lof=n/a region=complete),CISD2 (oe_lof=0.19 region=complete),SLC9B1 (oe_lof=0.63 region=complete),PABPC1P7 (oe_lof=n/a region=complete),ACTR3BP4 (oe_lof=n/a region=complete),SLC9B2 (oe_lof=0.52 region=complete),BDH2 (oe_lof=0.85 region=complete),CENPE (oe_lof=0.23 region=complete),DDX3P3 (oe_lof=n/a region=complete),TACR3 (oe_lof=1.24 region=complete),RNU6-635P (oe_lof=n/a region=complete),CXXC4 (oe_lof=0.00 region=complete),RNU6-351P (oe_lof=n/a region=complete),SNORA31 (oe_lof=n/a region=complete),TET2 (oe_lof=1.14 region=complete),TET2-AS1 (oe_lof=n/a region=complete),RN7SL89P (oe_lof=n/a region=complete),PPA2 (oe_lof=0.85 region=complete),RNU6-553P (oe_lof=n/a region=complete),EEF1A1P9 (oe_lof=n/a region=complete),ATP5F1EP1 (oe_lof=n/a region=complete),ARHGEF38 (oe_lof=0.62 region=complete),ARHGEF38-IT1 (oe_lof=n/a region=complete),INTS12 (oe_lof=0.17 region=complete),GSTCD (oe_lof=0.53 region=complete),NPNT (oe_lof=0.64 region=complete),TBCK (oe_lof=0.65 region=exonic/splicing),AIMP1 (oe_lof=0.75 region=exonic/splicing)	AIMP1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	1176804 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58034 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685167 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685817 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686259 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688222 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],915974 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Hypotonia, infantile, with psychomotor retardation and characteristic facies 3"]	117143_[GENE=CENPE_PHENOS=Microcephaly_13,primary,autosomal_recessive,616051,Autosomal_recessive],162332_[GENE=TACR3_PHENOS=Hypogonadotropic_hypogonadism_11_with_or_without_anosmia,614840,Autosomal_recessive],603605_[GENE=AIMP1_PHENOS=Leukodystrophy,hypomyelinating,3,260600,Autosomal_recessive],609489_[GENE=MANBA_PHENOS=Mannosidosis,beta,248510,Autosomal_recessive],609988_[GENE=PPA2_PHENOS=Sudden_cardiac_failure,alcohol-induced,617223,Autosomal_recessive/Sudden_cardiac_failure,infantile,617222,Autosomal_recessive],611507_[GENE=CISD2_PHENOS=Wolfram_syndrome_2,604928,Autosomal_recessive],612839_[GENE=TET2_PHENOS=Myelodysplastic_syndrome,somatic,614286/Immunodeficiency_75,619126,Autosomal_recessive],616899_[GENE=TBCK_PHENOS=Hypotonia,infantile,with_psychomotor_retardation_and_characteristic_facies_3,616900,Autosomal_recessive]
chr4	113567497	113567617	trio	120	1	5	0.02442	0.032	0.000		LARP7,MIR302B,MIR367,MIR302D,MIR302A,MIR302C	LARP7 (oe_lof=0.55 region=exonic/splicing),MIR302B (oe_lof=n/a region=exonic/splicing),MIR367 (oe_lof=n/a region=intronic/intergenic),MIR302D (oe_lof=n/a region=intronic/intergenic),MIR302A (oe_lof=n/a region=intronic/intergenic),MIR302C (oe_lof=n/a region=intronic/intergenic)		396614 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	612026_[GENE=LARP7_PHENOS=Alazami_syndrome,615071,Autosomal_recessive]
chr4	119239523	119253031	trio	13508	3	3	0.08439	0.217	0.000		PRSS12	PRSS12 (oe_lof=0.96 region=exonic/splicing)			606709_[GENE=PRSS12_PHENOS=Mental_retardation,autosomal_recessive_1,249500,Autosomal_recessive]
chr4	122791423	122791662	trio	239	4	4	0.02866	0.248	0.000		BBS7	BBS7 (oe_lof=0.51 region=exonic/splicing)			607590_[GENE=BBS7_PHENOS=Bardet-Biedl_syndrome_7,615984,Autosomal_recessive]
chr4	128886217	128887149	trio	932	3	4	0.05775	0.197	0.000		MFSD8,ABHD18	MFSD8 (oe_lof=0.75 region=exonic/splicing),ABHD18 (oe_lof=0.88 region=intronic/intergenic)	MFSD8 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		611124_[GENE=MFSD8_PHENOS=Macular_dystrophy_with_central_cone_involvement,616170,Autosomal_recessive/Ceroid_lipofuscinosis,neuronal,7,610951,Autosomal_recessive]
chr4	148601464	148605290	trio	3826	3	6	0.00895	0.096	0.000		PRMT9	PRMT9 (oe_lof=0.66 region=exonic/splicing)		147312 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153878 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],687334 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	
chr4	184365779	184366232	trio	453	3	4	0.04132	0.121	0.000		CDKN2AIP	CDKN2AIP (oe_lof=0.10 region=exonic/splicing)		161066 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33229 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58063 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr5	254498	254631	trio	133	3	6	0.01385	0.057	0.000	Cri du Chat Syndrome (5p deletion) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/2]	SDHA	SDHA (oe_lof=0.60 region=exonic/splicing)		1180547 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],147750 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148877 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150451 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152721 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154579 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394397 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394581 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395562 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563020 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563021 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57221 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57400 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59557 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59577 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59578 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59580 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],624532 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814650 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814651 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979670 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	600857_[GENE=SDHA_PHENOS=Cardiomyopathy,dilated,1GG,613642,Autosomal_recessive/Mitochondrial_complex_II_deficiency,nuclear_type_1,252011,Autosomal_recessive/Neurodegeneration_with_ataxia_and_late-onset_optic_atrophy,619259,Autosomal_dominant/Paragangliomas_5,614165,Autosomal_dominant]
chr5	1416203	1420828	trio	4625	3	7	0.01312	0.108	0.000	Cri du Chat Syndrome (5p deletion) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/2]	SLC6A3	SLC6A3 (oe_lof=0.10 region=exonic/splicing)		1180547 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],147750 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148877 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150451 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152721 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154579 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394397 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394581 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395562 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563020 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563021 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57057 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57221 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57400 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59557 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59577 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59578 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59580 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],624532 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814650 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],814651 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979670 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	126455_[GENE=SLC6A3_PHENOS=Parkinsonism-dystonia,infantile,1,613135,Autosomal_recessive/Nicotine_dependence,protection_against,188890]
chr5	6632987	6633483	trio	496	4	7	0.01277	0.172	0.000	Cri du Chat Syndrome (5p deletion) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/2]	NSUN2,SRD5A1	NSUN2 (oe_lof=0.34 region=exonic/splicing),SRD5A1 (oe_lof=0.74 region=intronic/intergenic)		148505 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58069 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610916_[GENE=NSUN2_PHENOS=Mental_retardation,autosomal_recessive_5,611091,Autosomal_recessive]
chr5	11346474	11565178	trio	218704	3	5	0.10777	0.217	0.000	Cri du Chat Syndrome (5p deletion) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/2]	CTNND2	CTNND2 (oe_lof=0.03 region=exonic/splicing)	CTNND2 [HI=Some evidence for dosage pathogenicity PMIDS=25106414,25807484,25473103]	979514 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	
chr5	11903919	11904120	trio	201	1	5	0.14839	0.376	0.000	Cri du Chat Syndrome (5p deletion) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/2]	CTNND2	CTNND2 (oe_lof=0.03 region=exonic/splicing)	CTNND2 [HI=Some evidence for dosage pathogenicity PMIDS=25106414,25807484,25473103]		
chr5	35856981	35857171	trio	190	3	3	0.01843	0.076	0.000		IL7R	IL7R (oe_lof=0.65 region=exonic/splicing)			146661_[GENE=IL7R_PHENOS=Severe_combined_immunodeficiency,T-cell_negative,B-cell/natural_killer_cell-positive_type,608971,Autosomal_recessive]
chr5	36876851	36953872	trio	77021	3	4	0.06442	0.140	0.000		NIPBL,KRT18P31	NIPBL (oe_lof=0.01 region=exonic/splicing),KRT18P31 (oe_lof=n/a region=complete)	NIPBL [HI=Sufficient evidence for dosage pathogenicity PMIDS=15146185,15146186,15318302]	441706 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],441862 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442914 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443203 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59607 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608667_[GENE=NIPBL_PHENOS=Cornelia_de_Lange_syndrome_1,122470,Autosomal_dominant]
chr5	38489170	38489357	trio	187	3	3	0.08114	0.223	0.000		LIFR	LIFR (oe_lof=0.52 region=exonic/splicing)		58094 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	151443_[GENE=LIFR_PHENOS=Stuve-Wiedemann_syndrome/Schwartz-Jampel_type_2_syndrome,601559,Autosomal_recessive]
chr5	52404342	52856600	trio	452258	3	8	0.02070	0.166	0.000		MOCS2,FST,NDUFS4	MOCS2 (oe_lof=0.71 region=exonic/splicing),FST (oe_lof=0.06 region=complete),NDUFS4 (oe_lof=0.62 region=exonic/splicing)	MOCS2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	979674 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	602694_[GENE=NDUFS4_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_1,252010,Autosomal_recessive],603708_[GENE=MOCS2_PHENOS=Molybdenum_cofactor_deficiency_B,252160,Autosomal_recessive]
chr5	74012402	74012508	trio	106	3	3	0.02988	0.070	0.000		HEXB,GFM2	HEXB (oe_lof=0.63 region=exonic/splicing),GFM2 (oe_lof=0.78 region=intronic/intergenic)			606544_[GENE=GFM2_PHENOS=Combined_oxidative_phosphorylation_deficiency_39,618397,Autosomal_recessive],606873_[GENE=HEXB_PHENOS=Sandhoff_disease,infantile,juvenile,and_adult_forms,268800,Autosomal_recessive]
chr5	77406021	77412068	trio	6047	3	3	0.13565	0.223	0.000		AP3B1	AP3B1 (oe_lof=0.22 region=exonic/splicing)		59627 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	603401_[GENE=AP3B1_PHENOS=Hermansky-Pudlak_syndrome_2,608233,Autosomal_recessive]
chr5	78280750	78282367	trio	1617	3	4	0.02366	0.217	0.000		ARSB	ARSB (oe_lof=0.70 region=exonic/splicing)			611542_[GENE=ARSB_PHENOS=Mucopolysaccharidosis_type_VI_(Maroteaux-Lamy),253200,Autosomal_recessive]
chr5	88056795	88179293	trio	122498	3	6	0.02882	0.096	0.000		MEF2C,MEF2C-AS1	MEF2C (oe_lof=0.32 region=exonic/splicing),MEF2C-AS1 (oe_lof=n/a region=exonic/splicing)	MEF2C [HI=Sufficient evidence for dosage pathogenicity PMIDS=23389741,20513142,19592390]	146291 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146840 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152422 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253415 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253672 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395015 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441749 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441978 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442195 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57325 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59628 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59631 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59632 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],689011 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814709 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],916351 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],980160 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	600662_[GENE=MEF2C_PHENOS=Chromosome_5q14.3_deletion_syndrome,613443,Autosomal_dominant/Neurodevelopmental_disorder_with_hypotonia,stereotypic_hand_movements,and_impaired_language,613443,Autosomal_dominant]
chr5	90098546	90098709	trio	163	3	7	0.01450	0.121	0.000		ADGRV1	ADGRV1 (oe_lof=0.44 region=exonic/splicing)		152422 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441749 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57299 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	602851_[GENE=ADGRV1_PHENOS=Usher_syndrome,type_2C,605472,Autosomal_recessive,Digenic_dominant/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472,Autosomal_recessive,Digenic_dominant/Febrile_seizures,familial,4,604352,Autosomal_dominant]
chr5	127641193	127641650	trio	457	3	1	0.03111	0.032	0.000		FBN2	FBN2 (oe_lof=0.14 region=exonic/splicing)		58357 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	612570_[GENE=FBN2_PHENOS=Macular_degeneration,early-onset,616118,Autosomal_dominant/Contractural_arachnodactyly,congenital,121050,Autosomal_dominant]
chr5	131892606	131893155	trio	549	3	4	0.04414	0.172	0.000		RAD50	RAD50 (oe_lof=0.70 region=exonic/splicing)		146119 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604040_[GENE=RAD50_PHENOS=Nijmegen_breakage_syndrome-like_disorder,613078,Autosomal_recessive]
chr5	131972797	131972902	trio	105	1	5	0.02613	0.070	0.000		RAD50	RAD50 (oe_lof=0.70 region=exonic/splicing)		146119 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604040_[GENE=RAD50_PHENOS=Nijmegen_breakage_syndrome-like_disorder,613078,Autosomal_recessive]
chr5	132202309	132202737	trio	428	3	14	0.01144	0.121	0.000		GDF9,UQCRQ	GDF9 (oe_lof=0.70 region=intronic/intergenic),UQCRQ (oe_lof=0.62 region=exonic/splicing)		146119 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58360 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	601918_[GENE=GDF9_PHENOS=Premature_ovarian_failure_14,618014,Autosomal_recessive],612080_[GENE=UQCRQ_PHENOS=Mitochondrial_complex_III_deficiency,nuclear_type_4,615159,Autosomal_recessive]
chr5	138609431	138609860	trio	429	4	17	0.00026	0.172	0.000		MATR3,SNORA74A	MATR3 (oe_lof=0.00 region=intronic/intergenic),SNORA74A (oe_lof=n/a region=intronic/intergenic)		144268 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145330 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58117 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],988915 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	164015_[GENE=MATR3_PHENOS=Amyotrophic_lateral_sclerosis_21,606070,Autosomal_dominant]
chr5	138629323	138629727	trio	404	4	9	0.00424	0.217	0.000		MATR3	MATR3 (oe_lof=0.00 region=exonic/splicing)		144268 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145330 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58117 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],988915 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	164015_[GENE=MATR3_PHENOS=Amyotrophic_lateral_sclerosis_21,606070,Autosomal_dominant]
chr5	140026831	140026957	trio	126	3	4	0.05315	0.096	0.000		TMCO6,NDUFA2,IK,MIR3655	TMCO6 (oe_lof=0.67 region=intronic/intergenic),NDUFA2 (oe_lof=0.00 region=exonic/splicing),IK (oe_lof=0.40 region=intronic/intergenic),MIR3655 (oe_lof=n/a region=intronic/intergenic)		145330 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563111 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	602137_[GENE=NDUFA2_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_13,618235,Autosomal_recessive]
chr5	146460612	146461043	trio	431	3	11	0.00264	0.025	0.000		PPP2R2B	PPP2R2B (oe_lof=0.09 region=exonic/splicing)		147500 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604325_[GENE=PPP2R2B_PHENOS=Spinocerebellar_ataxia_12,604326,Autosomal_dominant]
chr5	149912497	149912604	trio	107	1	5	0.03497	0.070	0.000		NDST1	NDST1 (oe_lof=0.07 region=exonic/splicing)			600853_[GENE=NDST1_PHENOS=Mental_retardation,autosomal_recessive_46,616116,Autosomal_recessive]
chr5	150632603	150632868	trio	265	3	7	0.00844	0.134	0.000		GM2A	GM2A (oe_lof=0.50 region=exonic/splicing)			613109_[GENE=GM2A_PHENOS=GM2-gangliosidosis,AB_variant,272750,Autosomal_recessive]
chr5	156607897	156608136	trio	239	3	6	0.02297	0.089	0.000		ITK	ITK (oe_lof=0.49 region=exonic/splicing)	ITK [HI=Gene associated with autosomal recessive phenotype PMIDS=]		186973_[GENE=ITK_PHENOS=Lymphoproliferative_syndrome_1,613011,Autosomal_recessive]
chr5	156638288	156638389	trio	101	3	4	0.01768	0.045	0.000		ITK	ITK (oe_lof=0.49 region=exonic/splicing)	ITK [HI=Gene associated with autosomal recessive phenotype PMIDS=]		186973_[GENE=ITK_PHENOS=Lymphoproliferative_syndrome_1,613011,Autosomal_recessive]
chr5	156675850	156676027	trio	177	3	4	0.01920	0.108	0.000		ITK	ITK (oe_lof=0.49 region=exonic/splicing)	ITK [HI=Gene associated with autosomal recessive phenotype PMIDS=]		186973_[GENE=ITK_PHENOS=Lymphoproliferative_syndrome_1,613011,Autosomal_recessive]
chr5	161275532	161275628	trio	96	1	5	0.03360	0.166	0.000		GABRA1	GABRA1 (oe_lof=0.14 region=intronic/intergenic)	GABRA1 [HI=Some evidence for dosage pathogenicity PMIDS=16718694,21714819,22812724]	443157 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],814757 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814759 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],980748 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	137160_[GENE=GABRA1_PHENOS=Epilepsy,juvenile_myoclonic,susceptibility_to,5,611136/Developmental_and_epileptic_encephalopathy_19,615744,Autosomal_dominant/Epilepsy,childhood_absence,susceptibility_to,4,611136]
chr5	172661743	172662325	trio	582	1	4	0.04096	0.255	0.000		NKX2-5	NKX2-5 (oe_lof=0.00 region=exonic/splicing)	NKX2-5 [HI=Sufficient evidence for dosage pathogenicity PMIDS=28690296,26679770,17891520]	58395 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58396 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600584_[GENE=NKX2-5_PHENOS=Hypoplastic_left_heart_syndrome_2,614435,Autosomal_dominant/Tetralogy_of_Fallot,187500,Autosomal_dominant/Hypothyroidism,congenital_nongoitrous,5,225250,Autosomal_dominant/Conotruncal_heart_malformations,variable,217095/Ventricular_septal_defect_3,614432,Autosomal_dominant/Atrial_septal_defect_7,with_or_without_AV_conduction_defects,108900,Autosomal_dominant]
chr6	31991697	31992439	trio	742	1	2	0.13947	0.140	1.000 (0.98,0.98)		C4B	C4B (oe_lof=0.16 region=exonic/splicing)		814807 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120820_[GENE=C4B_PHENOS=C4B_deficiency,614379]
chr6	32805304	32806024	trio	720	3	5	0.02682	0.134	0.000		TAP2,PSMB8	TAP2 (oe_lof=0.57 region=exonic/splicing),PSMB8 (oe_lof=0.37 region=intronic/intergenic)		814807 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	170261_[GENE=TAP2_PHENOS=Bare_lymphocyte_syndrome,type_I,due_to_TAP2_deficiency,604571,Autosomal_recessive],177046_[GENE=PSMB8_PHENOS=Proteasome-associated_autoinflammatory_syndrome_1_and_digenic_forms,256040,Autosomal_recessive]
chr6	32819876	32820289	trio	413	3	11	0.00014	0.051	0.000		PSMB9,TAP1	PSMB9 (oe_lof=0.48 region=intronic/intergenic),TAP1 (oe_lof=0.43 region=exonic/splicing)		814807 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	170260_[GENE=TAP1_PHENOS=Bare_lymphocyte_syndrome,type_I,604571,Autosomal_recessive],177045_[GENE=PSMB9_PHENOS=Proteasome-associated_autoinflammatory_syndrome_3,digenic,617591,Autosomal_recessive]
chr6	33280984	33281651	trio	667	3	2	0.05775	0.191	0.000		TAPBP,ZBTB22,DAXX	TAPBP (oe_lof=0.77 region=exonic/splicing),ZBTB22 (oe_lof=0.25 region=intronic/intergenic),DAXX (oe_lof=0.26 region=intronic/intergenic)		814807 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	601962_[GENE=TAPBP_PHENOS=Bare_lymphocyte_syndrome,type_I,604571,Autosomal_recessive]
chr6	35427449	35427547	trio	98	1	4	0.04421	0.057	0.000		FANCE	FANCE (oe_lof=0.56 region=exonic/splicing)	FANCE [HI=Gene associated with autosomal recessive phenotype PMIDS=]	563171 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],997072 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Severe intrauterine growth retardation"]	613976_[GENE=FANCE_PHENOS=Fanconi_anemia,complementation_group_E,600901,Autosomal_recessive]
chr6	39880626	39880758	trio	132	1	4	0.01768	0.032	0.000		MOCS1	MOCS1 (oe_lof=0.67 region=exonic/splicing)			603707_[GENE=MOCS1_PHENOS=Molybdenum_cofactor_deficiency_A,252150,Autosomal_recessive]
chr6	43543868	43544187	trio	319	3	8	0.01367	0.089	0.000		XPO5,POLH	XPO5 (oe_lof=0.15 region=intronic/intergenic),POLH (oe_lof=0.57 region=intronic/intergenic)	POLH [HI=Gene associated with autosomal recessive phenotype PMIDS=]	57326 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58428 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	603968_[GENE=POLH_PHENOS=Xeroderma_pigmentosum,variant_type,278750,Autosomal_recessive]
chr6	52925724	52925854	trio	130	3	7	0.01463	0.089	0.000		CILK1,FBXO9	CILK1 (oe_lof=0.40 region=intronic/intergenic),FBXO9 (oe_lof=0.42 region=intronic/intergenic)		147999 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	612325_[GENE=CILK1_PHENOS=Epilepsy,juvenile_myoclonic,susceptibility_to,10,617924,Autosomal_dominant/Endocrine-cerebroosteodysplasia,612651,Autosomal_recessive]
chr6	57072416	57072521	trio	105	3	3	0.02518	0.038	0.000		RAB23	RAB23 (oe_lof=0.42 region=exonic/splicing)			606144_[GENE=RAB23_PHENOS=Carpenter_syndrome,201000,Autosomal_recessive]
chr6	88234265	88234380	trio	115	3	5	0.03312	0.210	0.000		RARS2	RARS2 (oe_lof=0.67 region=exonic/splicing)	RARS2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	814842 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	611524_[GENE=RARS2_PHENOS=Pontocerebellar_hypoplasia,type_6,611523,Autosomal_recessive]
chr6	88299630	88299745	trio	115	3	4	0.04262	0.172	0.000		RARS2,ORC3	RARS2 (oe_lof=0.67 region=exonic/splicing),ORC3 (oe_lof=0.50 region=intronic/intergenic)	RARS2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	814842 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	611524_[GENE=RARS2_PHENOS=Pontocerebellar_hypoplasia,type_6,611523,Autosomal_recessive]
chr6	100841353	100868844	trio	27491	3	8	0.15127	0.255	0.000		SIM1	SIM1 (oe_lof=0.11 region=exonic/splicing)	SIM1 [HI=Little evidence for dosage pathogenicity PMIDS=10587584]	58439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr6	100897229	100897581	trio	352	1	3	0.07839	0.172	0.000		SIM1	SIM1 (oe_lof=0.11 region=exonic/splicing)	SIM1 [HI=Little evidence for dosage pathogenicity PMIDS=10587584]	58439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr6	100964046	100966028	trio	1982	3	7	0.03262	0.070	0.000		ASCC3	ASCC3 (oe_lof=0.45 region=exonic/splicing)		58439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr6	101846851	101847278	trio	427	1	3	0.05715	0.229	0.000		GRIK2	GRIK2 (oe_lof=0.13 region=exonic/splicing)	GRIK2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	58439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	138244_[GENE=GRIK2_PHENOS=Mental_retardation,autosomal_recessive,6,611092,Autosomal_recessive]
chr6	107780184	107780789	trio	605	3	7	0.01571	0.096	0.000		PDSS2	PDSS2 (oe_lof=0.72 region=exonic/splicing)		1047881 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Autistic disorder of childhood onset"],152877 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610564_[GENE=PDSS2_PHENOS=Coenzyme_Q10_deficiency,primary,3,614652,Autosomal_recessive]
chr6	110012414	110012714	trio	300	3	5	0.02518	0.204	0.000		AK9,FIG4	AK9 (oe_lof=0.59 region=intronic/intergenic),FIG4 (oe_lof=0.98 region=exonic/splicing)		148323 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],152877 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	609390_[GENE=FIG4_PHENOS=Yunis-Varon_syndrome,216340,Autosomal_recessive/Polymicrogyria,bilateral_temporooccipital,612691,Autosomal_recessive/Amyotrophic_lateral_sclerosis_11,612577,Autosomal_dominant/Charcot-Marie-Tooth_disease,type_4J,611228,Autosomal_recessive]
chr6	152557942	152558093	trio	151	3	4	0.04988	0.178	0.000		SYNE1	SYNE1 (oe_lof=0.37 region=exonic/splicing)		814879 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979577 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	608441_[GENE=SYNE1_PHENOS=Arthrogryposis_multiplex_congenita_3,myogenic_type,618484,Autosomal_recessive/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998,Autosomal_dominant/Spinocerebellar_ataxia,autosomal_recessive_8,610743,Autosomal_recessive]
chr6	152622994	152623208	trio	214	3	6	0.01891	0.146	0.000		SYNE1	SYNE1 (oe_lof=0.37 region=exonic/splicing)		814879 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979577 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	608441_[GENE=SYNE1_PHENOS=Arthrogryposis_multiplex_congenita_3,myogenic_type,618484,Autosomal_recessive/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998,Autosomal_dominant/Spinocerebellar_ataxia,autosomal_recessive_8,610743,Autosomal_recessive]
chr6	152639988	152640160	trio	172	3	3	0.02740	0.032	0.000		SYNE1	SYNE1 (oe_lof=0.37 region=exonic/splicing)		814879 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979577 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	608441_[GENE=SYNE1_PHENOS=Arthrogryposis_multiplex_congenita_3,myogenic_type,618484,Autosomal_recessive/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998,Autosomal_dominant/Spinocerebellar_ataxia,autosomal_recessive_8,610743,Autosomal_recessive]
chr6	152763200	152763390	trio	190	3	3	0.08332	0.166	0.000		SYNE1	SYNE1 (oe_lof=0.37 region=exonic/splicing)		814879 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979577 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	608441_[GENE=SYNE1_PHENOS=Arthrogryposis_multiplex_congenita_3,myogenic_type,618484,Autosomal_recessive/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998,Autosomal_dominant/Spinocerebellar_ataxia,autosomal_recessive_8,610743,Autosomal_recessive]
chr6	157222500	157222669	trio	169	3	5	0.03263	0.159	0.000		ARID1B	ARID1B (oe_lof=0.04 region=exonic/splicing)	ARID1B [HI=Sufficient evidence for dosage pathogenicity PMIDS=22426308,21801163,22405089]	1047882 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Corpus callosum, agenesis of;Neurodevelopmental delay;Cleft lip;Ectopic scrotum"],145547 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],147313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395957 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397140 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442537 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57138 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],625549 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Coffin-Siris syndrome 1"],625786 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Coffin-Siris syndrome 1"],813718 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Microcephaly"],814887 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	614556_[GENE=ARID1B_PHENOS=Coffin-Siris_syndrome_1,135900,Autosomal_dominant]
chr6	157431596	157431705	trio	109	4	8	0.01144	0.280	0.000		ARID1B	ARID1B (oe_lof=0.04 region=exonic/splicing)	ARID1B [HI=Sufficient evidence for dosage pathogenicity PMIDS=22426308,21801163,22405089]	1047882 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Corpus callosum, agenesis of;Neurodevelopmental delay;Cleft lip;Ectopic scrotum"],145547 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],147313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395957 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396649 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397140 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442537 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],563243 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],625549 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Coffin-Siris syndrome 1"],625786 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Coffin-Siris syndrome 1"],813718 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Microcephaly"],979578 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	614556_[GENE=ARID1B_PHENOS=Coffin-Siris_syndrome_1,135900,Autosomal_dominant]
chr6	157488164	157488329	trio	165	3	4	0.02842	0.096	0.000		ARID1B	ARID1B (oe_lof=0.04 region=exonic/splicing)	ARID1B [HI=Sufficient evidence for dosage pathogenicity PMIDS=22426308,21801163,22405089]	1047882 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Corpus callosum, agenesis of;Neurodevelopmental delay;Cleft lip;Ectopic scrotum"],145547 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],147313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395957 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396649 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396712 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397140 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442537 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],625549 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Coffin-Siris syndrome 1"],625786 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Coffin-Siris syndrome 1"]	614556_[GENE=ARID1B_PHENOS=Coffin-Siris_syndrome_1,135900,Autosomal_dominant]
chr6	161152767	161152935	trio	168	3	4	0.03866	0.070	0.000		PLG	PLG (oe_lof=0.28 region=exonic/splicing)			173350_[GENE=PLG_PHENOS=Dysplasminogenemia,217090,Autosomal_recessive/Angioedema,hereditary,4,619360,Autosomal_dominant/Plasminogen_deficiency,type_I,217090,Autosomal_recessive]
chr7	73461016	73461107	trio	91	4	4	0.07715	0.293	0.000	7q11.23 duplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/43],Williams-Beuren Syndrome (WBS) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/3]	ELN	ELN (oe_lof=0.64 region=exonic/splicing)	ELN [HI=Sufficient evidence for dosage pathogenicity PMIDS=]	144156 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144925 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146774 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146803 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146807 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146838 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147066 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147170 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147629 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149043 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149044 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149308 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149309 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150236 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150322 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151015 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151986 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152064 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153242 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153973 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153978 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154080 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154259 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154347 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154623 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154824 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155323 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155565 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160822 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160823 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],221994 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253423 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253539 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253635 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],268059 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32380 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32643 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33969 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395004 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395817 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395890 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396001 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396015 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396172 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396497 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396539 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396547 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396805 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396832 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396835 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397265 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397405 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397483 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441785 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442110 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442171 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442230 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442280 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442483 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442651 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442785 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442970 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443008 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443182 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443244 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443396 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443516 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443615 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443819 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443917 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],523283 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Global developmental delay;Abnormal facial shape;Generalized hypotonia"],523284 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="15 conditions"],563394 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563396 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563397 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563398 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563399 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563405 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563406 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563409 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57316 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58217 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58218 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58219 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58237 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58238 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58239 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58240 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59315 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59316 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59317 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59318 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59319 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59320 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59321 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],610153 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610154 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610155 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610156 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610158 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610159 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610160 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625551 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],625629 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],625630 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],625631 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],625632 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],814990 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814991 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],929343 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],979621 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979622 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980829 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],988936 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	130160_[GENE=ELN_PHENOS=Cutis_laxa,autosomal_dominant,123700,Autosomal_dominant/Supravalvar_aortic_stenosis,185500,Autosomal_dominant]
chr7	73474696	73474841	trio	145	1	5	0.01707	0.045	0.000	7q11.23 duplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/43],Williams-Beuren Syndrome (WBS) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/3]	ELN,ELN-AS1	ELN (oe_lof=0.64 region=exonic/splicing),ELN-AS1 (oe_lof=n/a region=intronic/intergenic)	ELN [HI=Sufficient evidence for dosage pathogenicity PMIDS=]	144156 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144925 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146774 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146803 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146807 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146838 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147066 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147170 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147629 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149043 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149044 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149308 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149309 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150236 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150322 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151015 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151986 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152064 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153242 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153973 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153978 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154080 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154259 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154347 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154623 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154824 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155323 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155565 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160822 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160823 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160898 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],221994 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253423 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253539 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253635 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],268059 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32380 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32643 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33969 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395004 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395455 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395817 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395890 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396001 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396015 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396172 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396497 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396539 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396547 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396805 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396832 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396835 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397265 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397405 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397483 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441785 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442110 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442171 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442230 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442280 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442483 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442651 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442785 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442970 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443008 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443182 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443244 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443396 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443516 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443615 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443819 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443917 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],523283 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Global developmental delay;Abnormal facial shape;Generalized hypotonia"],523284 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="15 conditions"],563394 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563396 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563397 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563398 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563399 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563405 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563406 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563409 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57316 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58217 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58218 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58219 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58237 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58238 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58239 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58240 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59315 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59316 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59317 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59318 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59319 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59320 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59321 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],610153 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610154 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610155 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610156 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610158 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610159 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610160 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625551 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],625629 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],625630 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],625631 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],625632 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],814990 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814991 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],929343 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],979621 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979622 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980829 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],988936 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	130160_[GENE=ELN_PHENOS=Cutis_laxa,autosomal_dominant,123700,Autosomal_dominant/Supravalvar_aortic_stenosis,185500,Autosomal_dominant]
chr7	74203373	74203669	trio	296	4	4	0.03323	0.191	1.000 (0.03,0.03)		STAG3L2,NCF1	STAG3L2 (oe_lof=n/a region=intronic/intergenic),NCF1 (oe_lof=0.65 region=exonic/splicing)	NCF1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	144156 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146838 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147170 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150322 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151015 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152064 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154347 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154623 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160823 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253341 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253423 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],268059 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33969 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396001 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441785 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442280 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443182 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563405 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563406 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563409 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57316 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58217 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58218 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58238 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58240 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60247 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],610157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625629 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],625630 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Williams syndrome"],687730 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],814990 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979622 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	608512_[GENE=NCF1_PHENOS=Chronic_granulomatous_disease_1,autosomal_recessive,233700,Autosomal_recessive]
chr7	94029498	94052440	trio	22942	3	19	0.11223	0.178	0.000		COL1A2	COL1A2 (oe_lof=0.12 region=exonic/splicing)		148490 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153321 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563412 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],610262 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],976777 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Myoclonic dystonia 11"]	120160_[GENE=COL1A2_PHENOS=Osteogenesis_imperfecta,type_III,259420,Autosomal_dominant/Osteoporosis,postmenopausal,166710,Autosomal_dominant/Ehlers-Danlos_syndrome,arthrochalasia_type,2,617821,Autosomal_dominant/Combined_osteogenesis_imperfecta_and_Ehlers-Danlos_syndrome_2,619120,Autosomal_dominant/Ehlers-Danlos_syndrome,cardiac_valvular_type,225320,Autosomal_recessive/Osteogenesis_imperfecta,type_IV,166220,Autosomal_dominant/Osteogenesis_imperfecta,type_II,166210,Autosomal_dominant]
chr7	99701022	99701152	trio	130	1	4	0.05134	0.191	0.000		MCM7,AP4M1,TAF6	MCM7 (oe_lof=0.97 region=intronic/intergenic),AP4M1 (oe_lof=0.95 region=exonic/splicing),TAF6 (oe_lof=0.53 region=intronic/intergenic)		146501 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563415 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],59713 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60280 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],929826 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	602296_[GENE=AP4M1_PHENOS=Spastic_paraplegia_50,autosomal_recessive,612936,Autosomal_recessive],602955_[GENE=TAF6_PHENOS=Alazami-Yuan_syndrome,617126,Autosomal_recessive]
chr7	103191504	103191753	trio	249	4	5	0.04062	0.280	0.000		RELN	RELN (oe_lof=0.12 region=exonic/splicing)	RELN [HI=Gene associated with autosomal recessive phenotype PMIDS=]	563407 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57092 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60283 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600514_[GENE=RELN_PHENOS=Epilepsy,familial_temporal_lobe,7,616436,Autosomal_dominant/Lissencephaly_2_(Norman-Roberts_type),257320,Autosomal_recessive]
chr7	103202250	103202410	trio	160	3	4	0.05074	0.108	0.000		RELN	RELN (oe_lof=0.12 region=exonic/splicing)	RELN [HI=Gene associated with autosomal recessive phenotype PMIDS=]	563407 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57092 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60283 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600514_[GENE=RELN_PHENOS=Epilepsy,familial_temporal_lobe,7,616436,Autosomal_dominant/Lissencephaly_2_(Norman-Roberts_type),257320,Autosomal_recessive]
chr7	127958000	127958169	trio	169	3	3	0.06193	0.159	0.000		RBM28	RBM28 (oe_lof=0.58 region=exonic/splicing)			612074_[GENE=RBM28_PHENOS=Alopecia,neurologic_defects,and_endocrinopathy_syndrome,612079,Autosomal_recessive]
chr7	127983720	127983972	trio	252	4	8	0.01152	0.287	0.000		RBM28,RNU7-27P	RBM28 (oe_lof=0.58 region=exonic/splicing),RNU7-27P (oe_lof=n/a region=intronic/intergenic)			612074_[GENE=RBM28_PHENOS=Alopecia,neurologic_defects,and_endocrinopathy_syndrome,612079,Autosomal_recessive]
chr7	128477681	128477819	trio	138	3	4	0.03156	0.064	0.000		FLNC	FLNC (oe_lof=0.17 region=exonic/splicing)			102565_[GENE=FLNC_PHENOS=Cardiomyopathy,familial_hypertrophic,26,617047,Autosomal_dominant/Cardiomyopathy,familial_restrictive_5,617047,Autosomal_dominant/Myopathy,distal,4,614065,Autosomal_dominant/Myopathy,myofibrillar,5,609524,Autosomal_dominant]
chr7	128480878	128481034	trio	156	1	9	0.00662	0.025	0.000		FLNC	FLNC (oe_lof=0.17 region=exonic/splicing)			102565_[GENE=FLNC_PHENOS=Cardiomyopathy,familial_hypertrophic,26,617047,Autosomal_dominant/Cardiomyopathy,familial_restrictive_5,617047,Autosomal_dominant/Myopathy,distal,4,614065,Autosomal_dominant/Myopathy,myofibrillar,5,609524,Autosomal_dominant]
chr7	128487989	128488132	trio	143	1	3	0.05715	0.299	0.000		FLNC	FLNC (oe_lof=0.17 region=exonic/splicing)			102565_[GENE=FLNC_PHENOS=Cardiomyopathy,familial_hypertrophic,26,617047,Autosomal_dominant/Cardiomyopathy,familial_restrictive_5,617047,Autosomal_dominant/Myopathy,distal,4,614065,Autosomal_dominant/Myopathy,myofibrillar,5,609524,Autosomal_dominant]
chr7	128495243	128495378	trio	135	1	8	0.00978	0.274	0.000		FLNC	FLNC (oe_lof=0.17 region=exonic/splicing)			102565_[GENE=FLNC_PHENOS=Cardiomyopathy,familial_hypertrophic,26,617047,Autosomal_dominant/Cardiomyopathy,familial_restrictive_5,617047,Autosomal_dominant/Myopathy,distal,4,614065,Autosomal_dominant/Myopathy,myofibrillar,5,609524,Autosomal_dominant]
chr7	142997006	142997154	trio	148	3	10	0.00848	0.070	0.000		CASP2,RN7SL481P	CASP2 (oe_lof=0.38 region=exonic/splicing),RN7SL481P (oe_lof=n/a region=intronic/intergenic)		144163 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57046 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr7	143029807	143036425	trio	6618	3	4	0.12455	0.102	0.000		CLCN1	CLCN1 (oe_lof=0.76 region=exonic/splicing)		144163 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57046 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	118425_[GENE=CLCN1_PHENOS=Myotonia_levior,recessive/Myotonia_congenita,recessive,255700,Autosomal_recessive/Myotonia_congenita,dominant,160800,Autosomal_dominant]
chr7	148080731	148080990	trio	259	3	3	0.07702	0.274	0.000		CNTNAP2	CNTNAP2 (oe_lof=0.40 region=exonic/splicing)	CNTNAP2 [HI=Little evidence for dosage pathogenicity PMIDS=22031302]	146688 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57185 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604569_[GENE=CNTNAP2_PHENOS=Pitt-Hopkins_like_syndrome_1,610042,Autosomal_recessive/Cortical_dysplasia-focal_epilepsy_syndrome,610042,Autosomal_recessive/Autism_susceptibility_15,612100]
chr8	1814682	1814778	trio	96	3	4	0.04262	0.178	0.000		ARHGEF10	ARHGEF10 (oe_lof=0.78 region=exonic/splicing)		145578 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147569 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148183 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],152253 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],161035 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32497 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563540 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60328 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60329 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60342 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60346 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625667 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],815067 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979227 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	608136_[GENE=ARHGEF10_PHENOS=Slowed_nerve_conduction_velocity,AD,608236,Autosomal_dominant]
chr8	1900861	1901003	trio	142	3	3	0.05221	0.083	0.000		ARHGEF10	ARHGEF10 (oe_lof=0.78 region=exonic/splicing)		145578 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147569 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148183 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],152253 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],161035 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32497 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563540 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60328 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60329 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60342 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625667 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],815067 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979227 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	608136_[GENE=ARHGEF10_PHENOS=Slowed_nerve_conduction_velocity,AD,608236,Autosomal_dominant]
chr8	24812976	24814141	trio	1165	1	5	0.02682	0.076	0.000		NEFL	NEFL (oe_lof=n/a region=exonic/splicing)		686366 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686595 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815113 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	162280_[GENE=NEFL_PHENOS=Charcot-Marie-Tooth_disease,type_1F,607734,Autosomal_dominant,Autosomal_recessive/Charcot-Marie-Tooth_disease,dominant_intermediate_G,617882,Autosomal_dominant/Charcot-Marie-Tooth_disease,type_2E,607684,Autosomal_dominant]
chr8	33367254	33367460	trio	206	3	3	0.05412	0.102	0.000		TTI2,SNORD13	TTI2 (oe_lof=0.66 region=exonic/splicing),SNORD13 (oe_lof=n/a region=intronic/intergenic)		563535 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	614426_[GENE=TTI2_PHENOS=Mental_retardation,autosomal_recessive_39,615541,Autosomal_recessive]
chr8	38003471	38003675	trio	204	3	5	0.01920	0.038	0.000		STAR	STAR (oe_lof=1.06 region=exonic/splicing)		145616 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150494 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395746 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59782 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600617_[GENE=STAR_PHENOS=Lipoid_adrenal_hyperplasia,201710,Autosomal_recessive]
chr8	38008263	38008610	trio	347	3	5	0.02270	0.261	0.000		STAR	STAR (oe_lof=1.06 region=exonic/splicing)		145616 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150494 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395746 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59782 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600617_[GENE=STAR_PHENOS=Lipoid_adrenal_hyperplasia,201710,Autosomal_recessive]
chr8	43024306	43025847	trio	1541	3	6	0.03058	0.076	0.000		HGSNAT	HGSNAT (oe_lof=0.49 region=exonic/splicing)		154596 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394062 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59784 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610453_[GENE=HGSNAT_PHENOS=Mucopolysaccharidosis_type_IIIC_(Sanfilippo_C),252930,Autosomal_recessive/Retinitis_pigmentosa_73,616544,Autosomal_recessive]
chr8	43048890	43048996	trio	106	3	8	0.01429	0.051	0.000		HGSNAT	HGSNAT (oe_lof=0.49 region=exonic/splicing)		154596 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394062 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59784 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610453_[GENE=HGSNAT_PHENOS=Mucopolysaccharidosis_type_IIIC_(Sanfilippo_C),252930,Autosomal_recessive/Retinitis_pigmentosa_73,616544,Autosomal_recessive]
chr8	48734155	48734363	trio	208	3	3	0.08850	0.217	0.000		PRKDC	PRKDC (oe_lof=0.02 region=exonic/splicing)		688051 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	600899_[GENE=PRKDC_PHENOS=Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966,Autosomal_recessive]
chr8	61192238	61192449	trio	211	3	5	0.04018	0.306	0.000		CA8	CA8 (oe_lof=0.36 region=exonic/splicing)	CA8 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	60363 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],977789 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="duplication 8q12"]	114815_[GENE=CA8_PHENOS=Cerebellar_ataxia_and_mental_retardation_with_or_without_quadrupedal_locomotion_3,613227,Autosomal_recessive]
chr8	90955471	90958533	trio	3062	3	5	0.00964	0.051	0.000		NBN	NBN (oe_lof=0.74 region=exonic/splicing)	NBN [HI=Sufficient evidence for dosage pathogenicity PMIDS=17957789,30590007,22864661]		602667_[GENE=NBN_PHENOS=Leukemia,acute_lymphoblastic,613065/Aplastic_anemia,609135/Nijmegen_breakage_syndrome,251260,Autosomal_recessive]
chr8	94767062	94768104	trio	1042	3	10	0.18069	0.197	0.000		TMEM67	TMEM67 (oe_lof=0.74 region=exonic/splicing)	TMEM67 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	147309 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441773 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],60381 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60383 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60386 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	609884_[GENE=TMEM67_PHENOS=Nephronophthisis_11,613550,Autosomal_recessive/Bardet-Biedl_syndrome_14,modifier_of,615991,Autosomal_recessive/Joubert_syndrome_6,610688,Autosomal_recessive/Meckel_syndrome_3,607361,Autosomal_recessive/RHYNS_syndrome,602152,Autosomal_recessive/COACH_syndrome_1,216360,Autosomal_recessive]
chr8	94929982	94930183	trio	201	3	5	0.02038	0.178	0.000		MIR378D2,PDP1	MIR378D2 (oe_lof=n/a region=intronic/intergenic),PDP1 (oe_lof=0.21 region=exonic/splicing)		147309 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441773 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],60381 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60383 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60386 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	605993_[GENE=PDP1_PHENOS=Pyruvate_dehydrogenase_phosphatase_deficiency,608782,Autosomal_recessive]
chr8	97245374	97246774	trio	1400	3	9	0.03449	0.172	0.000		UQCRB,MTERF3	UQCRB (oe_lof=0.47 region=exonic/splicing),MTERF3 (oe_lof=0.82 region=intronic/intergenic)		60388 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],666435 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="Leri pleonosteosis"],815145 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],979843 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	191330_[GENE=UQCRB_PHENOS=Mitochondrial_complex_III_deficiency,nuclear_type_3,615158,Autosomal_recessive]
chr8	100830669	100831126	trio	457	3	3	0.01920	0.038	0.000		VPS13B	VPS13B (oe_lof=0.55 region=exonic/splicing)	VPS13B [HI=Gene associated with autosomal recessive phenotype PMIDS=]	148247 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],563534 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607817_[GENE=VPS13B_PHENOS=Cohen_syndrome,216550,Autosomal_recessive]
chr8	100871522	100871718	trio	196	4	4	0.05619	0.223	0.000		VPS13B	VPS13B (oe_lof=0.55 region=exonic/splicing)	VPS13B [HI=Gene associated with autosomal recessive phenotype PMIDS=]	148247 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],563534 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607817_[GENE=VPS13B_PHENOS=Cohen_syndrome,216550,Autosomal_recessive]
chr8	120831576	120845084	trio	13508	3	10	0.01450	0.153	0.000		TAF2,DSCC1	TAF2 (oe_lof=0.28 region=exonic/splicing),DSCC1 (oe_lof=0.36 region=intronic/intergenic)	TAF2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	60406 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604912_[GENE=TAF2_PHENOS=Mental_retardation,autosomal_recessive_40,615599,Autosomal_recessive]
chr8	126044473	126044646	trio	173	3	4	0.04992	0.076	0.000		WASHC5	WASHC5 (oe_lof=0.57 region=exonic/splicing)		57127 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610657_[GENE=WASHC5_PHENOS=Ritscher-Schinzel_syndrome_1,220210,Autosomal_recessive/Spastic_paraplegia_8,autosomal_dominant,603563,Autosomal_dominant]
chr8	133895049	133895254	trio	205	3	7	0.01843	0.102	0.000		TG	TG (oe_lof=0.76 region=exonic/splicing)		57119 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	188450_[GENE=TG_PHENOS=Autoimmune_thyroid_disease,susceptibility_to,3,608175/Thyroid_dyshormonogenesis_3,274700,Autosomal_recessive]
chr8	133909884	133910041	trio	157	3	7	0.01707	0.121	0.000		TG	TG (oe_lof=0.76 region=exonic/splicing)		57119 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	188450_[GENE=TG_PHENOS=Autoimmune_thyroid_disease,susceptibility_to,3,608175/Thyroid_dyshormonogenesis_3,274700,Autosomal_recessive]
chr8	133920421	133920595	trio	174	3	5	0.04062	0.102	0.000		TG	TG (oe_lof=0.76 region=exonic/splicing)		57119 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	188450_[GENE=TG_PHENOS=Autoimmune_thyroid_disease,susceptibility_to,3,608175/Thyroid_dyshormonogenesis_3,274700,Autosomal_recessive]
chr8	140714943	140715309	trio	366	1	7	0.01920	0.242	0.000		KCNK9	KCNK9 (oe_lof=0.00 region=exonic/splicing)			605874_[GENE=KCNK9_PHENOS=Birk-Barel_syndrome,612292]
chr8	140744212	140898223	trio	154011	4	8	0.04030	0.210	0.000		TRAPPC9	TRAPPC9 (oe_lof=0.55 region=exonic/splicing)	TRAPPC9 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	915964 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Mental retardation, autosomal recessive 13"]	611966_[GENE=TRAPPC9_PHENOS=Mental_retardation,autosomal_recessive_13,613192,Autosomal_recessive]
chr8	141297697	141297843	trio	146	3	7	0.02459	0.089	0.000		TRAPPC9	TRAPPC9 (oe_lof=0.55 region=exonic/splicing)	TRAPPC9 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		611966_[GENE=TRAPPC9_PHENOS=Mental_retardation,autosomal_recessive_13,613192,Autosomal_recessive]
chr8	141468370	141468688	trio	318	3	4	0.04424	0.166	0.000		TRAPPC9	TRAPPC9 (oe_lof=0.55 region=exonic/splicing)	TRAPPC9 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		611966_[GENE=TRAPPC9_PHENOS=Mental_retardation,autosomal_recessive_13,613192,Autosomal_recessive]
chr8	145006558	145007529	trio	971	1	3	0.02271	0.121	0.000		PLEC	PLEC (oe_lof=0.31 region=exonic/splicing)		146735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152355 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],523293 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Intellectual disability"],563531 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625552 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Verheij syndrome"],815173 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979858 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	601282_[GENE=PLEC_PHENOS=Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487,Autosomal_recessive/Epidermolysis_bullosa_simplex,Ogna_type,131950,Autosomal_dominant/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138,Autosomal_recessive/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723,Autosomal_recessive/Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670,Autosomal_recessive]
chr8	145008156	145008623	trio	467	4	17	0.00223	0.083	0.000		PLEC	PLEC (oe_lof=0.31 region=exonic/splicing)		146735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152355 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],523293 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Intellectual disability"],563531 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625552 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Verheij syndrome"],815173 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979858 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	601282_[GENE=PLEC_PHENOS=Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487,Autosomal_recessive/Epidermolysis_bullosa_simplex,Ogna_type,131950,Autosomal_dominant/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138,Autosomal_recessive/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723,Autosomal_recessive/Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670,Autosomal_recessive]
chr8	145009169	145011249	trio	2080	1	7	0.10522	0.191	0.000		PLEC	PLEC (oe_lof=0.31 region=exonic/splicing)		146735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152355 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],523293 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Intellectual disability"],563531 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625552 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Verheij syndrome"],815173 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979858 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	601282_[GENE=PLEC_PHENOS=Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487,Autosomal_recessive/Epidermolysis_bullosa_simplex,Ogna_type,131950,Autosomal_dominant/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138,Autosomal_recessive/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723,Autosomal_recessive/Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670,Autosomal_recessive]
chr9	286451	289591	trio	3140	3	4	0.10592	0.217	0.000		DOCK8	DOCK8 (oe_lof=0.36 region=exonic/splicing)		144708 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147488 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148184 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148849 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149486 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154196 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154563 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154749 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155570 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395051 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397097 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442111 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],547120 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],563599 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],563623 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],563670 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57352 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59063 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59066 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59837 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],689070 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815182 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815184 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815191 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980911 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983185 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],997066 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Autistic disorder of childhood onset"]	611432_[GENE=DOCK8_PHENOS=Hyper-IgE_recurrent_infection_syndrome,autosomal_recessive,243700,Autosomal_recessive]
chr9	470284	470384	trio	100	6	44	0.00000	0.191	0.000		KANK1	KANK1 (oe_lof=0.71 region=intronic/intergenic)		144708 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147488 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148184 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148849 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154196 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154563 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154749 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155570 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395051 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442111 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563623 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],563670 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57352 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59063 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59066 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59837 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],689070 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815184 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815198 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],980911 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983185 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	607704_[GENE=KANK1_PHENOS=Cerebral_palsy,spastic_quadriplegic,2,612900]
chr9	2073202	2073352	trio	150	3	5	0.01768	0.025	0.000		SMARCA2	SMARCA2 (oe_lof=0.12 region=exonic/splicing)		144708 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148184 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148849 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154196 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154563 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154749 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155570 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395051 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396183 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442111 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563670 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57352 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59063 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59066 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59837 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],689070 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983185 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600014_[GENE=SMARCA2_PHENOS=Nicolaides-Baraitser_syndrome,601358,Autosomal_dominant/Blepharophimosis-impaired_intellectual_development_syndrome,619293,Autosomal_dominant]
chr9	34646625	34647968	trio	1343	3	13	0.00737	0.057	0.000		GALT,IL11RA	GALT (oe_lof=0.55 region=exonic/splicing),IL11RA (oe_lof=1.13 region=intronic/intergenic)		145374 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600939_[GENE=IL11RA_PHENOS=Craniosynostosis_and_dental_anomalies,614188,Autosomal_recessive],606999_[GENE=GALT_PHENOS=Galactosemia,230400,Autosomal_recessive]
chr9	35079138	35658025	trio	578887	4	6	0.06097	0.121	0.003 (0.42)		FANCG,PIGO,STOML2,FAM214B,UNC13B,ATP8B5P,ZFAND6P1,RPL36AP33,RUSC2,FAM166B,TESK1,MIR4667,CD72,SIT1,RMRP,CCDC107,ARHGEF39	FANCG (oe_lof=0.78 region=exonic/splicing),PIGO (oe_lof=0.57 region=complete),STOML2 (oe_lof=0.39 region=complete),FAM214B (oe_lof=0.16 region=complete),UNC13B (oe_lof=0.46 region=complete),ATP8B5P (oe_lof=n/a region=complete),ZFAND6P1 (oe_lof=n/a region=complete),RPL36AP33 (oe_lof=n/a region=complete),RUSC2 (oe_lof=0.14 region=complete),FAM166B (oe_lof=1.15 region=complete),TESK1 (oe_lof=0.11 region=complete),MIR4667 (oe_lof=n/a region=complete),CD72 (oe_lof=0.32 region=complete),SIT1 (oe_lof=0.60 region=complete),RMRP (oe_lof=n/a region=exonic/splicing),CCDC107 (oe_lof=1.09 region=intronic/intergenic),ARHGEF39 (oe_lof=0.85 region=intronic/intergenic)	FANCG [HI=Gene associated with autosomal recessive phenotype PMIDS=],PIGO [HI=Gene associated with autosomal recessive phenotype PMIDS=]	1210154 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Neurodevelopmental disorder"],144556 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145374 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	157660_[GENE=RMRP_PHENOS=Anauxetic_dysplasia_1,607095,Autosomal_recessive/Metaphyseal_dysplasia_without_hypotrichosis,250460,Autosomal_recessive/Cartilage-hair_hypoplasia,250250,Autosomal_recessive],602956_[GENE=FANCG_PHENOS=Fanconi_anemia,complementation_group_G,614082,Autosomal_recessive],611053_[GENE=RUSC2_PHENOS=Mental_retardation,autosomal_recessive_61,617773,Autosomal_recessive],614730_[GENE=PIGO_PHENOS=Hyperphosphatasia_with_mental_retardation_syndrome_2,614749,Autosomal_recessive]
chr9	35684719	35684814	trio	95	1	3	0.03442	0.051	0.000		CA9,TPM2	CA9 (oe_lof=0.73 region=intronic/intergenic),TPM2 (oe_lof=0.47 region=exonic/splicing)		1210154 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Neurodevelopmental disorder"],144556 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145374 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	190990_[GENE=TPM2_PHENOS=Arthrogryposis,distal,type_2B4,108120,Autosomal_dominant/Arthrogryposis,distal,type_1A,108120,Autosomal_dominant/Nemaline_myopathy_4,autosomal_dominant,609285,Autosomal_dominant/CAP_myopathy_2,609285,Autosomal_dominant]
chr9	94871012	94871126	trio	114	3	3	0.07656	0.229	0.000		SPTLC1,MTND4P15	SPTLC1 (oe_lof=0.68 region=exonic/splicing),MTND4P15 (oe_lof=n/a region=intronic/intergenic)			605712_[GENE=SPTLC1_PHENOS=Neuropathy,hereditary_sensory_and_autonomic,type_IA,162400,Autosomal_dominant]
chr9	98270206	98270332	trio	126	1	4	0.03623	0.045	0.000		PTCH1	PTCH1 (oe_lof=0.02 region=intronic/intergenic)	PTCH1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=30411536,21368767,29575684]	145977 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],217298 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Gorlin syndrome"],393722 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],394717 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443720 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563570 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563665 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],59120 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59121 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],688061 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],872678 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	601309_[GENE=PTCH1_PHENOS=Basal_cell_carcinoma,somatic,605462/Holoprosencephaly_7,610828,Autosomal_dominant/Basal_cell_nevus_syndrome,109400,Autosomal_dominant]
chr9	111651602	111651683	trio	81	3	10	0.00737	0.108	0.000		ELP1	ELP1 (oe_lof=0.58 region=exonic/splicing)		394021 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	603722_[GENE=ELP1_PHENOS=Dysautonomia,familial,223900,Autosomal_recessive/Medulloblastoma,155255,Autosomal_dominant,Autosomal_recessive,Somatic_mutation]
chr9	123342188	123342447	trio	259	3	4	0.04322	0.287	0.000		CDK5RAP2	CDK5RAP2 (oe_lof=0.53 region=exonic/splicing)			608201_[GENE=CDK5RAP2_PHENOS=Microcephaly_3,primary,autosomal_recessive,604804,Autosomal_recessive]
chr9	123737047	123737219	trio	172	3	3	0.01973	0.025	0.000		C5	C5 (oe_lof=0.55 region=exonic/splicing)		59124 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	120900_[GENE=C5_PHENOS=C5_deficiency,609536,Autosomal_recessive/Eculizumab,poor_response_to,615749,Autosomal_dominant]
chr9	123744112	123744227	trio	115	3	5	0.02011	0.076	0.000		C5	C5 (oe_lof=0.55 region=exonic/splicing)		59124 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	120900_[GENE=C5_PHENOS=C5_deficiency,609536,Autosomal_recessive/Eculizumab,poor_response_to,615749,Autosomal_dominant]
chr9	124062324	124062414	trio	90	1	5	0.04041	0.229	0.000		GSN	GSN (oe_lof=0.59 region=exonic/splicing)		59124 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	137350_[GENE=GSN_PHENOS=Amyloidosis,Finnish_type,105120,Autosomal_dominant]
chr9	124065179	124065353	trio	174	3	5	0.03498	0.191	0.000		GSN	GSN (oe_lof=0.59 region=exonic/splicing)		59124 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	137350_[GENE=GSN_PHENOS=Amyloidosis,Finnish_type,105120,Autosomal_dominant]
chr9	124080674	124081168	trio	494	1	2	0.03360	0.096	0.000		GSN	GSN (oe_lof=0.59 region=exonic/splicing)		59124 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	137350_[GENE=GSN_PHENOS=Amyloidosis,Finnish_type,105120,Autosomal_dominant]
chr9	127265348	129377858	trio	2112510	1	7	0.07178	0.223	0.000		NR5A1,NR6A1,RN7SL302P,MIR181A2HG,MIR181A2,MIR181B2,OLFML2A,WDR38,RPL35,ARPC5L,GOLGA1,RNU4-82P,SCAI,PPP6C,PRPS1P2,RABEPK,HSPA5,GAPVD1,RNU6-1020P,MAPKAP1,RN7SL30P,HNRNPA1P15,PBX3,MVB12B,NRON,LMX1B	NR5A1 (oe_lof=0.06 region=exonic/splicing),NR6A1 (oe_lof=0.12 region=complete),RN7SL302P (oe_lof=n/a region=complete),MIR181A2HG (oe_lof=n/a region=complete),MIR181A2 (oe_lof=n/a region=complete),MIR181B2 (oe_lof=n/a region=complete),OLFML2A (oe_lof=0.67 region=complete),WDR38 (oe_lof=1.05 region=complete),RPL35 (oe_lof=0.15 region=complete),ARPC5L (oe_lof=0.15 region=complete),GOLGA1 (oe_lof=0.37 region=complete),RNU4-82P (oe_lof=n/a region=complete),SCAI (oe_lof=0.12 region=complete),PPP6C (oe_lof=0.15 region=complete),PRPS1P2 (oe_lof=n/a region=complete),RABEPK (oe_lof=0.93 region=complete),HSPA5 (oe_lof=0.18 region=complete),GAPVD1 (oe_lof=0.05 region=complete),RNU6-1020P (oe_lof=n/a region=complete),MAPKAP1 (oe_lof=0.03 region=complete),RN7SL30P (oe_lof=n/a region=complete),HNRNPA1P15 (oe_lof=n/a region=complete),PBX3 (oe_lof=0.23 region=complete),MVB12B (oe_lof=0.20 region=complete),NRON (oe_lof=n/a region=complete),LMX1B (oe_lof=0.18 region=exonic/splicing)	LMX1B [HI=Sufficient evidence for dosage pathogenicity PMIDS=9618165,9837817,18414507],NR5A1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=15579739,15472171,21654157]	148721 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153090 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396676 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57204 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59125 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612035 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983307 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Nail-patella syndrome;Early infantile epileptic encephalopathy 4"]	184757_[GENE=NR5A1_PHENOS=46,XX_sex_reversal_4,617480,Autosomal_dominant/Premature_ovarian_failure_7,612964,Autosomal_dominant/46XY_sex_reversal_3,612965,Autosomal_dominant/Adrenocortical_insufficiency,612964,Autosomal_dominant/Spermatogenic_failure_8,613957,Autosomal_dominant],602575_[GENE=LMX1B_PHENOS=Focal_segmental_glomerulosclerosis_10,256020,Autosomal_dominant/Nail-patella_syndrome,161200,Autosomal_dominant],618315_[GENE=RPL35_PHENOS=Diamond-Blackfan_anemia_19,618312,Autosomal_dominant]
chr9	130425474	130425642	trio	168	3	3	0.08833	0.229	0.000		STXBP1	STXBP1 (oe_lof=0.00 region=exonic/splicing)	STXBP1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=19557857,23409955]	148721 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253429 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396676 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396884 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57204 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59125 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612035 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625638 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Early infantile epileptic encephalopathy 4"],815296 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983307 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Nail-patella syndrome;Early infantile epileptic encephalopathy 4"],984763 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Infantile epilepsy syndrome"]	602926_[GENE=STXBP1_PHENOS=Developmental_and_epileptic_encephalopathy_4,612164,Autosomal_dominant]
chr9	130700087	131267193	trio	567106	3	20	0.00003	0.121	0.000		DPM2,FAM102A,NAIF1,SLC25A25,PTGES2,LCN2,BBLN,CIZ1,DNM1,MIR199B,MIR3154,GOLGA2,SWI5,TRUB2,COQ4,SLC27A4,TMSB4XP4,URM1,MIR219A2,CERCAM,ODF2,ODF2-AS1,GLE1	DPM2 (oe_lof=0.24 region=exonic/splicing),FAM102A (oe_lof=0.28 region=exonic/splicing),NAIF1 (oe_lof=0.25 region=complete),SLC25A25 (oe_lof=0.31 region=complete),PTGES2 (oe_lof=0.83 region=complete),LCN2 (oe_lof=1.11 region=complete),BBLN (oe_lof=1.34 region=complete),CIZ1 (oe_lof=0.25 region=complete),DNM1 (oe_lof=0.13 region=complete),MIR199B (oe_lof=n/a region=complete),MIR3154 (oe_lof=n/a region=complete),GOLGA2 (oe_lof=0.18 region=complete),SWI5 (oe_lof=0.56 region=complete),TRUB2 (oe_lof=0.73 region=complete),COQ4 (oe_lof=1.00 region=complete),SLC27A4 (oe_lof=0.43 region=complete),TMSB4XP4 (oe_lof=n/a region=complete),URM1 (oe_lof=0.50 region=complete),MIR219A2 (oe_lof=n/a region=complete),CERCAM (oe_lof=0.52 region=complete),ODF2 (oe_lof=0.30 region=exonic/splicing),ODF2-AS1 (oe_lof=n/a region=complete),GLE1 (oe_lof=0.53 region=exonic/splicing)		148721 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150008 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396676 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396884 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59125 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59134 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59906 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612035 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815297 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983307 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Nail-patella syndrome;Early infantile epileptic encephalopathy 4"],984763 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Infantile epilepsy syndrome"]	602377_[GENE=DNM1_PHENOS=Developmental_and_epileptic_encephalopathy_31,616346,Autosomal_dominant],603371_[GENE=GLE1_PHENOS=Lethal_congenital_contracture_syndrome_1,253310,Autosomal_recessive/Congenital_arthrogryposis_with_anterior_horn_cell_disease,611890,Autosomal_recessive],603564_[GENE=DPM2_PHENOS=Congenital_disorder_of_glycosylation,type_Iu,615042,Autosomal_recessive],604194_[GENE=SLC27A4_PHENOS=Ichthyosis_prematurity_syndrome,608649,Autosomal_recessive],612898_[GENE=COQ4_PHENOS=Coenzyme_Q10_deficiency,primary,7,616276,Autosomal_recessive]
chr9	131289725	131289814	trio	89	1	3	0.01429	0.096	0.000		GLE1	GLE1 (oe_lof=0.53 region=exonic/splicing)		148721 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150008 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396884 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59125 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59134 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59906 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612035 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815297 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],984763 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Infantile epilepsy syndrome"]	603371_[GENE=GLE1_PHENOS=Lethal_congenital_contracture_syndrome_1,253310,Autosomal_recessive/Congenital_arthrogryposis_with_anterior_horn_cell_disease,611890,Autosomal_recessive]
chr9	131367565	131367766	trio	201	3	4	0.05329	0.032	0.000		SPTAN1	SPTAN1 (oe_lof=0.06 region=exonic/splicing)		148721 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150008 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396884 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59125 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59134 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59906 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612035 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815297 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],984763 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Infantile epilepsy syndrome"]	182810_[GENE=SPTAN1_PHENOS=Developmental_and_epileptic_encephalopathy_5,613477,Autosomal_dominant]
chr9	131644771	131645198	trio	427	3	8	0.00874	0.102	0.000		KYAT1,LRRC8A	KYAT1 (oe_lof=0.86 region=intronic/intergenic),LRRC8A (oe_lof=0.13 region=intronic/intergenic)		150008 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396884 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59125 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59134 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59906 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612035 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815297 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	608360_[GENE=LRRC8A_PHENOS=Agammaglobulinemia_5,613506,Autosomal_dominant]
chr9	134386714	134386864	trio	150	3	3	0.08439	0.134	0.000		POMT1	POMT1 (oe_lof=0.70 region=exonic/splicing)		59135 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59909 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625553 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	607423_[GENE=POMT1_PHENOS=Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,1,236670,Autosomal_recessive/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,1,609308,Autosomal_recessive/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,1,613155,Autosomal_recessive]
chr9	135152437	135152549	trio	112	1	4	0.26771	0.382	0.000		SETX	SETX (oe_lof=0.21 region=exonic/splicing)		59135 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608465_[GENE=SETX_PHENOS=Spinocerebellar_ataxia,autosomal_recessive,with_axonal_neuropathy_2,606002,Autosomal_recessive/Amyotrophic_lateral_sclerosis_4,juvenile,602433,Autosomal_dominant]
chr9	135206429	135206536	trio	107	3	6	0.01843	0.019	0.000		SETX	SETX (oe_lof=0.21 region=exonic/splicing)		59135 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608465_[GENE=SETX_PHENOS=Spinocerebellar_ataxia,autosomal_recessive,with_axonal_neuropathy_2,606002,Autosomal_recessive/Amyotrophic_lateral_sclerosis_4,juvenile,602433,Autosomal_dominant]
chr9	135218067	135218196	trio	129	3	3	0.07625	0.146	0.000		SETX	SETX (oe_lof=0.21 region=exonic/splicing)			608465_[GENE=SETX_PHENOS=Spinocerebellar_ataxia,autosomal_recessive,with_axonal_neuropathy_2,606002,Autosomal_recessive/Amyotrophic_lateral_sclerosis_4,juvenile,602433,Autosomal_dominant]
chr9	135786830	135786965	trio	135	3	4	0.04557	0.185	0.000		TSC1	TSC1 (oe_lof=0.04 region=exonic/splicing)	TSC1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=32917966,23389244,17304050]	1176589 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],253482 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],872680 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605284_[GENE=TSC1_PHENOS=Focal_cortical_dysplasia,type_II,somatic,607341/Tuberous_sclerosis-1,191100,Autosomal_dominant/Lymphangioleiomyomatosis,606690]
chr9	135977853	135977968	trio	115	1	4	0.03348	0.064	0.000		RALGDS	RALGDS (oe_lof=0.19 region=exonic/splicing)			
chr9	139090488	139091736	trio	1248	1	4	0.03659	0.051	0.000		LHX3	LHX3 (oe_lof=0.38 region=exonic/splicing)		148759 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151031 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154888 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155327 [CN_TYPE=gain CN=4 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],393947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442899 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443824 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59136 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59943 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612151 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],813716 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Microcephaly"]	600577_[GENE=LHX3_PHENOS=Pituitary_hormone_deficiency,combined,3,221750,Autosomal_recessive]
chr9	139262079	139262290	trio	211	1	3	0.04132	0.172	0.000		DNLZ,CARD9	DNLZ (oe_lof=1.15 region=intronic/intergenic),CARD9 (oe_lof=0.79 region=exonic/splicing)		148759 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151031 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154888 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155327 [CN_TYPE=gain CN=4 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],161082 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34625 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442899 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443824 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57416 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59136 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59139 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59943 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612151 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],813716 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Microcephaly"]	607212_[GENE=CARD9_PHENOS=Candidiasis,familial,2,autosomal_recessive,212050,Autosomal_recessive]
chr9	140674077	140674179	trio	102	1	4	0.06365	0.280	0.000	9q subtelomeric deletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/52]	EHMT1	EHMT1 (oe_lof=0.02 region=exonic/splicing)	EHMT1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=16826528,19264732]	1047897 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Cryptorchidism;Coarctation of aorta"],147707 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148759 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151031 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154888 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154911 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155260 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155327 [CN_TYPE=gain CN=4 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],161082 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34625 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394188 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394314 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395375 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395868 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396056 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396328 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441869 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442186 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442767 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442899 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443824 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],563589 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],563643 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563648 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57197 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57416 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57424 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59136 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59140 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59141 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59151 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59152 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59153 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59154 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59155 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59156 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59943 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59944 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612151 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685384 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686011 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],813716 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Microcephaly"],815304 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815306 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980356 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607001_[GENE=EHMT1_PHENOS=Kleefstra_syndrome_1,610253,Autosomal_dominant]
chr9	140707448	140707635	trio	187	3	5	0.05134	0.204	0.000	9q subtelomeric deletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/52]	EHMT1	EHMT1 (oe_lof=0.02 region=exonic/splicing)	EHMT1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=16826528,19264732]	1047897 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Cryptorchidism;Coarctation of aorta"],147707 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148759 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151031 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154888 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154911 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155260 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155327 [CN_TYPE=gain CN=4 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],161082 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34625 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394188 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394314 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395375 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395868 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396056 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396328 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441543 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442186 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442767 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442899 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443824 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],563582 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],563643 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563648 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57197 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57416 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57424 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59136 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59140 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59141 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59151 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59152 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59153 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59154 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59155 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59156 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59943 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59944 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],612151 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685384 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686011 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],813716 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Microcephaly"],815304 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815306 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980356 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607001_[GENE=EHMT1_PHENOS=Kleefstra_syndrome_1,610253,Autosomal_dominant]
chr10	6104041	6104343	trio	302	3	6	0.02238	0.178	0.000		IL2RA	IL2RA (oe_lof=0.31 region=exonic/splicing)			147730_[GENE=IL2RA_PHENOS=Immunodeficiency_41_with_lymphoproliferation_and_autoimmunity,606367,Autosomal_recessive/Diabetes,mellitus,insulin-dependent,susceptibility_to,10,601942]
chr10	43607537	43607682	trio	145	1	12	0.00498	0.057	0.000		RET	RET (oe_lof=0.04 region=exonic/splicing)	RET [HI=Sufficient evidence for dosage pathogenicity PMIDS=11694544,11953745,30970187]		164761_[GENE=RET_PHENOS=Hirschsprung_disease,susceptibility_to,1,142623,Autosomal_dominant/Multiple_endocrine_neoplasia_IIA,171400,Autosomal_dominant/Hirschsprung_disease,protection_against,142623,Autosomal_dominant/Medullary_thyroid_carcinoma,155240,Autosomal_dominant/Pheochromocytoma,171300,Autosomal_dominant/Multiple_endocrine_neoplasia_IIB,162300,Autosomal_dominant]
chr10	43615519	43615661	trio	142	1	3	0.05715	0.051	0.000		RET	RET (oe_lof=0.04 region=exonic/splicing)	RET [HI=Sufficient evidence for dosage pathogenicity PMIDS=11694544,11953745,30970187]		164761_[GENE=RET_PHENOS=Hirschsprung_disease,susceptibility_to,1,142623,Autosomal_dominant/Multiple_endocrine_neoplasia_IIA,171400,Autosomal_dominant/Hirschsprung_disease,protection_against,142623,Autosomal_dominant/Medullary_thyroid_carcinoma,155240,Autosomal_dominant/Pheochromocytoma,171300,Autosomal_dominant/Multiple_endocrine_neoplasia_IIB,162300,Autosomal_dominant]
chr10	50857544	50857692	trio	148	3	5	0.03310	0.159	0.000		CHAT	CHAT (oe_lof=0.62 region=exonic/splicing)		1180522 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],149971 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150503 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253661 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394957 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],441891 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],441949 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442310 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],563787 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563788 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],563789 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563790 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57411 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58551 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],600467 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],684951 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685237 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686364 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689042 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],977791 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="10q11.22q11.23 microdeletion including CHAT and SLC18A3"],980914 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],980915 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],992645 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	118490_[GENE=CHAT_PHENOS=Myasthenic_syndrome,congenital,6,presynaptic,254210,Autosomal_recessive]
chr10	50863131	50863292	trio	161	3	4	0.02667	0.038	0.000		CHAT	CHAT (oe_lof=0.62 region=exonic/splicing)		1180522 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],149971 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150503 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253661 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394957 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],441891 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],441949 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442310 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],563787 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563788 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],563789 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563790 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57411 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58551 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],600467 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],684951 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685237 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686364 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689042 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],977791 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="10q11.22q11.23 microdeletion including CHAT and SLC18A3"],980914 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],980915 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],992645 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	118490_[GENE=CHAT_PHENOS=Myasthenic_syndrome,congenital,6,presynaptic,254210,Autosomal_recessive]
chr10	73375251	73375383	trio	132	1	6	0.01118	0.045	0.000		CDH23	CDH23 (oe_lof=0.38 region=exonic/splicing)			605516_[GENE=CDH23_PHENOS=Usher_syndrome,type_1D,601067,Autosomal_recessive,Digenic_recessive/Pituitary_adenoma_5,multiple_types,617540,Autosomal_dominant/Usher_syndrome,type_1D/F_digenic,601067,Autosomal_recessive,Digenic_recessive/Deafness,autosomal_recessive_12,601386,Autosomal_recessive]
chr10	73439134	73439259	trio	125	1	4	0.05988	0.115	0.000		CDH23	CDH23 (oe_lof=0.38 region=exonic/splicing)			605516_[GENE=CDH23_PHENOS=Usher_syndrome,type_1D,601067,Autosomal_recessive,Digenic_recessive/Pituitary_adenoma_5,multiple_types,617540,Autosomal_dominant/Usher_syndrome,type_1D/F_digenic,601067,Autosomal_recessive,Digenic_recessive/Deafness,autosomal_recessive_12,601386,Autosomal_recessive]
chr10	73555518	73555846	trio	328	1	4	0.02112	0.019	0.000		CDH23	CDH23 (oe_lof=0.38 region=intronic/intergenic)			605516_[GENE=CDH23_PHENOS=Usher_syndrome,type_1D,601067,Autosomal_recessive,Digenic_recessive/Pituitary_adenoma_5,multiple_types,617540,Autosomal_dominant/Usher_syndrome,type_1D/F_digenic,601067,Autosomal_recessive,Digenic_recessive/Deafness,autosomal_recessive_12,601386,Autosomal_recessive]
chr10	73565915	73567173	trio	1258	3	14	0.00163	0.045	0.000		CDH23	CDH23 (oe_lof=0.38 region=exonic/splicing)			605516_[GENE=CDH23_PHENOS=Usher_syndrome,type_1D,601067,Autosomal_recessive,Digenic_recessive/Pituitary_adenoma_5,multiple_types,617540,Autosomal_dominant/Usher_syndrome,type_1D/F_digenic,601067,Autosomal_recessive,Digenic_recessive/Deafness,autosomal_recessive_12,601386,Autosomal_recessive]
chr10	73571062	73571357	trio	295	1	4	0.10096	0.223	0.000		CDH23,PSAP	CDH23 (oe_lof=0.38 region=exonic/splicing),PSAP (oe_lof=0.11 region=intronic/intergenic)			176801_[GENE=PSAP_PHENOS=Combined_SAP_deficiency,611721,Autosomal_recessive/Krabbe_disease,atypical,611722,Autosomal_recessive/Metachromatic_leukodystrophy_due_to_SAP-b_deficiency,249900,Autosomal_recessive/Gaucher_disease,atypical,610539/Parkinson_disease_24,autosomal_dominant,susceptibility_to,619491,Autosomal_dominant],605516_[GENE=CDH23_PHENOS=Usher_syndrome,type_1D,601067,Autosomal_recessive,Digenic_recessive/Pituitary_adenoma_5,multiple_types,617540,Autosomal_dominant/Usher_syndrome,type_1D/F_digenic,601067,Autosomal_recessive,Digenic_recessive/Deafness,autosomal_recessive_12,601386,Autosomal_recessive]
chr10	89623185	89624315	trio	1130	3	6	0.01891	0.153	0.000		KLLN,PTEN	KLLN (oe_lof=1.15 region=intronic/intergenic),PTEN (oe_lof=0.24 region=exonic/splicing)	PTEN [HI=Sufficient evidence for dosage pathogenicity PMIDS=21194675,32003824]	59703 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],979281 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	601728_[GENE=PTEN_PHENOS=Glioma_susceptibility_2,613028/Meningioma,607174,Autosomal_dominant/Lhermitte-Duclos_syndrome,158350,Autosomal_dominant/Cowden_syndrome_1,158350,Autosomal_dominant/Prostate_cancer,somatic,176807/Macrocephaly/autism_syndrome,605309,Autosomal_dominant],612105_[GENE=KLLN_PHENOS=Cowden_syndrome_4,615107]
chr10	96058126	96058436	trio	310	3	5	0.01846	0.115	0.000		PLCE1	PLCE1 (oe_lof=0.35 region=exonic/splicing)		148854 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625558 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	608414_[GENE=PLCE1_PHENOS=Nephrotic_syndrome,type_3,610725,Autosomal_recessive]
chr10	97373713	97373928	trio	215	3	5	0.03058	0.051	0.000		ALDH18A1	ALDH18A1 (oe_lof=0.33 region=exonic/splicing)			138250_[GENE=ALDH18A1_PHENOS=Spastic_paraplegia_9A,autosomal_dominant,601162,Autosomal_dominant/Cutis_laxa,autosomal_recessive,type_IIIA,219150,Autosomal_recessive/Spastic_paraplegia_9B,autosomal_recessive,616586,Autosomal_recessive/Cutis_laxa,autosomal_dominant_3,616603,Autosomal_dominant]
chr10	97515399	97515533	trio	134	3	3	0.08439	0.185	0.000		ENTPD1,ENTPD1-AS1	ENTPD1 (oe_lof=0.33 region=exonic/splicing),ENTPD1-AS1 (oe_lof=n/a region=exonic/splicing)			601752_[GENE=ENTPD1_PHENOS=Spastic_paraplegia_64,autosomal_recessive,615683,Autosomal_recessive]
chr10	101491707	101492433	trio	726	3	6	0.01571	0.159	0.000		COX15,CUTC	COX15 (oe_lof=0.92 region=exonic/splicing),CUTC (oe_lof=0.47 region=exonic/splicing)	COX15 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		603646_[GENE=COX15_PHENOS=Mitochondrial_complex_IV_deficiency,nuclear_type_6,615119,Autosomal_recessive]
chr10	105792422	105792736	trio	314	3	4	0.01973	0.057	0.000		SLK,COL17A1	SLK (oe_lof=0.23 region=intronic/intergenic),COL17A1 (oe_lof=0.60 region=exonic/splicing)			113811_[GENE=COL17A1_PHENOS=Epithelial_recurrent_erosion_dystrophy,122400,Autosomal_dominant/Epidermolysis_bullosa,junctional,localisata_variant,226650,Autosomal_recessive/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650,Autosomal_recessive]
chr10	105803249	105803349	trio	100	3	6	0.01707	0.134	0.000		COL17A1,MIR936	COL17A1 (oe_lof=0.60 region=exonic/splicing),MIR936 (oe_lof=n/a region=intronic/intergenic)			113811_[GENE=COL17A1_PHENOS=Epithelial_recurrent_erosion_dystrophy,122400,Autosomal_dominant/Epidermolysis_bullosa,junctional,localisata_variant,226650,Autosomal_recessive/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650,Autosomal_recessive]
chr10	105809157	105809239	trio	82	3	6	0.00910	0.045	0.000		COL17A1,MIR936	COL17A1 (oe_lof=0.60 region=exonic/splicing),MIR936 (oe_lof=n/a region=intronic/intergenic)			113811_[GENE=COL17A1_PHENOS=Epithelial_recurrent_erosion_dystrophy,122400,Autosomal_dominant/Epidermolysis_bullosa,junctional,localisata_variant,226650,Autosomal_recessive/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650,Autosomal_recessive]
chr10	105823495	105836197	trio	12702	3	3	0.03976	0.076	0.000		COL17A1	COL17A1 (oe_lof=0.60 region=exonic/splicing)			113811_[GENE=COL17A1_PHENOS=Epithelial_recurrent_erosion_dystrophy,122400,Autosomal_dominant/Epidermolysis_bullosa,junctional,localisata_variant,226650,Autosomal_recessive/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650,Autosomal_recessive]
chr11	792860	792998	trio	138	1	4	0.04017	0.057	0.000		CEND1,SLC25A22	CEND1 (oe_lof=0.00 region=intronic/intergenic),SLC25A22 (oe_lof=0.41 region=exonic/splicing)		154856 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57258 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57274 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58855 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59748 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],983191 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	609302_[GENE=SLC25A22_PHENOS=Developmental_and_epileptic_encephalopathy_3,609304,Autosomal_recessive]
chr11	796033	796273	trio	240	4	10	0.00187	0.185	0.000		SLC25A22,PIDD1	SLC25A22 (oe_lof=0.41 region=intronic/intergenic),PIDD1 (oe_lof=0.81 region=intronic/intergenic)		154856 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57258 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57274 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58855 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59748 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],983191 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	609302_[GENE=SLC25A22_PHENOS=Developmental_and_epileptic_encephalopathy_3,609304,Autosomal_recessive]
chr11	1862039	1862447	trio	408	1	2	0.24614	0.217	0.000		SYT8,TNNI2	SYT8 (oe_lof=1.60 region=intronic/intergenic),TNNI2 (oe_lof=0.30 region=exonic/splicing)		147689 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154397 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154856 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57258 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57274 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58855 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59748 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980415 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983191 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	191043_[GENE=TNNI2_PHENOS=Arthrogryposis,distal,type_2B1,601680,Autosomal_dominant]
chr11	2187853	2188272	trio	419	1	3	0.04356	0.191	0.000		TH	TH (oe_lof=0.50 region=exonic/splicing)		146876 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147689 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154397 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57258 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57274 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59748 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980415 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983191 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	191290_[GENE=TH_PHENOS=Segawa_syndrome,recessive,605407,Autosomal_recessive]
chr11	3876923	3877649	trio	726	3	14	0.00164	0.108	0.000		STIM1,MIR4687	STIM1 (oe_lof=0.19 region=exonic/splicing),MIR4687 (oe_lof=n/a region=exonic/splicing)		57258 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59750 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],983191 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	605921_[GENE=STIM1_PHENOS=Myopathy,tubular_aggregate,1,160565,Autosomal_dominant/Stormorken_syndrome,185070,Autosomal_dominant/Immunodeficiency_10,612783,Autosomal_recessive]
chr11	6638847	6640156	trio	1309	3	5	0.08642	0.102	0.000		TAF10,TPP1,DCHS1	TAF10 (oe_lof=0.00 region=intronic/intergenic),TPP1 (oe_lof=0.51 region=exonic/splicing),DCHS1 (oe_lof=0.16 region=intronic/intergenic)		147641 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253548 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59750 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	603057_[GENE=DCHS1_PHENOS=Mitral_valve_prolapse_2,607829,Autosomal_dominant/Van_Maldergem_syndrome_1,601390,Autosomal_recessive],607998_[GENE=TPP1_PHENOS=Ceroid_lipofuscinosis,neuronal,2,204500,Autosomal_recessive/Spinocerebellar_ataxia,autosomal_recessive_7,609270,Autosomal_recessive]
chr11	17538938	17539031	trio	93	3	5	0.03283	0.083	0.000		USH1C	USH1C (oe_lof=0.67 region=exonic/splicing)	USH1C [HI=Gene associated with autosomal recessive phenotype PMIDS=]		605242_[GENE=USH1C_PHENOS=Usher_syndrome,type_1C,276904,Autosomal_recessive/Deafness,autosomal_recessive_18A,602092,Autosomal_recessive]
chr11	17548760	17548888	trio	128	1	3	0.07668	0.121	0.000		USH1C	USH1C (oe_lof=0.67 region=exonic/splicing)	USH1C [HI=Gene associated with autosomal recessive phenotype PMIDS=]		605242_[GENE=USH1C_PHENOS=Usher_syndrome,type_1C,276904,Autosomal_recessive/Deafness,autosomal_recessive_18A,602092,Autosomal_recessive]
chr11	31832653	31832889	trio	236	3	7	0.01571	0.121	0.000	WAGR 11p13 deletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/35]	PAX6	PAX6 (oe_lof=0.04 region=intronic/intergenic)	PAX6 [HI=Sufficient evidence for dosage pathogenicity PMIDS=]	150269 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151275 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253466 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],376753 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome"],395339 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396222 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563875 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607108_[GENE=PAX6_PHENOS=Optic_nerve_hypoplasia,165550,Autosomal_dominant/Cataract_with_late-onset_corneal_dystrophy,106210,Autosomal_dominant/Coloboma,ocular,120200,Autosomal_dominant/Coloboma_of_optic_nerve,120430,Autosomal_dominant/Aniridia,106210,Autosomal_dominant/Anterior_segment_dysgenesis_5,multiple_subtypes,604229,Autosomal_dominant/Morning_glory_disc_anomaly,120430,Autosomal_dominant/Foveal_hypoplasia_1,136520,Autosomal_dominant/Keratitis,148190,Autosomal_dominant]
chr11	44331137	44331726	trio	589	1	3	0.08439	0.166	0.000	Potocki-Shaffer syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/34]	ALX4	ALX4 (oe_lof=0.23 region=exonic/splicing)	ALX4 [HI=Sufficient evidence for dosage pathogenicity PMIDS=11137991,11106354,16319823]	154181 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58891 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59752 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],613388 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605420_[GENE=ALX4_PHENOS=Parietal_foramina_2,609597,Autosomal_dominant/Craniosynostosis_5,susceptibility_to,615529,Autosomal_dominant/Frontonasal_dysplasia_2,613451,Autosomal_recessive]
chr11	47236483	47238033	trio	1550	4	18	0.00323	0.172	0.000		DDB2	DDB2 (oe_lof=0.52 region=exonic/splicing)		151005 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57329 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600811_[GENE=DDB2_PHENOS=Xeroderma_pigmentosum,group_E,DDB-negative_subtype,278740,Autosomal_recessive]
chr11	47464198	47464376	trio	178	3	5	0.03196	0.064	0.000		RAPSN	RAPSN (oe_lof=0.41 region=exonic/splicing)		57329 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	601592_[GENE=RAPSN_PHENOS=Fetal_akinesia_deformation_sequence_2,618388,Autosomal_recessive/Myasthenic_syndrome,congenital,11,associated_with_acetylcholine_receptor_deficiency,616326,Autosomal_recessive]
chr11	62473665	62473797	trio	132	4	6	0.01843	0.185	0.000		BSCL2,HNRNPUL2-BSCL2,GNG3	BSCL2 (oe_lof=0.68 region=intronic/intergenic),HNRNPUL2-BSCL2 (oe_lof=n/a region=intronic/intergenic),GNG3 (oe_lof=0.00 region=intronic/intergenic)		149385 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394819 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59754 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59755 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	606158_[GENE=BSCL2_PHENOS=Lipodystrophy,congenital_generalized,type_2,269700,Autosomal_recessive/Neuropathy,distal_hereditary_motor,type_VC,619112,Autosomal_dominant/Silver_spastic_paraplegia_syndrome,270685,Autosomal_dominant/Encephalopathy,progressive,with_or_without_lipodystrophy,615924,Autosomal_recessive]
chr11	63978073	63978653	trio	580	1	5	0.01751	0.076	0.000		FERMT3	FERMT3 (oe_lof=0.35 region=exonic/splicing)		152302 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	607901_[GENE=FERMT3_PHENOS=Leukocyte_adhesion_deficiency,type_III,612840,Autosomal_recessive]
chr11	65487506	65487645	trio	139	4	17	0.00016	0.076	0.000		KAT5,RNASEH2C	KAT5 (oe_lof=0.26 region=intronic/intergenic),RNASEH2C (oe_lof=0.65 region=exonic/splicing)		443398 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],625593 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	601409_[GENE=KAT5_PHENOS=Neurodevelopmental_disorder_wtih_dysmorphic_facies,sleep_disturbance,and_brain_abnormalities,619103],610330_[GENE=RNASEH2C_PHENOS=Aicardi-Goutieres_syndrome_3,610329,Autosomal_recessive]
chr11	65635322	65635902	trio	580	3	8	0.00022	0.038	0.000		MUS81,EFEMP2	MUS81 (oe_lof=0.70 region=intronic/intergenic),EFEMP2 (oe_lof=0.33 region=exonic/splicing)		154814 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443398 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],625593 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	604633_[GENE=EFEMP2_PHENOS=Cutis_laxa,autosomal_recessive,type_IB,614437,Autosomal_recessive]
chr11	66617398	66617597	trio	199	3	5	0.02387	0.032	0.000		RCE1,PC	RCE1 (oe_lof=0.27 region=intronic/intergenic),PC (oe_lof=0.27 region=exonic/splicing)		154814 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443398 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59757 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625593 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	608786_[GENE=PC_PHENOS=Pyruvate_carboxylase_deficiency,266150,Autosomal_recessive]
chr11	67761137	67763365	trio	2228	1	6	0.01571	0.013	0.000		UNC93B1	UNC93B1 (oe_lof=0.26 region=exonic/splicing)		146304 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608204_[GENE=UNC93B1_PHENOS=Encephalopathy,acute,infection-induced_(herpes-specific),susceptibility_to,1,610551]
chr11	67764063	67764265	trio	202	3	4	0.03898	0.127	0.000		UNC93B1	UNC93B1 (oe_lof=0.26 region=exonic/splicing)		146304 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608204_[GENE=UNC93B1_PHENOS=Encephalopathy,acute,infection-induced_(herpes-specific),susceptibility_to,1,610551]
chr11	67771117	67771278	trio	161	1	4	0.10231	0.299	0.000		UNC93B1,ALDH3B1	UNC93B1 (oe_lof=0.26 region=exonic/splicing),ALDH3B1 (oe_lof=0.60 region=intronic/intergenic)		146304 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608204_[GENE=UNC93B1_PHENOS=Encephalopathy,acute,infection-induced_(herpes-specific),susceptibility_to,1,610551]
chr11	67811028	67811384	trio	356	1	3	0.04322	0.070	0.000		TCIRG1	TCIRG1 (oe_lof=0.63 region=exonic/splicing)	TCIRG1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146304 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153941 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442080 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604592_[GENE=TCIRG1_PHENOS=Osteopetrosis,autosomal_recessive_1,259700,Autosomal_recessive]
chr11	68216267	68216753	trio	486	1	5	0.02613	0.172	0.000		LRP5	LRP5 (oe_lof=0.22 region=exonic/splicing)	LRP5 [HI=Some evidence for dosage pathogenicity PMIDS=15024691,20340138]	146304 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153941 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442080 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58893 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	603506_[GENE=LRP5_PHENOS=Osteopetrosis,autosomal_dominant_1,607634,Autosomal_dominant/Bone_mineral_density_variability_1,601884,Autosomal_dominant/Osteoporosis,166710,Autosomal_dominant/Hyperostosis,endosteal,144750,Autosomal_dominant/Osteosclerosis,144750,Autosomal_dominant/Polycystic_liver_disease_4_with_or_without_kidney_cysts,617875,Autosomal_dominant/Osteoporosis-pseudoglioma_syndrome,259770,Autosomal_recessive/Exudative_vitreoretinopathy_4,601813,Autosomal_dominant,Autosomal_recessive/van_Buchem_disease,type_2,607636]
chr11	68582792	68673716	trio	90924	3	4	0.08142	0.096	0.000		CPT1A,MRPL21,IGHMBP2	CPT1A (oe_lof=0.46 region=exonic/splicing),MRPL21 (oe_lof=1.37 region=exonic/splicing),IGHMBP2 (oe_lof=0.71 region=exonic/splicing)	CPT1A [HI=Gene associated with autosomal recessive phenotype PMIDS=],IGHMBP2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146304 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153941 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442080 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	600502_[GENE=IGHMBP2_PHENOS=Neuronopathy,distal_hereditary_motor,type_VI,604320,Autosomal_recessive/Charcot-Marie-Tooth_disease,axonal,type_2S,616155,Autosomal_recessive],600528_[GENE=CPT1A_PHENOS=CPT_deficiency,hepatic,type_IA,255120,Autosomal_recessive]
chr11	76894103	76894212	trio	109	1	4	0.02291	0.025	0.000		MYO7A	MYO7A (oe_lof=0.70 region=exonic/splicing)			276903_[GENE=MYO7A_PHENOS=Deafness,autosomal_recessive_2,600060,Autosomal_recessive/Usher_syndrome,type_1B,276900,Autosomal_recessive/Deafness,autosomal_dominant_11,601317,Autosomal_dominant]
chr11	77850530	86749238	trio	8898708	3	14	0.00480	0.185	0.010 (0.05,0.05,0.23,0.13,0.04,0.04,0.04,0.04,0.04,0.03,0.02,0.02,0.03,0.05,0.05,0.05,0.20)		ALG8,KCTD21-AS1,KCTD21,USP35,GAB2,NARS2,RNU6-311P,COPS8P3,TENM4,MIR708,MIR5579,RNU6-544P,ARL6IP1P3,MIR4300,SNORD112,FAM181B,PRCP,DDIAS,RAB30,SNORA70E,RAB30-DT,BCAS2P1,PCF11,ANKRD42,CCDC90B,CYCSP28,DLG2,LDHAL6DP,HNRNPA1P72,HNRNPCP6,RNU6-1292P,TMEM126B,TMEM126A,CREBZF,CCDC89,SYTL2,CCDC83,SLC25A1P1,PICALM,RNU6-560P,FNTAP1,EED,SETP17,HIKESHI,RN7SL225P,CCDC81,PTP4A1P6,ME3,PRSS23,OR7E13P,OR7E2P,FZD4,HNRNPCP8,TMEM135	ALG8 (oe_lof=0.56 region=exonic/splicing),KCTD21-AS1 (oe_lof=n/a region=exonic/splicing),KCTD21 (oe_lof=0.79 region=complete),USP35 (oe_lof=0.48 region=complete),GAB2 (oe_lof=0.13 region=complete),NARS2 (oe_lof=0.57 region=complete),RNU6-311P (oe_lof=n/a region=complete),COPS8P3 (oe_lof=n/a region=complete),TENM4 (oe_lof=0.10 region=complete),MIR708 (oe_lof=n/a region=complete),MIR5579 (oe_lof=n/a region=complete),RNU6-544P (oe_lof=n/a region=complete),ARL6IP1P3 (oe_lof=n/a region=complete),MIR4300 (oe_lof=n/a region=complete),SNORD112 (oe_lof=n/a region=complete),FAM181B (oe_lof=0.50 region=complete),PRCP (oe_lof=0.79 region=complete),DDIAS (oe_lof=0.59 region=complete),RAB30 (oe_lof=0.08 region=complete),SNORA70E (oe_lof=n/a region=complete),RAB30-DT (oe_lof=n/a region=complete),BCAS2P1 (oe_lof=n/a region=complete),PCF11 (oe_lof=0.00 region=complete),ANKRD42 (oe_lof=0.82 region=complete),CCDC90B (oe_lof=0.65 region=complete),CYCSP28 (oe_lof=n/a region=complete),DLG2 (oe_lof=0.21 region=complete),LDHAL6DP (oe_lof=n/a region=complete),HNRNPA1P72 (oe_lof=n/a region=complete),HNRNPCP6 (oe_lof=n/a region=complete),RNU6-1292P (oe_lof=n/a region=complete),TMEM126B (oe_lof=0.86 region=complete),TMEM126A (oe_lof=0.63 region=complete),CREBZF (oe_lof=0.33 region=complete),CCDC89 (oe_lof=0.65 region=complete),SYTL2 (oe_lof=0.77 region=complete),CCDC83 (oe_lof=0.73 region=complete),SLC25A1P1 (oe_lof=n/a region=complete),PICALM (oe_lof=0.09 region=complete),RNU6-560P (oe_lof=n/a region=complete),FNTAP1 (oe_lof=n/a region=complete),EED (oe_lof=0.04 region=complete),SETP17 (oe_lof=n/a region=complete),HIKESHI (oe_lof=0.19 region=complete),RN7SL225P (oe_lof=n/a region=complete),CCDC81 (oe_lof=0.92 region=complete),PTP4A1P6 (oe_lof=n/a region=complete),ME3 (oe_lof=0.76 region=complete),PRSS23 (oe_lof=0.59 region=complete),OR7E13P (oe_lof=n/a region=complete),OR7E2P (oe_lof=n/a region=complete),FZD4 (oe_lof=0.07 region=complete),HNRNPCP8 (oe_lof=n/a region=complete),TMEM135 (oe_lof=0.19 region=exonic/splicing)	DLG2 [HI=Little evidence for dosage pathogenicity PMIDS=21792059,25055870,18511947],FZD4 [HI=Sufficient evidence for dosage pathogenicity PMIDS=12172548,15223780,14507768]	268072 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815445 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	603025_[GENE=PICALM_PHENOS=Leukemia,acute_myeloid,somatic,601626],604579_[GENE=FZD4_PHENOS=Retinopathy_of_prematurity,133780,Autosomal_dominant/Exudative_vitreoretinopathy_1,133780,Autosomal_dominant],605984_[GENE=EED_PHENOS=Cohen-Gibson_syndrome,617561,Autosomal_dominant],608103_[GENE=ALG8_PHENOS=Congenital_disorder_of_glycosylation,type_Ih,608104,Autosomal_recessive/Polycystic_liver_disease_3_with_or_without_kidney_cysts,617874,Autosomal_dominant],610084_[GENE=TENM4_PHENOS=Essential_tremor,hereditary,5,616736,Autosomal_dominant],612803_[GENE=NARS2_PHENOS=Combined_oxidative_phosphorylation_deficiency_24,616239,Autosomal_recessive/Deafness,autosomal_recessive_94,618434,Autosomal_recessive],612988_[GENE=TMEM126A_PHENOS=Optic_atrophy_7,612989,Autosomal_recessive],614908_[GENE=HIKESHI_PHENOS=Leukodystrophy,hypomyelinating,13,616881,Autosomal_recessive],615533_[GENE=TMEM126B_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_29,618250,Autosomal_recessive]
chr11	88068095	88070951	trio	2856	3	7	0.00082	0.121	0.000		CTSC	CTSC (oe_lof=0.66 region=exonic/splicing)		687705 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	602365_[GENE=CTSC_PHENOS=Periodontitis_1,juvenile,170650,Autosomal_recessive/Haim-Munk_syndrome,245010,Autosomal_recessive/Papillon-Lefevre_syndrome,245000,Autosomal_recessive]
chr11	95657029	102980508	trio	7323479	3	9	0.00856	0.102	0.004 (0.21,0.21,0.99,0.03,0.03,0.03,0.50,0.05,0.17,0.04,0.04,0.58,0.58,0.58,0.58,0.58,0.04,0.14,0.14,0.14)		MTMR2,MAML2,MIR1260B,CCDC82,JRKL,JRKL-AS1,RNA5SP346,MED28P5,RNA5SP347,CNTN5,RN7SKP53,RPA2P3,RN7SL222P,ARHGAP42,RN7SKP115,PGR,TRPC6,MIR3920,ANGPTL5,CEP126,CFAP300,YAP1,RNU6-952P,BIRC3,BIRC2,TMEM123,MMP7,MMP20,MMP27,MMP8,MMP10,WTAPP1,MMP1,MMP3,MMP12,RNU7-159P,MMP13,DCUN1D5,DYNC2H1	MTMR2 (oe_lof=0.44 region=exonic/splicing),MAML2 (oe_lof=0.12 region=complete),MIR1260B (oe_lof=n/a region=complete),CCDC82 (oe_lof=0.56 region=complete),JRKL (oe_lof=0.49 region=complete),JRKL-AS1 (oe_lof=n/a region=complete),RNA5SP346 (oe_lof=n/a region=complete),MED28P5 (oe_lof=n/a region=complete),RNA5SP347 (oe_lof=n/a region=complete),CNTN5 (oe_lof=0.33 region=complete),RN7SKP53 (oe_lof=n/a region=complete),RPA2P3 (oe_lof=n/a region=complete),RN7SL222P (oe_lof=n/a region=complete),ARHGAP42 (oe_lof=n/a region=complete),RN7SKP115 (oe_lof=n/a region=complete),PGR (oe_lof=0.27 region=complete),TRPC6 (oe_lof=0.44 region=complete),MIR3920 (oe_lof=n/a region=complete),ANGPTL5 (oe_lof=0.85 region=complete),CEP126 (oe_lof=0.72 region=complete),CFAP300 (oe_lof=0.69 region=complete),YAP1 (oe_lof=0.04 region=complete),RNU6-952P (oe_lof=n/a region=complete),BIRC3 (oe_lof=0.28 region=complete),BIRC2 (oe_lof=0.22 region=complete),TMEM123 (oe_lof=0.13 region=complete),MMP7 (oe_lof=0.98 region=complete),MMP20 (oe_lof=0.95 region=complete),MMP27 (oe_lof=1.25 region=complete),MMP8 (oe_lof=1.33 region=complete),MMP10 (oe_lof=0.99 region=complete),WTAPP1 (oe_lof=n/a region=complete),MMP1 (oe_lof=1.09 region=complete),MMP3 (oe_lof=0.99 region=complete),MMP12 (oe_lof=n/a region=complete),RNU7-159P (oe_lof=n/a region=complete),MMP13 (oe_lof=1.09 region=complete),DCUN1D5 (oe_lof=0.00 region=complete),DYNC2H1 (oe_lof=0.49 region=exonic/splicing)	YAP1 [HI=Little evidence for dosage pathogenicity PMIDS=24462371]	147688 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563877 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120353_[GENE=MMP1_PHENOS=COPD,rate_of_decline_of_lung_function_in,606963/Epidermolysis_bullosa_dystrophica,autosomal_recessive,modifier_of,226600,Autosomal_recessive],185250_[GENE=MMP3_PHENOS=Coronary_heart_disease,susceptibility_to,6,614466],600108_[GENE=MMP13_PHENOS=Spondyloepimetaphyseal_dysplasia,Missouri_type,602111,Autosomal_dominant/Metaphyseal_anadysplasia_1,602111,Autosomal_dominant/Metaphyseal_dysplasia,Spahr_type,250400,Autosomal_recessive],603297_[GENE=DYNC2H1_PHENOS=Short-rib_thoracic_dysplasia_3_with_or_without_polydactyly,613091,Autosomal_recessive,Digenic_recessive],603557_[GENE=MTMR2_PHENOS=Charcot-Marie-Tooth_disease,type_4B1,601382,Autosomal_recessive],603652_[GENE=TRPC6_PHENOS=Glomerulosclerosis,focal_segmental,2,603965,Autosomal_dominant],604629_[GENE=MMP20_PHENOS=Amelogenesis_imperfecta,type_IIA2,612529,Autosomal_recessive],606608_[GENE=YAP1_PHENOS=Coloboma,ocular,with_or_without_hearing_impairment,cleft_lip/palate,and/or_mental_retardation,120433,Autosomal_dominant],607311_[GENE=PGR_PHENOS=Progesterone_resistance,264080,Autosomal_recessive],607537_[GENE=MAML2_PHENOS=Mucoepidermoid_salivary_gland_carcinoma],618058_[GENE=CFAP300_PHENOS=Ciliary_dyskinesia,primary,38,618063,Autosomal_recessive]
chr11	108005859	108005979	trio	120	3	7	0.00988	0.045	0.000		ACAT1	ACAT1 (oe_lof=0.67 region=exonic/splicing)		147281 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	607809_[GENE=ACAT1_PHENOS=Alpha-methylacetoacetic_aciduria,203750,Autosomal_recessive]
chr11	108141781	108142143	trio	362	3	4	0.03360	0.057	0.000		ATM	ATM (oe_lof=0.60 region=exonic/splicing)	ATM [HI=Sufficient evidence for dosage pathogenicity PMIDS=3574400,27595995,15928302]		607585_[GENE=ATM_PHENOS=Lymphoma,B-cell_non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal_recessive/Breast_cancer,susceptibility_to,114480,Autosomal_dominant,Somatic_mutation/T-cell_prolymphocytic_leukemia,somatic/Lymphoma,mantle_cell,somatic]
chr11	111741488	111742014	trio	526	3	11	0.00123	0.134	0.000		ALG9,FDXACB1	ALG9 (oe_lof=0.38 region=intronic/intergenic),FDXACB1 (oe_lof=0.78 region=intronic/intergenic)			606941_[GENE=ALG9_PHENOS=Gillessen-Kaesbach-Nishimura_syndrome,263210,Autosomal_recessive/Congenital_disorder_of_glycosylation,type_Il,608776,Autosomal_recessive]
chr11	118215049	118215203	trio	154	3	7	0.00856	0.057	0.000		CD3D,CD3G	CD3D (oe_lof=0.78 region=intronic/intergenic),CD3G (oe_lof=0.70 region=exonic/splicing)		563876 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	186740_[GENE=CD3G_PHENOS=Immunodeficiency_17,CD3_gamma_deficient,615607,Autosomal_recessive],186790_[GENE=CD3D_PHENOS=Immunodeficiency_19,615617,Autosomal_recessive]
chr11	119215015	119215111	trio	96	3	5	0.02479	0.178	0.000		C1QTNF5,MFRP	C1QTNF5 (oe_lof=0.00 region=intronic/intergenic),MFRP (oe_lof=0.88 region=exonic/splicing)	MFRP [HI=Gene associated with autosomal recessive phenotype PMIDS=]	563876 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	606227_[GENE=MFRP_PHENOS=Microphthalmia,isolated_5,611040,Autosomal_recessive/Nanophthalmos_2,609549],608752_[GENE=C1QTNF5_PHENOS=Retinal_degeneration,late-onset,autosomal_dominant,605670,Autosomal_dominant]
chr12	464314	464425	trio	111	3	4	0.01144	0.032	0.000		KDM5A	KDM5A (oe_lof=0.09 region=exonic/splicing)		147092 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148625 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149561 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152450 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152732 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154528 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253551 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397352 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],563972 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],563979 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],563982 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57044 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58952 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59798 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],979958 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	
chr12	6439754	6439887	trio	133	1	5	0.03097	0.051	0.000		PLEKHG6,TNFRSF1A	PLEKHG6 (oe_lof=0.75 region=intronic/intergenic),TNFRSF1A (oe_lof=0.05 region=exonic/splicing)			191190_[GENE=TNFRSF1A_PHENOS=Multiple_sclerosis,susceptibility_to,5,614810/Periodic_fever,familial,142680,Autosomal_dominant]
chr12	6442893	6451293	trio	8400	3	14	0.00648	0.038	0.000		TNFRSF1A,RN7SL391P,SCNN1A	TNFRSF1A (oe_lof=0.05 region=exonic/splicing),RN7SL391P (oe_lof=n/a region=intronic/intergenic),SCNN1A (oe_lof=0.64 region=intronic/intergenic)			191190_[GENE=TNFRSF1A_PHENOS=Multiple_sclerosis,susceptibility_to,5,614810/Periodic_fever,familial,142680,Autosomal_dominant],600228_[GENE=SCNN1A_PHENOS=Pseudohypoaldosteronism,type_I,264350,Autosomal_recessive/Liddle_syndrome_3,618126,Autosomal_dominant/Bronchiectasis_with_or_without_elevated_sweat_chloride_2,613021,Autosomal_dominant]
chr12	7341749	7343175	trio	1426	3	10	0.01854	0.115	0.000		PEX5	PEX5 (oe_lof=0.38 region=exonic/splicing)		58985 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600414_[GENE=PEX5_PHENOS=Peroxisome_biogenesis_disorder_2B,202370,Autosomal_recessive/Peroxisome_biogenesis_disorder_2A_(Zellweger),214110,Autosomal_recessive/Rhizomelic_chondrodysplasia_punctata,type_5,616716,Autosomal_recessive]
chr12	7356018	7360408	trio	4390	3	4	0.03047	0.127	0.000		PEX5	PEX5 (oe_lof=0.38 region=exonic/splicing)		58985 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600414_[GENE=PEX5_PHENOS=Peroxisome_biogenesis_disorder_2B,202370,Autosomal_recessive/Peroxisome_biogenesis_disorder_2A_(Zellweger),214110,Autosomal_recessive/Rhizomelic_chondrodysplasia_punctata,type_5,616716,Autosomal_recessive]
chr12	8757801	8758091	trio	290	3	3	0.07715	0.236	0.000		AICDA	AICDA (oe_lof=0.76 region=exonic/splicing)			605257_[GENE=AICDA_PHENOS=Immunodeficiency_with_hyper-IgM,type_2,605258,Autosomal_recessive]
chr12	31226769	31227035	trio	266	3	6	0.01612	0.159	0.000		DDX11-AS1,DDX11,SNORA75	DDX11-AS1 (oe_lof=n/a region=exonic/splicing),DDX11 (oe_lof=0.74 region=intronic/intergenic),SNORA75 (oe_lof=n/a region=intronic/intergenic)			601150_[GENE=DDX11_PHENOS=Warsaw_breakage_syndrome,613398,Autosomal_recessive]
chr12	31255167	31255255	trio	88	1	5	0.04132	0.178	0.000		DDX11	DDX11 (oe_lof=0.74 region=exonic/splicing)			601150_[GENE=DDX11_PHENOS=Warsaw_breakage_syndrome,613398,Autosomal_recessive]
chr12	32906842	32908897	trio	2055	3	11	0.00000	0.083	0.000		YARS2	YARS2 (oe_lof=0.85 region=exonic/splicing)		59805 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610957_[GENE=YARS2_PHENOS=Myopathy,lactic_acidosis,and_sideroblastic_anemia_2,613561,Autosomal_recessive]
chr12	48298337	48298824	trio	487	3	8	0.01414	0.146	0.000		VDR	VDR (oe_lof=0.53 region=exonic/splicing)			601769_[GENE=VDR_PHENOS=Rickets,vitamin_D-resistant,type_IIA,277440,Autosomal_recessive]
chr12	48367862	48368655	trio	793	1	3	0.02753	0.197	0.000		COL2A1	COL2A1 (oe_lof=0.07 region=exonic/splicing)	COL2A1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=27390512,27408751,17721977]		120140_[GENE=COL2A1_PHENOS=Vitreoretinopathy_with_phalangeal_epiphyseal_dysplasia,619248,Autosomal_dominant/Czech_dysplasia,609162,Autosomal_dominant/Achondrogenesis,type_II_or_hypochondrogenesis,200610,Autosomal_dominant/Spondyloperipheral_dysplasia,271700,Autosomal_dominant/SMED_Strudwick_type,184250,Autosomal_dominant/Stickler_sydrome,type_I,nonsyndromic_ocular,609508,Autosomal_dominant/Epiphyseal_dysplasia,multiple,with_myopia_and_deafness,132450,Autosomal_dominant/SED_congenita,183900,Autosomal_dominant/Kniest_dysplasia,156550,Autosomal_dominant/Osteoarthritis_with_mild_chondrodysplasia,604864,Autosomal_dominant/Stickler_syndrome,type_I,108300,Autosomal_dominant/Platyspondylic_skeletal_dysplasia,Torrance_type,151210,Autosomal_dominant/Spondyloepiphyseal_dysplasia,Stanescu_type,616583,Autosomal_dominant/Avascular_necrosis_of_the_femoral_head,608805,Autosomal_dominant/Legg-Calve-Perthes_disease,150600,Autosomal_dominant]
chr12	48380109	48381502	trio	1393	3	5	0.13147	0.159	0.000		COL2A1	COL2A1 (oe_lof=0.07 region=exonic/splicing)	COL2A1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=27390512,27408751,17721977]		120140_[GENE=COL2A1_PHENOS=Vitreoretinopathy_with_phalangeal_epiphyseal_dysplasia,619248,Autosomal_dominant/Czech_dysplasia,609162,Autosomal_dominant/Achondrogenesis,type_II_or_hypochondrogenesis,200610,Autosomal_dominant/Spondyloperipheral_dysplasia,271700,Autosomal_dominant/SMED_Strudwick_type,184250,Autosomal_dominant/Stickler_sydrome,type_I,nonsyndromic_ocular,609508,Autosomal_dominant/Epiphyseal_dysplasia,multiple,with_myopia_and_deafness,132450,Autosomal_dominant/SED_congenita,183900,Autosomal_dominant/Kniest_dysplasia,156550,Autosomal_dominant/Osteoarthritis_with_mild_chondrodysplasia,604864,Autosomal_dominant/Stickler_syndrome,type_I,108300,Autosomal_dominant/Platyspondylic_skeletal_dysplasia,Torrance_type,151210,Autosomal_dominant/Spondyloepiphyseal_dysplasia,Stanescu_type,616583,Autosomal_dominant/Avascular_necrosis_of_the_femoral_head,608805,Autosomal_dominant/Legg-Calve-Perthes_disease,150600,Autosomal_dominant]
chr12	49423174	49424561	trio	1387	3	4	0.09199	0.121	0.000		KMT2D	KMT2D (oe_lof=0.07 region=exonic/splicing)	KMT2D [HI=Sufficient evidence for dosage pathogenicity PMIDS=20711175,21671394,21607748]	633775 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Kabuki syndrome 1"]	602113_[GENE=KMT2D_PHENOS=Kabuki_syndrome_1,147920,Autosomal_dominant]
chr12	49436849	49436979	trio	130	3	5	0.02626	0.070	0.000		KMT2D	KMT2D (oe_lof=0.07 region=exonic/splicing)	KMT2D [HI=Sufficient evidence for dosage pathogenicity PMIDS=20711175,21671394,21607748]	633775 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Kabuki syndrome 1"],872306 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	602113_[GENE=KMT2D_PHENOS=Kabuki_syndrome_1,147920,Autosomal_dominant]
chr12	49437641	49437791	trio	150	3	4	0.02988	0.013	0.000		KMT2D	KMT2D (oe_lof=0.07 region=exonic/splicing)	KMT2D [HI=Sufficient evidence for dosage pathogenicity PMIDS=20711175,21671394,21607748]	633775 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Kabuki syndrome 1"]	602113_[GENE=KMT2D_PHENOS=Kabuki_syndrome_1,147920,Autosomal_dominant]
chr12	49440382	49440583	trio	201	3	5	0.01006	0.025	0.000		KMT2D	KMT2D (oe_lof=0.07 region=exonic/splicing)	KMT2D [HI=Sufficient evidence for dosage pathogenicity PMIDS=20711175,21671394,21607748]	633775 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Kabuki syndrome 1"]	602113_[GENE=KMT2D_PHENOS=Kabuki_syndrome_1,147920,Autosomal_dominant]
chr12	51019749	51019840	trio	91	3	6	0.01579	0.166	0.000		DIP2B	DIP2B (oe_lof=0.18 region=exonic/splicing)		153751 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	611379_[GENE=DIP2B_PHENOS=Mental_retardation,FRA12A_type,136630,Autosomal_dominant]
chr12	51072452	51072669	trio	217	3	3	0.07493	0.146	0.000		DIP2B	DIP2B (oe_lof=0.18 region=exonic/splicing)		152062 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153751 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	611379_[GENE=DIP2B_PHENOS=Mental_retardation,FRA12A_type,136630,Autosomal_dominant]
chr12	51090834	51090968	trio	134	3	11	0.00244	0.057	0.000		DIP2B	DIP2B (oe_lof=0.18 region=exonic/splicing)		152062 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153751 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	611379_[GENE=DIP2B_PHENOS=Mental_retardation,FRA12A_type,136630,Autosomal_dominant]
chr12	53702734	53708235	trio	5501	3	5	0.06566	0.051	0.000		MYG1,AAAS	MYG1 (oe_lof=0.78 region=intronic/intergenic),AAAS (oe_lof=0.71 region=exonic/splicing)		148968 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59017 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59018 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980437 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	605378_[GENE=AAAS_PHENOS=Achalasia-addisonianism-alacrimia_syndrome,231550,Autosomal_recessive]
chr12	53714339	53715422	trio	1083	3	5	0.13845	0.268	0.000		AAAS,SP7	AAAS (oe_lof=0.71 region=exonic/splicing),SP7 (oe_lof=0.18 region=intronic/intergenic)		148968 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59017 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59018 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980437 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	605378_[GENE=AAAS_PHENOS=Achalasia-addisonianism-alacrimia_syndrome,231550,Autosomal_recessive],606633_[GENE=SP7_PHENOS=Osteogenesis_imperfecta,type_XII,613849,Autosomal_recessive]
chr12	56391033	56391133	trio	100	3	7	0.01144	0.096	0.000		RAB5B,SUOX	RAB5B (oe_lof=0.36 region=intronic/intergenic),SUOX (oe_lof=0.67 region=intronic/intergenic)		152934 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	606887_[GENE=SUOX_PHENOS=Sulfite_oxidase_deficiency,272300,Autosomal_recessive]
chr12	56486521	56486614	trio	93	3	4	0.02613	0.051	0.000		ERBB3	ERBB3 (oe_lof=0.52 region=exonic/splicing)		152934 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	190151_[GENE=ERBB3_PHENOS=Lethal_congenital_contractural_syndrome_2,607598,Autosomal_recessive/Erythroleukemia,familial,susceptibility_to,133180,Autosomal_dominant/Visceral_neuropathy,familial,1,autosomal_recessive,243180,Autosomal_recessive]
chr12	57976874	57977008	trio	134	3	10	0.00763	0.083	0.000		KIF5A	KIF5A (oe_lof=0.13 region=exonic/splicing)		59020 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815529 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	602821_[GENE=KIF5A_PHENOS=Myoclonus,intractable,neonatal,617235,Autosomal_dominant/Amyotrophic_lateral_sclerosis,susceptibility_to,25,617921,Autosomal_dominant/Spastic_paraplegia_10,autosomal_dominant,604187,Autosomal_dominant]
chr12	58158151	58158343	trio	192	3	6	0.01707	0.057	0.000		MARCHF9,CYP27B1,METTL1	MARCHF9 (oe_lof=0.15 region=intronic/intergenic),CYP27B1 (oe_lof=0.63 region=exonic/splicing),METTL1 (oe_lof=0.52 region=intronic/intergenic)		59020 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815529 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	609506_[GENE=CYP27B1_PHENOS=Vitamin_D-dependent_rickets,type_I,264700,Autosomal_recessive]
chr12	58176518	58176651	trio	133	5	9	0.01463	0.242	0.000		EEF1AKMT3,TSFM	EEF1AKMT3 (oe_lof=0.77 region=intronic/intergenic),TSFM (oe_lof=0.93 region=exonic/splicing)		59020 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815529 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	604723_[GENE=TSFM_PHENOS=Combined_oxidative_phosphorylation_deficiency_3,610505,Autosomal_recessive]
chr12	65138579	65138697	trio	118	3	7	0.00970	0.045	0.000	12q14 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/76]	GNS	GNS (oe_lof=0.37 region=exonic/splicing)			607664_[GENE=GNS_PHENOS=Mucopolysaccharidosis_type_IIID,252940,Autosomal_recessive]
chr12	65152855	65153236	trio	381	3	3	0.05259	0.248	0.000	12q14 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/76]	GNS	GNS (oe_lof=0.37 region=exonic/splicing)			607664_[GENE=GNS_PHENOS=Mucopolysaccharidosis_type_IIID,252940,Autosomal_recessive]
chr12	66786078	66786292	trio	214	3	3	0.06762	0.236	0.000	12q14 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/76]	GRIP1	GRIP1 (oe_lof=0.22 region=exonic/splicing)	GRIP1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	59022 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604597_[GENE=GRIP1_PHENOS=Fraser_syndrome_3,617667,Autosomal_recessive]
chr12	81102293	81102403	trio	110	1	4	0.03348	0.076	0.000		MYF6	MYF6 (oe_lof=0.54 region=exonic/splicing)		57586 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57587 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57588 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57589 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],601321 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	
chr12	102869411	102869587	trio	176	3	3	0.05437	0.255	0.000		IGF1	IGF1 (oe_lof=0.26 region=exonic/splicing)			147440_[GENE=IGF1_PHENOS=Growth_retardation_with_deafness_and_mental_retardation_due_to_IGF1_deficiency,608747,Autosomal_recessive]
chr12	106773799	106773927	trio	128	1	3	0.05999	0.229	0.000		POLR3B	POLR3B (oe_lof=0.68 region=exonic/splicing)			614366_[GENE=POLR3B_PHENOS=Leukodystrophy,hypomyelinating,8,with_or_without_oligodontia_and/or_hypogonadotropic_hypogonadism,614381,Autosomal_recessive]
chr12	109535913	109536453	trio	540	3	4	0.03761	0.159	0.000		ALKBH2,UNG	ALKBH2 (oe_lof=0.57 region=intronic/intergenic),UNG (oe_lof=0.45 region=exonic/splicing)			191525_[GENE=UNG_PHENOS=Immunodeficiency_with_hyper_IgM,type_5,608106,Autosomal_recessive]
chr12	110011490	110011688	trio	198	3	4	0.04239	0.153	0.000		MMAB,MVK	MMAB (oe_lof=0.45 region=intronic/intergenic),MVK (oe_lof=0.26 region=intronic/intergenic)			251170_[GENE=MVK_PHENOS=Hyper-IgD_syndrome,260920,Autosomal_recessive/Porokeratosis_3,multiple_types,175900,Autosomal_dominant/Mevalonic_aciduria,610377,Autosomal_recessive],607568_[GENE=MMAB_PHENOS=Methylmalonic_aciduria,vitamin_B12-responsive,cblB_type,251110,Autosomal_recessive]
chr12	111953948	111954177	trio	229	4	4	0.07948	0.357	0.000		ATXN2	ATXN2 (oe_lof=0.20 region=exonic/splicing)			601517_[GENE=ATXN2_PHENOS=Amyotrophic_lateral_sclerosis,susceptibility_to,13,183090,Autosomal_dominant/Spinocerebellar_ataxia_2,183090,Autosomal_dominant/Parkinson_disease,late-onset,susceptibility_to,168600,Autosomal_dominant,Multifactorial]
chr12	119624820	119624903	trio	83	1	4	0.04041	0.064	0.000		HSPB8	HSPB8 (oe_lof=0.44 region=exonic/splicing)		396436 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	608014_[GENE=HSPB8_PHENOS=Neuronopathy,distal_hereditary_motor,type_IIA,158590,Autosomal_dominant/Charcot-Marie-Tooth_disease,axonal,type_2L,608673,Autosomal_dominant]
chr12	120966733	120966974	trio	241	4	10	0.00763	0.242	0.000		COQ5	COQ5 (oe_lof=0.56 region=exonic/splicing)		396436 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57609 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	616359_[GENE=COQ5_PHENOS=Coenzyme_Q10_deficiency,primary,9,619028,Autosomal_recessive]
chr12	122277423	122277964	trio	541	3	7	0.00026	0.140	0.000		HPD	HPD (oe_lof=0.39 region=exonic/splicing)		57609 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57610 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57611 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	609695_[GENE=HPD_PHENOS=Hawkinsinuria,140350,Autosomal_dominant/Tyrosinemia,type_III,276710,Autosomal_recessive]
chr12	122985177	123718481	trio	733304	3	7	0.00970	0.127	0.004 (1.00,1.00)		ZCCHC8,RSRC2,KNTC1,HCAR1,HCAR2,HCAR3,DENR,CCDC62,HIP1R,VPS37B,ABCB9,OGFOD2,ARL6IP4,PITPNM2,MIR4304,MPHOSPH9,MTRFR	ZCCHC8 (oe_lof=0.15 region=exonic/splicing),RSRC2 (oe_lof=0.07 region=exonic/splicing),KNTC1 (oe_lof=0.69 region=complete),HCAR1 (oe_lof=0.83 region=complete),HCAR2 (oe_lof=0.86 region=complete),HCAR3 (oe_lof=1.57 region=complete),DENR (oe_lof=0.09 region=complete),CCDC62 (oe_lof=0.79 region=complete),HIP1R (oe_lof=0.57 region=complete),VPS37B (oe_lof=0.34 region=complete),ABCB9 (oe_lof=0.39 region=complete),OGFOD2 (oe_lof=1.21 region=complete),ARL6IP4 (oe_lof=0.51 region=complete),PITPNM2 (oe_lof=0.09 region=complete),MIR4304 (oe_lof=n/a region=complete),MPHOSPH9 (oe_lof=0.46 region=exonic/splicing),MTRFR (oe_lof=0.29 region=intronic/intergenic)		393913 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396162 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57610 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	613541_[GENE=MTRFR_PHENOS=Spastic_paraplegia_55,autosomal_recessive,615035,Autosomal_recessive/Combined_oxidative_phosphorylation_deficiency_7,613559,Autosomal_recessive],616381_[GENE=ZCCHC8_PHENOS=Pulmonary_fibrosis_and/or_bone_marrow_failure,telomere-related,5,618674,Autosomal_dominant]
chr13	32798362	32798532	trio	170	3	3	0.09674	0.242	0.000		FRY	FRY (oe_lof=0.15 region=exonic/splicing)		441635 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57637 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57639 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr13	32852592	32868717	trio	16125	3	6	0.01707	0.146	0.000		FRY	FRY (oe_lof=0.15 region=exonic/splicing)		441635 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57637 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57639 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	
chr13	52513177	52516700	trio	3523	3	7	0.10452	0.178	0.000		ATP7B	ATP7B (oe_lof=0.93 region=exonic/splicing)	ATP7B [HI=Gene associated with autosomal recessive phenotype PMIDS=]	396425 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	606882_[GENE=ATP7B_PHENOS=Wilson_disease,277900,Autosomal_recessive]
chr13	108866876	108870726	trio	3850	3	3	0.03301	0.255	0.000		LIG4,ABHD13	LIG4 (oe_lof=0.50 region=intronic/intergenic),ABHD13 (oe_lof=0.09 region=intronic/intergenic)	LIG4 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	152966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394870 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57712 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815620 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	601837_[GENE=LIG4_PHENOS=LIG4_syndrome,606593,Autosomal_recessive/Multiple_myeloma,resistance_to,254500,Somatic_mutation]
chr13	110831260	110831778	trio	518	3	4	0.10488	0.229	0.000		COL4A1	COL4A1 (oe_lof=0.07 region=exonic/splicing)		152966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57712 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],807059 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120130_[GENE=COL4A1_PHENOS=Retinal_arteries,tortuosity_of,180000,Autosomal_dominant/Hemorrhage,intracerebral,susceptibility_to,614519/Angiopathy,hereditary,with_nephropathy,aneurysms,and_muscle_cramps,611773,Autosomal_dominant/Microangiopathy_and_leukoencephalopathy,pontine,autosomal_dominant,618564,Autosomal_dominant/Brain_small_vessel_disease_with_or_without_ocular_anomalies,175780,Autosomal_dominant]
chr13	111077071	111080940	trio	3869	3	4	0.08600	0.134	0.000		COL4A2	COL4A2 (oe_lof=0.45 region=exonic/splicing)		152966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	120090_[GENE=COL4A2_PHENOS=Brain_small_vessel_disease_2,614483,Autosomal_dominant/Hemorrhage,intracerebral,susceptibility_to,614519]
chr13	111111108	111111291	trio	183	3	3	0.04497	0.076	0.000		COL4A2,COL4A2-AS2	COL4A2 (oe_lof=0.45 region=exonic/splicing),COL4A2-AS2 (oe_lof=n/a region=intronic/intergenic)		152966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	120090_[GENE=COL4A2_PHENOS=Brain_small_vessel_disease_2,614483,Autosomal_dominant/Hemorrhage,intracerebral,susceptibility_to,614519]
chr13	111114615	111132747	trio	18132	3	9	0.12688	0.217	0.000		COL4A2,COL4A2-AS2	COL4A2 (oe_lof=0.45 region=exonic/splicing),COL4A2-AS2 (oe_lof=n/a region=exonic/splicing)		152966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	120090_[GENE=COL4A2_PHENOS=Brain_small_vessel_disease_2,614483,Autosomal_dominant/Hemorrhage,intracerebral,susceptibility_to,614519]
chr13	111137992	111141865	trio	3873	3	5	0.02112	0.185	0.000		COL4A2	COL4A2 (oe_lof=0.45 region=exonic/splicing)		152966 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	120090_[GENE=COL4A2_PHENOS=Brain_small_vessel_disease_2,614483,Autosomal_dominant/Hemorrhage,intracerebral,susceptibility_to,614519]
chr14	20774036	20937704	trio	163668	3	4	0.02602	0.140	0.000		TTC5,CCNB1IP1,SNORA79,SNORD126,RPPH1,PARP2,TEP1,RNA5SP382,KLHL33,OSGEP,APEX1,PIP4P1,PNP	TTC5 (oe_lof=0.50 region=exonic/splicing),CCNB1IP1 (oe_lof=0.62 region=complete),SNORA79 (oe_lof=n/a region=complete),SNORD126 (oe_lof=n/a region=complete),RPPH1 (oe_lof=n/a region=complete),PARP2 (oe_lof=0.71 region=complete),TEP1 (oe_lof=0.71 region=complete),RNA5SP382 (oe_lof=n/a region=complete),KLHL33 (oe_lof=0.56 region=complete),OSGEP (oe_lof=0.69 region=complete),APEX1 (oe_lof=0.79 region=complete),PIP4P1 (oe_lof=0.13 region=complete),PNP (oe_lof=0.68 region=exonic/splicing)	PNP [HI=Gene associated with autosomal recessive phenotype PMIDS=]	148657 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57246 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57743 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59933 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980000 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	164050_[GENE=PNP_PHENOS=Immunodeficiency_due_to_purine_nucleoside_phosphorylase_deficiency,613179,Autosomal_recessive],610107_[GENE=OSGEP_PHENOS=Galloway-Mowat_syndrome_3,617729,Autosomal_recessive],619014_[GENE=TTC5_PHENOS=Neurodevelopmental_disorder_with_cerebral_atrophy_and_variable_facial_dysmorphism,619244,Autosomal_recessive]
chr14	23895976	23896083	trio	107	1	7	0.02582	0.389	0.000		MYH7	MYH7 (oe_lof=0.45 region=exonic/splicing)		148657 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57246 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],666446 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	160760_[GENE=MYH7_PHENOS=Laing_distal_myopathy,160500,Autosomal_dominant/Cardiomyopathy,hypertrophic,1,192600,Autosomal_dominant,Digenic_dominant/Left_ventricular_noncompaction_5,613426,Autosomal_dominant/Cardiomyopathy,dilated,1S,613426,Autosomal_dominant/Scapuloperoneal_syndrome,myopathic_type,181430,Autosomal_dominant/Myopathy,myosin_storage,autosomal_dominant,608358,Autosomal_dominant/Myopathy,myosin_storage,autosomal_recessive,255160,Autosomal_recessive]
chr14	24723348	24723504	trio	156	1	6	0.01865	0.032	0.000		TGM1	TGM1 (oe_lof=0.67 region=exonic/splicing)		148657 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154806 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	190195_[GENE=TGM1_PHENOS=Ichthyosis,congenital,autosomal_recessive_1,242300,Autosomal_recessive]
chr14	24728900	24729274	trio	374	1	5	0.01232	0.070	0.000		TGM1	TGM1 (oe_lof=0.67 region=exonic/splicing)		148657 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154806 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	190195_[GENE=TGM1_PHENOS=Ichthyosis,congenital,autosomal_recessive_1,242300,Autosomal_recessive]
chr14	32030581	32030763	trio	182	4	6	0.06543	0.248	0.000		NUBPL	NUBPL (oe_lof=0.56 region=exonic/splicing)		154183 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],688414 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	613621_[GENE=NUBPL_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_21,618242,Autosomal_recessive]
chr14	35182870	35183033	trio	163	3	10	0.00424	0.051	0.000		CFL2	CFL2 (oe_lof=0.83 region=exonic/splicing)		57752 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	601443_[GENE=CFL2_PHENOS=Nemaline_myopathy_7,autosomal_recessive,610687,Autosomal_recessive]
chr14	45605126	45605752	trio	626	3	8	0.01026	0.070	0.000		FKBP3,FANCM	FKBP3 (oe_lof=0.54 region=intronic/intergenic),FANCM (oe_lof=0.46 region=exonic/splicing)			609644_[GENE=FANCM_PHENOS=Premature_ovarian_failure_15,618096,Autosomal_recessive/Spermatogenic_failure_28,618086,Autosomal_recessive]
chr14	50778719	50778957	trio	238	3	4	0.04639	0.191	0.000		L2HGDH,DMAC2L	L2HGDH (oe_lof=0.48 region=exonic/splicing),DMAC2L (oe_lof=0.80 region=intronic/intergenic)			609584_[GENE=L2HGDH_PHENOS=L-2-hydroxyglutaric_aciduria,236792,Autosomal_recessive]
chr14	51026733	51027027	trio	294	3	4	0.03348	0.172	0.000		ATL1	ATL1 (oe_lof=0.15 region=exonic/splicing)			606439_[GENE=ATL1_PHENOS=Spastic_paraplegia_3A,autosomal_dominant,182600,Autosomal_dominant/Neuropathy,hereditary_sensory,type_ID,613708,Autosomal_dominant]
chr14	55312476	55312580	trio	104	3	10	0.00445	0.172	0.000		GCH1	GCH1 (oe_lof=0.08 region=exonic/splicing)	GCH1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=17804835,17111153,21287604]	146623 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564130 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	600225_[GENE=GCH1_PHENOS=Dystonia,DOPA-responsive,with_or_without_hyperphenylalaninemia,128230,Autosomal_dominant,Autosomal_recessive/Hyperphenylalaninemia,BH4-deficient,B,233910,Autosomal_recessive]
chr14	75469602	75470108	trio	506	3	17	0.00119	0.070	0.000		EIF2B2	EIF2B2 (oe_lof=0.99 region=exonic/splicing)		57808 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625564 [CN_TYPE=loss CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	606454_[GENE=EIF2B2_PHENOS=Leukoencephalopathy_with_vanishing_white_matter,603896,Autosomal_recessive/Ovarioleukodystrophy,603896,Autosomal_recessive]
chr14	77745062	77745222	trio	160	1	5	0.02613	0.051	0.000		POMT2	POMT2 (oe_lof=0.57 region=exonic/splicing)		148347 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57808 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57809 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	607439_[GENE=POMT2_PHENOS=Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,2,613158,Autosomal_recessive/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,2,613156,Autosomal_recessive/Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,2,613150,Autosomal_recessive]
chr14	77915626	77915710	trio	84	3	5	0.04153	0.191	0.000		VIPAS39	VIPAS39 (oe_lof=0.55 region=exonic/splicing)		148347 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57808 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57809 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	613401_[GENE=VIPAS39_PHENOS=Arthrogryposis,renal_dysfunction,and_cholestasis_2,613404,Autosomal_recessive]
chr14	77923428	77923993	trio	565	3	9	0.01006	0.070	0.000		VIPAS39,AHSA1	VIPAS39 (oe_lof=0.55 region=exonic/splicing),AHSA1 (oe_lof=0.00 region=intronic/intergenic)		148347 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57808 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57809 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	613401_[GENE=VIPAS39_PHENOS=Arthrogryposis,renal_dysfunction,and_cholestasis_2,613404,Autosomal_recessive]
chr15	23060805	23060915	trio	110	3	4	0.05315	0.204	0.000	Angelman syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/4],Prader-Willi syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/14]	NIPA1	NIPA1 (oe_lof=0.49 region=exonic/splicing)		1012382 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1172565 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],1175875 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1199402 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],146208 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252972 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],446342 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],503578 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],523248 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Global developmental delay"],523249 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="10 conditions"],638109 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],666449 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="Chromosome 15q11.2 deletion syndrome"],816481 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],816484 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],816494 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],816512 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],816521 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],929315 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],929332 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],929338 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],929376 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],929824 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],929829 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],979405 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],979406 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],988923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],988924 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],988925 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],988927 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],988928 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],997051 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Autistic disorder of childhood onset;Delayed speech and language development"],997065 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Epileptic encephalopathy|Global developmental delay"]	608145_[GENE=NIPA1_PHENOS=Spastic_paraplegia_6,autosomal_dominant,600363,Autosomal_dominant]
chr15	25200125	25200219	trio	94	3	8	0.01087	0.134	0.000	Angelman syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/4],Angelman syndrome (Type 2) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/54],Prader-Willi Syndrome (Type 2) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/53],Prader-Willi syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/14]	SNRPN,SNURF	SNRPN (oe_lof=0.36 region=intronic/intergenic),SNURF (oe_lof=0.18 region=exonic/splicing)	SNURF [HI=Little evidence for dosage pathogenicity PMIDS=22511895]	1012382 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1180527 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],144574 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145034 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146184 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146634 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147566 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147585 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147819 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148195 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148318 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148320 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148846 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148891 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149915 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150851 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151256 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151262 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151937 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153993 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154787 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155599 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155649 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155677 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160797 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160798 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160927 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32168 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32921 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33733 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395075 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395545 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395546 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395788 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395874 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395950 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396730 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397224 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441569 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441669 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],441725 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441794 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442072 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442188 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442553 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442664 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442976 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443030 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443750 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443863 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564156 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564158 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564159 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564162 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57194 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58075 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58599 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58601 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58603 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58605 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58606 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58608 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58627 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58628 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58631 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58633 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58634 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58635 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],602024 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],602025 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614549 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614550 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614551 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614552 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625716 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome;Angelman syndrome"],625717 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome;Angelman syndrome"],625718 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome"],625746 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 15q11-q13 duplication syndrome"],815689 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816547 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	182279_[GENE=SNRPN_PHENOS=Prader-Willi_syndrome,176270,Autosomal_dominant]
chr15	25222014	25223475	trio	1461	3	5	0.13239	0.229	0.000	Angelman syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/4],Angelman syndrome (Type 2) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/54],Prader-Willi Syndrome (Type 2) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/53],Prader-Willi syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/14]	SNRPN,SNURF,SNHG14	SNRPN (oe_lof=0.36 region=exonic/splicing),SNURF (oe_lof=0.18 region=intronic/intergenic),SNHG14 (oe_lof=n/a region=intronic/intergenic)	SNURF [HI=Little evidence for dosage pathogenicity PMIDS=22511895]	1012382 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1180527 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],144574 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145034 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146184 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146634 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147566 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147585 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147819 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148195 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148318 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148320 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148846 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148891 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149915 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150851 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151256 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151262 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151937 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153993 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154787 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155599 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155649 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155677 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160797 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160798 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160927 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32168 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32921 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33733 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395075 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395545 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395546 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395788 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395874 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395950 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396730 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397224 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441569 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441669 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],441725 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441794 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442072 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442553 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442664 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442976 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443030 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443750 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443863 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564156 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564158 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564159 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564162 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57194 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58075 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58599 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58601 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58603 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58605 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58606 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58608 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58627 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58628 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58631 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58633 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58634 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58635 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],602024 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],602025 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614549 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614550 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614551 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614552 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625716 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome;Angelman syndrome"],625717 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome;Angelman syndrome"],625718 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome"],625746 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 15q11-q13 duplication syndrome"],815689 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816547 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	182279_[GENE=SNRPN_PHENOS=Prader-Willi_syndrome,176270,Autosomal_dominant]
chr15	25599665	25601213	trio	1548	3	3	0.02459	0.006	0.000	Angelman syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/4],Angelman syndrome (Type 2) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/54],Prader-Willi Syndrome (Type 2) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/53],Prader-Willi syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/14]	SNHG14,UBE3A	SNHG14 (oe_lof=n/a region=intronic/intergenic),UBE3A (oe_lof=0.08 region=exonic/splicing)	UBE3A [HI=Sufficient evidence for dosage pathogenicity PMIDS=20034088,19213023,8988172]	1012382 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1180527 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],144574 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145034 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146184 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146634 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147566 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147585 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147713 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147819 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148195 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148318 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148320 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148846 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148891 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149915 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150851 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151256 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151262 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151937 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153993 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154787 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155599 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155649 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155677 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160797 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160798 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160927 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253397 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32168 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32921 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33733 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395075 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395545 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395546 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395788 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395874 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395950 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396730 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397224 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441569 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441725 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441794 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442072 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442553 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442664 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442976 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443030 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443750 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443863 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564156 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564158 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564159 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564162 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57194 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57213 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57843 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58075 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58599 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58601 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58603 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58605 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58606 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58608 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58627 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58628 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58631 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58633 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58634 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58635 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],602024 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],602025 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614549 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614550 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614551 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614552 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625716 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome;Angelman syndrome"],625717 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome;Angelman syndrome"],625718 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome"],625746 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 15q11-q13 duplication syndrome"],815689 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816547 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816549 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	601623_[GENE=UBE3A_PHENOS=Angelman_syndrome,105830,Autosomal_dominant]
chr15	25653757	25654364	trio	607	3	4	0.10582	0.210	0.000	Angelman syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/4],Angelman syndrome (Type 2) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/54],Prader-Willi Syndrome (Type 2) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/53],Prader-Willi syndrome (Type 1) [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/14]	SNHG14,UBE3A	SNHG14 (oe_lof=n/a region=intronic/intergenic),UBE3A (oe_lof=0.08 region=exonic/splicing)	UBE3A [HI=Sufficient evidence for dosage pathogenicity PMIDS=20034088,19213023,8988172]	1012382 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1180527 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],144574 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145034 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146184 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146634 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147566 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147585 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147713 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147819 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148195 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148318 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148320 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148846 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148891 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149915 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150851 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151256 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151262 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151937 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153993 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154787 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155599 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155649 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155677 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160797 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160798 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160927 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253397 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32168 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32921 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33733 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395075 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395545 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395546 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395788 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395874 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395950 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396730 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397224 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441569 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441725 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441794 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442072 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442553 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442664 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442976 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443030 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443750 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443863 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564156 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564157 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564158 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564159 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564162 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57194 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57843 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58075 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58599 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58601 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58603 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58605 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58606 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58608 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58627 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58628 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58631 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58633 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58634 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58635 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],602024 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],602025 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614549 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614550 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614551 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],614552 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625716 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome;Angelman syndrome"],625717 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome;Angelman syndrome"],625718 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Prader-Willi syndrome"],625746 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 15q11-q13 duplication syndrome"],815689 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816547 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	601623_[GENE=UBE3A_PHENOS=Angelman_syndrome,105830,Autosomal_dominant]
chr15	34610752	40698182	trio	6087430	3	13	0.00988	0.064	0.034 (0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,0.98,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,1.00,0.29,0.29,0.29,0.20,0.20,0.23,1.00,0.96,0.96)		SLC12A6,NOP10,NUTM1,LPCAT4,GOLGA8A,MIR1233-1,HNRNPLP2,GOLGA8B,MIR1233-2,SNORA18,GJD2,ACTC1,AQR,ZNF770,NANOGP8,PRELID1P4,ANP32AP1,DPH6,MIR3942,HNRNPA1P45,DPH6-DT,MIR4510,COX6CP4,CDIN1,LARP4P,TPST2P1,CSNK1A1P1,MEIS2,TMCO5A,SPRED1,FAM98B,RASGRP1,LINC02694,C15ORF54,THBS1,FSIP1,GPR176,EIF2AK4,H3P38,SRP14,SRP14-AS1,BMF,BUB1B,PAK6,C15ORF56,ANKRD63,PLCB2,PLCB2-AS1,INAFM2,CCDC9B,RNA5SP392,PHGR1,DISP2,KNSTRN,IVD	SLC12A6 (oe_lof=0.26 region=exonic/splicing),NOP10 (oe_lof=0.00 region=complete),NUTM1 (oe_lof=0.32 region=complete),LPCAT4 (oe_lof=0.22 region=complete),GOLGA8A (oe_lof=1.00 region=complete),MIR1233-1 (oe_lof=n/a region=complete),HNRNPLP2 (oe_lof=n/a region=complete),GOLGA8B (oe_lof=1.18 region=complete),MIR1233-2 (oe_lof=n/a region=complete),SNORA18 (oe_lof=n/a region=complete),GJD2 (oe_lof=0.27 region=complete),ACTC1 (oe_lof=0.15 region=complete),AQR (oe_lof=0.13 region=complete),ZNF770 (oe_lof=0.09 region=complete),NANOGP8 (oe_lof=n/a region=complete),PRELID1P4 (oe_lof=n/a region=complete),ANP32AP1 (oe_lof=n/a region=complete),DPH6 (oe_lof=0.64 region=complete),MIR3942 (oe_lof=n/a region=complete),HNRNPA1P45 (oe_lof=n/a region=complete),DPH6-DT (oe_lof=n/a region=complete),MIR4510 (oe_lof=n/a region=complete),COX6CP4 (oe_lof=n/a region=complete),CDIN1 (oe_lof=0.66 region=complete),LARP4P (oe_lof=n/a region=complete),TPST2P1 (oe_lof=n/a region=complete),CSNK1A1P1 (oe_lof=n/a region=complete),MEIS2 (oe_lof=0.04 region=complete),TMCO5A (oe_lof=0.63 region=complete),SPRED1 (oe_lof=0.12 region=complete),FAM98B (oe_lof=0.35 region=complete),RASGRP1 (oe_lof=0.17 region=complete),LINC02694 (oe_lof=1.46 region=complete),C15ORF54 (oe_lof=0.98 region=complete),THBS1 (oe_lof=0.13 region=complete),FSIP1 (oe_lof=0.88 region=complete),GPR176 (oe_lof=0.40 region=complete),EIF2AK4 (oe_lof=0.44 region=complete),H3P38 (oe_lof=n/a region=complete),SRP14 (oe_lof=0.00 region=complete),SRP14-AS1 (oe_lof=n/a region=complete),BMF (oe_lof=0.48 region=complete),BUB1B (oe_lof=0.42 region=complete),PAK6 (oe_lof=0.43 region=complete),C15ORF56 (oe_lof=0.83 region=complete),ANKRD63 (oe_lof=0.21 region=complete),PLCB2 (oe_lof=0.66 region=complete),PLCB2-AS1 (oe_lof=n/a region=complete),INAFM2 (oe_lof=n/a region=complete),CCDC9B (oe_lof=0.81 region=complete),RNA5SP392 (oe_lof=n/a region=complete),PHGR1 (oe_lof=0.52 region=complete),DISP2 (oe_lof=0.24 region=complete),KNSTRN (oe_lof=0.61 region=complete),IVD (oe_lof=0.95 region=exonic/splicing)	ACTC1 [HI=Little evidence for dosage pathogenicity PMIDS=17947298,24503780],MEIS2 [HI=Some evidence for dosage pathogenicity PMIDS=20425846,24678003],SPRED1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=17704776,19443465]	395223 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441671 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],564191 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],564194 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57226 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57451 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57878 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58570 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],624481 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],685290 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686274 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815698 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815702 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	102540_[GENE=ACTC1_PHENOS=Left_ventricular_noncompaction_4,613424,Autosomal_dominant/Cardiomyopathy,hypertrophic,11,612098,Autosomal_dominant/Atrial_septal_defect_5,612794,Autosomal_dominant/Cardiomyopathy,dilated,1R,613424,Autosomal_dominant],601740_[GENE=MEIS2_PHENOS=Cleft_palate,cardiac_defects,and_mental_retardation,600987,Autosomal_dominant],602860_[GENE=BUB1B_PHENOS=Colorectal_cancer,somatic,114500/Premature_chromatid_separation_trait,176430,Autosomal_dominant/Mosaic_variegated_aneuploidy_syndrome_1,257300,Autosomal_recessive],603962_[GENE=RASGRP1_PHENOS=Immunodeficiency_64,618534,Autosomal_recessive],604114_[GENE=PLCB2_PHENOS=Platelet_PLC_beta-2_deficiency],604878_[GENE=SLC12A6_PHENOS=Agenesis_of_the_corpus_callosum_with_peripheral_neuropathy,218000,Autosomal_recessive],606471_[GENE=NOP10_PHENOS=Dyskeratosis_congenita,autosomal_recessive_1,224230,Autosomal_recessive],607036_[GENE=IVD_PHENOS=Isovaleric_acidemia,243500,Autosomal_recessive],609280_[GENE=EIF2AK4_PHENOS=Pulmonary_venoocclusive_disease_2,234810,Autosomal_recessive],609291_[GENE=SPRED1_PHENOS=Legius_syndrome,611431,Autosomal_dominant],614718_[GENE=KNSTRN_PHENOS=Roifman-Chitayat_syndrome,digenic,613328,Digenic_recessive],615626_[GENE=CDIN1_PHENOS=Dyserythropoietic_anemia,congenital,type_Ib,615631,Autosomal_recessive]
chr15	40703449	40703562	trio	113	3	3	0.03405	0.025	0.000		IVD	IVD (oe_lof=0.95 region=exonic/splicing)		564194 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58570 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	607036_[GENE=IVD_PHENOS=Isovaleric_acidemia,243500,Autosomal_recessive]
chr15	45386751	45386899	trio	148	3	6	0.02479	0.178	0.000		DUOX2	DUOX2 (oe_lof=1.06 region=exonic/splicing)		547142 [CN_TYPE=loss CN=2 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	606759_[GENE=DUOX2_PHENOS=Thyroid_dyshormonogenesis_6,607200,Autosomal_recessive]
chr15	45403299	45403485	trio	186	1	8	0.00964	0.051	0.000		DUOX2,DUOXA2	DUOX2 (oe_lof=1.06 region=exonic/splicing),DUOXA2 (oe_lof=1.52 region=intronic/intergenic)		547142 [CN_TYPE=loss CN=2 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	606759_[GENE=DUOX2_PHENOS=Thyroid_dyshormonogenesis_6,607200,Autosomal_recessive],612772_[GENE=DUOXA2_PHENOS=Thyroid_dyshormonogenesis_5,274900,Autosomal_recessive]
chr15	48719754	48719980	trio	226	1	3	0.36999	0.401	0.000		FBN1	FBN1 (oe_lof=0.02 region=exonic/splicing)	FBN1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=17701892,30286810,21063442]	395978 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815710 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	134797_[GENE=FBN1_PHENOS=Geleophysic_dysplasia_2,614185,Autosomal_dominant/Weill-Marchesani_syndrome_2,dominant,608328,Autosomal_dominant/Ectopia_lentis,familial,129600,Autosomal_dominant/MASS_syndrome,604308,Autosomal_dominant/Marfan_lipodystrophy_syndrome,616914,Autosomal_dominant/Acromicric_dysplasia,102370,Autosomal_dominant/Marfan_syndrome,154700,Autosomal_dominant/Stiff_skin_syndrome,184900,Autosomal_dominant]
chr15	48784648	48787795	trio	3147	3	5	0.18267	0.236	0.000		FBN1	FBN1 (oe_lof=0.02 region=exonic/splicing)	FBN1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=17701892,30286810,21063442]	144202 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395978 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443299 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],815710 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	134797_[GENE=FBN1_PHENOS=Geleophysic_dysplasia_2,614185,Autosomal_dominant/Weill-Marchesani_syndrome_2,dominant,608328,Autosomal_dominant/Ectopia_lentis,familial,129600,Autosomal_dominant/MASS_syndrome,604308,Autosomal_dominant/Marfan_lipodystrophy_syndrome,616914,Autosomal_dominant/Acromicric_dysplasia,102370,Autosomal_dominant/Marfan_syndrome,154700,Autosomal_dominant/Stiff_skin_syndrome,184900,Autosomal_dominant]
chr15	49089848	49089937	trio	89	3	6	0.01463	0.038	0.000		CEP152	CEP152 (oe_lof=0.66 region=exonic/splicing)		395978 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815710 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	613529_[GENE=CEP152_PHENOS=Microcephaly_9,primary,autosomal_recessive,614852,Autosomal_recessive/Seckel_syndrome_5,613823,Autosomal_recessive]
chr15	51233853	51240366	trio	6513	3	4	0.14931	0.217	0.000		AP4E1,DCAF13P3	AP4E1 (oe_lof=0.28 region=exonic/splicing),DCAF13P3 (oe_lof=n/a region=exonic/splicing)			607244_[GENE=AP4E1_PHENOS=Stuttering,familial_persistent,1,184450,Autosomal_dominant/Spastic_paraplegia_51,autosomal_recessive,613744,Autosomal_recessive]
chr15	52672009	52675395	trio	3386	3	8	0.02334	0.140	0.000		MYO5A	MYO5A (oe_lof=0.21 region=exonic/splicing)	MYO5A [HI=Gene associated with autosomal recessive phenotype PMIDS=]	980039 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	160777_[GENE=MYO5A_PHENOS=Griscelli_syndrome,type_1,214450,Autosomal_recessive]
chr15	55522589	55522694	trio	105	3	6	0.02442	0.185	0.000		RAB27A	RAB27A (oe_lof=1.00 region=exonic/splicing)			603868_[GENE=RAB27A_PHENOS=Griscelli_syndrome,type_2,607624,Autosomal_recessive]
chr15	72978510	72978602	trio	92	4	5	0.02682	0.217	0.000		HIGD2B,BBS4	HIGD2B (oe_lof=n/a region=intronic/intergenic),BBS4 (oe_lof=0.86 region=exonic/splicing)		148272 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153074 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154681 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253560 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443649 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564215 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57140 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57428 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58078 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],687381 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687513 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688538 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815734 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980531 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	600374_[GENE=BBS4_PHENOS=Bardet-Biedl_syndrome_4,615982,Autosomal_recessive]
chr15	74490083	74494633	trio	4550	3	3	0.22798	0.268	0.000	15q24 recurrent microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/66]	STRA6	STRA6 (oe_lof=0.58 region=exonic/splicing)		148272 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153074 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154681 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253560 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253605 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443649 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564215 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57428 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58078 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],687381 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687513 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688538 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815734 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980532 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	610745_[GENE=STRA6_PHENOS=Microphthalmia,syndromic_9,601186,Autosomal_recessive/Microphthalmia,isolated,with_coloboma_8,601186,Autosomal_recessive]
chr15	76668493	76668662	trio	169	3	3	0.05619	0.178	0.000		SCAPER	SCAPER (oe_lof=0.26 region=exonic/splicing)		147979 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	611611_[GENE=SCAPER_PHENOS=Intellectual_developmental_disorder_and_retinitis_pigmentosa,618195,Autosomal_recessive]
chr15	80445223	80445487	trio	264	4	4	0.04234	0.236	0.000		FAH	FAH (oe_lof=1.01 region=exonic/splicing)	FAH [HI=Gene associated with autosomal recessive phenotype PMIDS=]		613871_[GENE=FAH_PHENOS=Tyrosinemia,type_I,276700,Autosomal_recessive]
chr15	91260569	91260681	trio	112	3	11	0.00083	0.127	0.000		BLM	BLM (oe_lof=0.56 region=intronic/intergenic)		687287 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	604610_[GENE=BLM_PHENOS=Bloom_syndrome,210900,Autosomal_recessive]
chr15	91565374	91565843	trio	469	4	27	0.00000	0.217	0.000		VPS33B	VPS33B (oe_lof=0.71 region=exonic/splicing)		687287 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	608552_[GENE=VPS33B_PHENOS=Arthrogryposis,renal_dysfunction,and_cholestasis_1,208085,Autosomal_recessive]
chr16	1244962	1245575	trio	613	1	5	0.07336	0.127	0.000		CACNA1H	CACNA1H (oe_lof=0.38 region=exonic/splicing)		145576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147509 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148760 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152879 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252979 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253622 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564251 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564252 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564253 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58595 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58596 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58597 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59425 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],614809 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625723 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p13.3 duplication syndrome"],687431 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688348 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607904_[GENE=CACNA1H_PHENOS=Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027,Autosomal_dominant/Epilepsy,idiopathic_generalized,susceptibility_to,6,611942]
chr16	1260025	1260661	trio	636	1	2	0.15015	0.108	0.000		CACNA1H	CACNA1H (oe_lof=0.38 region=exonic/splicing)		145576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147509 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148760 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152879 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252979 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253622 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564251 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564252 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564253 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58595 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58596 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58597 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59425 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],614809 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625723 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p13.3 duplication syndrome"],687431 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688348 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607904_[GENE=CACNA1H_PHENOS=Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027,Autosomal_dominant/Epilepsy,idiopathic_generalized,susceptibility_to,6,611942]
chr16	1261158	1261616	trio	458	1	3	0.05061	0.064	0.000		CACNA1H	CACNA1H (oe_lof=0.38 region=exonic/splicing)		145576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147509 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148760 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152879 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252979 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253622 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564251 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564252 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564253 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58595 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58596 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58597 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59425 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],614809 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625723 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p13.3 duplication syndrome"],687431 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688348 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607904_[GENE=CACNA1H_PHENOS=Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027,Autosomal_dominant/Epilepsy,idiopathic_generalized,susceptibility_to,6,611942]
chr16	1505125	1505806	trio	681	1	5	0.08465	0.102	0.000		CLCN7	CLCN7 (oe_lof=0.23 region=exonic/splicing)		145576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147509 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148760 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252979 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253622 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564252 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564253 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564256 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58595 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58596 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58597 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58600 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58602 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59425 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],614809 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625723 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p13.3 duplication syndrome"],688348 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	602727_[GENE=CLCN7_PHENOS=Hypopigmentation,organomegaly,and_delayed_myelination_and_development,618541,Autosomal_dominant/Osteopetrosis,autosomal_recessive_4,611490,Autosomal_recessive/Osteopetrosis,autosomal_dominant_2,166600,Autosomal_dominant]
chr16	1507685	1510959	trio	3274	1	8	0.03623	0.038	0.000		CLCN7	CLCN7 (oe_lof=0.23 region=exonic/splicing)		145576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147509 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148760 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252979 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253622 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564252 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564253 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564256 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58595 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58596 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58597 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58600 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58602 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59425 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],614809 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625723 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p13.3 duplication syndrome"],688348 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	602727_[GENE=CLCN7_PHENOS=Hypopigmentation,organomegaly,and_delayed_myelination_and_development,618541,Autosomal_dominant/Osteopetrosis,autosomal_recessive_4,611490,Autosomal_recessive/Osteopetrosis,autosomal_dominant_2,166600,Autosomal_dominant]
chr16	2134942	2135333	trio	391	1	3	0.14448	0.178	0.000		TSC2,PKD1,MIR1225	TSC2 (oe_lof=0.02 region=exonic/splicing),PKD1 (oe_lof=0.12 region=intronic/intergenic),MIR1225 (oe_lof=n/a region=intronic/intergenic)	TSC2 [HI=Sufficient evidence for dosage pathogenicity PMIDS=31525612,10205261,29932062]	1179116 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Polycystic kidney disease, adult type"],147509 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152270 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253529 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564253 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564256 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564257 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58595 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58597 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58600 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625723 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p13.3 duplication syndrome"],830072 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Polycystic kidney disease, adult type"]	191092_[GENE=TSC2_PHENOS=Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341/Tuberous_sclerosis-2,613254,Autosomal_dominant],601313_[GENE=PKD1_PHENOS=Polycystic_kidney_disease_1,173900,Autosomal_dominant]
chr16	2152372	2152644	trio	272	3	4	0.03902	0.038	0.000		PKD1	PKD1 (oe_lof=0.12 region=exonic/splicing)	PKD1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=25491204,24694054,29529603]	1179116 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Polycystic kidney disease, adult type"],1179161 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Polycystic kidney disease, adult type"],1179163 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Polycystic kidney disease, adult type"],147509 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564253 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564256 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564257 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58595 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58597 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58600 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625723 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p13.3 duplication syndrome"]	601313_[GENE=PKD1_PHENOS=Polycystic_kidney_disease_1,173900,Autosomal_dominant]
chr16	2334270	2335009	trio	739	1	4	0.03545	0.019	0.000		ABCA3	ABCA3 (oe_lof=0.36 region=exonic/splicing)		147509 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564253 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564256 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58595 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58597 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625723 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p13.3 duplication syndrome"]	601615_[GENE=ABCA3_PHENOS=Surfactant_metabolism_dysfunction,pulmonary,3,610921,Autosomal_recessive]
chr16	2549348	2549941	trio	593	1	4	0.12455	0.140	0.000		TBC1D24	TBC1D24 (oe_lof=0.73 region=exonic/splicing)		147509 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152712 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],564253 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564256 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58595 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58597 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58619 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59427 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625723 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p13.3 duplication syndrome"]	613577_[GENE=TBC1D24_PHENOS=Deafness,autosomal_recessive_86,614617,Autosomal_recessive/Epilepsy,rolandic,with_proxysmal_exercise-induce_dystonia_and_writer's_cramp,608105,Autosomal_recessive/Myoclonic_epilepsy,infantile,familial,605021,Autosomal_recessive/Deafness,autosomal_dominant_65,616044,Autosomal_dominant/Developmental_and_epileptic_encephalopathy_16,615338,Autosomal_recessive/DOORS_syndrome,220500,Autosomal_recessive]
chr16	5130937	5131067	trio	130	1	4	0.03272	0.057	0.000		ALG1,EEF2KMT	ALG1 (oe_lof=1.09 region=exonic/splicing),EEF2KMT (oe_lof=1.27 region=intronic/intergenic)		1179164 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="ALG1-CDG"],443444 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59428 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685643 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605907_[GENE=ALG1_PHENOS=Congenital_disorder_of_glycosylation,type_Ik,608540,Autosomal_recessive]
chr16	9862698	9862956	trio	258	1	3	0.03214	0.134	0.000		GRIN2A	GRIN2A (oe_lof=0.08 region=exonic/splicing)	GRIN2A [HI=Little evidence for dosage pathogenicity PMIDS=20890276]	149100 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	138253_[GENE=GRIN2A_PHENOS=Epilepsy,focal,with_speech_disorder_and_with_or_without_impaired_intellectual_development,245570,Autosomal_dominant]
chr16	10275724	10276621	trio	897	1	6	0.00163	0.057	0.000		GRIN2A	GRIN2A (oe_lof=0.08 region=intronic/intergenic)	GRIN2A [HI=Little evidence for dosage pathogenicity PMIDS=20890276]	684953 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	138253_[GENE=GRIN2A_PHENOS=Epilepsy,focal,with_speech_disorder_and_with_or_without_impaired_intellectual_development,245570,Autosomal_dominant]
chr16	10971045	10971249	trio	204	4	6	0.03097	0.280	0.000		CIITA	CIITA (oe_lof=0.40 region=exonic/splicing)		684953 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	600005_[GENE=CIITA_PHENOS=Rheumatoid_arthritis,susceptibility_to,180300/Bare_lymphocyte_syndrome,type_II,complementation_group_A,209920,Autosomal_recessive]
chr16	11009417	11010326	trio	909	3	8	0.01385	0.146	0.000		CIITA	CIITA (oe_lof=0.40 region=exonic/splicing)		684953 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	600005_[GENE=CIITA_PHENOS=Rheumatoid_arthritis,susceptibility_to,180300/Bare_lymphocyte_syndrome,type_II,complementation_group_A,209920,Autosomal_recessive]
chr16	11645553	11645670	trio	117	4	4	0.12701	0.280	0.000		LITAF	LITAF (oe_lof=0.50 region=exonic/splicing)			603795_[GENE=LITAF_PHENOS=Charcot-Marie-Tooth_disease,type_1C,601098,Autosomal_dominant]
chr16	23464137	23464522	trio	385	3	9	0.01105	0.115	0.000	16p11.2-p12.2 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/68],16p11.2-p12.2 microduplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/96]	COG7	COG7 (oe_lof=0.45 region=exonic/splicing)	COG7 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		606978_[GENE=COG7_PHENOS=Congenital_disorder_of_glycosylation,type_IIe,608779,Autosomal_recessive]
chr16	28502793	28503633	trio	840	3	11	0.01277	0.140	0.000	16p11.2-p12.2 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/68],16p11.2-p12.2 microduplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/96]	CLN3,APOBR	CLN3 (oe_lof=0.59 region=exonic/splicing),APOBR (oe_lof=0.51 region=intronic/intergenic)		148506 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148782 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148886 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150642 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151637 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152023 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253631 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],268058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394291 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395542 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442530 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442963 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564309 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60446 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685632 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685912 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687737 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815815 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	607042_[GENE=CLN3_PHENOS=Ceroid_lipofuscinosis,neuronal,3,204200,Autosomal_recessive]
chr16	28857529	28857739	trio	210	4	9	0.00964	0.197	0.000	16p11.2-p12.2 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/68],16p11.2-p12.2 microduplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/96]	TUFM,MIR4721,SH2B1	TUFM (oe_lof=0.39 region=exonic/splicing),MIR4721 (oe_lof=n/a region=intronic/intergenic),SH2B1 (oe_lof=0.14 region=intronic/intergenic)	TUFM [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146471 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],146479 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148483 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148506 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148525 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148782 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148886 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149239 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149412 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149864 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150642 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151536 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151637 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152023 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153218 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155233 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155463 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],202225 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253631 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],268058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34150 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394291 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395146 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic/Likely pathogenic" PHENOTYPE="See cases"],395300 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],395542 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395931 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396537 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396629 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396738 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396746 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396940 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397053 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397218 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397473 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397474 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442163 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442530 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442823 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442963 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],503583 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564309 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564311 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564312 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564314 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59641 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59643 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59644 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59684 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60372 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60446 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625600 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 deletion syndrome, 220 kb"],625601 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 deletion syndrome, 220 kb"],685632 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685912 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687737 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815815 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],929355 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],979439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],997064 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Hypospadias, penile;Abnormality of the anus;Atrioventricular septal defect"]	602389_[GENE=TUFM_PHENOS=Combined_oxidative_phosphorylation_deficiency_4,610678,Autosomal_recessive]
chr16	28947823	28947931	trio	108	4	8	0.00884	0.268	0.000	16p11.2-p12.2 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/68],16p11.2-p12.2 microduplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/96]	CD19	CD19 (oe_lof=0.17 region=exonic/splicing)		146471 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],146479 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148434 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148483 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148506 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148525 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148782 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148886 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149239 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149412 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149864 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150642 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151536 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151637 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152023 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153218 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155233 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155463 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],202225 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253631 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],268058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32783 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34150 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394291 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395146 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic/Likely pathogenic" PHENOTYPE="See cases"],395300 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],395542 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395931 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396537 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396629 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396738 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396746 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396940 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397053 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397218 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397473 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397474 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441576 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442163 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442530 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442823 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442963 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],503583 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],523253 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Intellectual disability, moderate;Macular dystrophy"],564309 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564311 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564312 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564313 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564314 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59641 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59643 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59644 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59684 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60372 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60446 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625601 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 deletion syndrome, 220 kb"],685176 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685632 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685912 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687737 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815815 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],929355 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],979439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979442 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],997064 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Hypospadias, penile;Abnormality of the anus;Atrioventricular septal defect"]	107265_[GENE=CD19_PHENOS=Immunodeficiency,common_variable,3,613493,Autosomal_recessive]
chr16	30064401	30064548	trio	147	5	15	0.00082	0.242	0.000	16p11.2 microduplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/78],16p11.2-p12.2 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/68]	ALDOA	ALDOA (oe_lof=0.42 region=intronic/intergenic)		1172563 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],1176676 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1176677 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1180509 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1199403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144509 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145047 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145049 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145958 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],146013 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146122 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146284 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146479 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146482 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146730 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146827 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146913 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148372 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148442 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148506 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148545 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148970 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148974 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149292 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149293 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149422 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149425 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149426 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149487 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149494 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150136 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150206 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150388 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151637 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151764 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151825 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152315 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152583 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152773 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153216 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153220 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153311 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153631 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153695 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153698 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153770 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153808 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154250 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154433 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154808 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154862 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155161 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155238 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155296 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155297 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155318 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155319 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155364 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155390 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155514 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155603 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160840 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160841 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160842 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160880 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160889 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160917 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],160918 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],161090 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252974 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253374 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253381 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253490 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253525 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253535 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253669 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],31956 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],31990 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32558 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32947 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33024 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],33185 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34150 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34167 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic/Likely pathogenic" PHENOTYPE="See cases"],34193 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393760 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394291 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395586 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395675 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395676 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395677 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395875 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396042 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396210 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396242 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396305 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396558 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396821 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396907 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397176 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397419 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397451 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397464 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397491 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441932 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441976 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442090 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442408 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442582 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442617 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442655 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442780 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442803 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442895 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442896 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442961 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442963 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442968 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443066 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443067 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443076 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443147 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],523254 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Narrow mouth;Obesity;Delayed speech and language development"],523255 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="9 conditions"],564317 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564318 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564319 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564320 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564321 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564322 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564323 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564324 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564325 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564326 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564327 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564328 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57462 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],602483 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60372 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60374 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60375 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60376 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60382 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60384 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60385 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60397 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60398 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60400 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60402 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60404 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],60405 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60407 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60413 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60414 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60446 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60447 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60464 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60465 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60466 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60467 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60469 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],625602 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625603 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625604 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625605 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625606 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625607 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625610 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625650 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625688 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],638096 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],666439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],666440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],685632 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687737 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815815 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815817 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815818 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],929398 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],979440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979441 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983165 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="See cases"],983192 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],992652 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],997050 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Severe sensorineural hearing impairment;Lower limb asymmetry;Upper limb asymmetry"],997070 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Abnormality of the fetal cardiovascular system"],997089 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Autistic disorder of childhood onset"]	103850_[GENE=ALDOA_PHENOS=Glycogen_storage_disease_XII,611881,Autosomal_recessive]
chr16	30066483	30066658	trio	175	3	8	0.01058	0.089	0.000	16p11.2 microduplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/78],16p11.2-p12.2 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/68]	ALDOA	ALDOA (oe_lof=0.42 region=intronic/intergenic)		1172563 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],1176676 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1176677 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1180509 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1199403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144509 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145047 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145049 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145958 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],146013 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146122 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146284 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146479 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146482 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146730 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146827 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146913 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148372 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148442 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148506 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148545 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148970 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148974 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149292 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149293 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149422 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149425 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149426 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149487 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149494 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150136 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150206 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150388 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151637 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151764 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151825 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152315 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152583 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152773 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153216 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153220 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153311 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153631 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153695 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153698 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153770 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153808 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154250 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154433 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154808 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154862 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155161 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155238 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155296 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155297 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155318 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155319 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155364 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155390 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155514 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155603 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160840 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160841 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160842 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160880 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160889 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160917 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],160918 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],161090 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252974 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253374 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253381 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253490 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253525 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253535 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253669 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],31956 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],31990 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32558 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32947 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33024 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],33185 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34150 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34167 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic/Likely pathogenic" PHENOTYPE="See cases"],34193 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393760 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394291 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395586 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395675 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395676 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395677 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395875 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396042 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396210 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396242 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396305 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396558 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396821 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396907 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397176 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397419 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397451 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397464 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397491 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441932 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441976 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442090 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442408 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442582 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442617 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442655 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442780 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442803 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442895 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442896 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442961 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442963 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442968 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443066 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443067 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443076 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443147 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],523254 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Narrow mouth;Obesity;Delayed speech and language development"],523255 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="9 conditions"],564317 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564318 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564319 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564320 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564321 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564322 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564323 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564324 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564325 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564326 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564327 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564328 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57462 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],602483 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60372 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60374 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60375 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60376 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60382 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60384 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60385 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60397 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60398 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60400 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60402 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60404 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],60405 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60407 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60413 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60414 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60446 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60447 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60464 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60465 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60466 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60467 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60469 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],625602 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625603 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625604 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625605 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625606 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625607 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625610 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625650 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625688 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],638096 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],666439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],666440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],685632 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687737 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815815 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815817 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815818 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],929398 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],979440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979441 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983165 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="See cases"],983192 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],992652 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],997050 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Severe sensorineural hearing impairment;Lower limb asymmetry;Upper limb asymmetry"],997070 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Abnormality of the fetal cardiovascular system"],997089 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Autistic disorder of childhood onset"]	103850_[GENE=ALDOA_PHENOS=Glycogen_storage_disease_XII,611881,Autosomal_recessive]
chr16	30078761	30080309	trio	1548	3	9	0.01288	0.019	0.000	16p11.2 microduplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/78],16p11.2-p12.2 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/68]	ALDOA	ALDOA (oe_lof=0.42 region=exonic/splicing)		1172563 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],1176676 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1176677 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1180509 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1199403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144509 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145047 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145049 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145058 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145958 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],146013 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146122 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146284 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146479 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146482 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146730 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146827 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146913 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148372 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148442 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148506 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148545 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148970 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148974 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149292 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149293 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149422 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149425 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149426 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149487 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149494 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150136 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150206 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150388 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151637 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151764 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151825 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152315 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152583 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152773 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153216 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153220 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153311 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153631 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153695 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153698 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153770 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153808 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154250 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154433 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154808 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154862 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155161 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155238 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155296 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155297 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155318 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155319 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155364 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155390 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155514 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155603 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160840 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160841 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160842 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160880 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160889 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160917 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],160918 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],161090 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252974 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253374 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253381 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253490 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253525 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253535 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253669 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],31956 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],31990 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32558 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32947 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33024 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],33185 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34150 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],34167 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic/Likely pathogenic" PHENOTYPE="See cases"],34193 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393760 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394291 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395586 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395675 [CN_TYPE=gain CN=4 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395676 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395677 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395875 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396042 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396210 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396242 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396305 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396558 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396667 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396821 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396907 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397176 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397419 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397451 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397464 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397467 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397491 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441932 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441976 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442090 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442408 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442582 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442617 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442655 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442780 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442803 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442895 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442896 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442961 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442963 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442968 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443066 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443067 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443076 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443147 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],523254 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Narrow mouth;Obesity;Delayed speech and language development"],523255 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="9 conditions"],564317 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564318 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564319 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564320 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564321 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564322 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564323 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564324 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564325 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564326 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564327 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564328 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57462 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],602483 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60372 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60374 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60375 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60376 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60378 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60382 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60384 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60385 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60397 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60398 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60400 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60402 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60404 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],60405 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60407 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60410 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60413 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60414 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60446 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60447 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60464 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60465 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60466 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60467 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60469 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],625602 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625603 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625604 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625605 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625606 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625607 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625610 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625650 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625688 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],638096 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],666439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],666440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],685632 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687737 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815815 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815817 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],815818 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],929398 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],979440 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979441 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],983165 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="See cases"],983192 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],992652 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],997050 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Severe sensorineural hearing impairment;Lower limb asymmetry;Upper limb asymmetry"],997070 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Abnormality of the fetal cardiovascular system"],997089 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Autistic disorder of childhood onset"]	103850_[GENE=ALDOA_PHENOS=Glycogen_storage_disease_XII,611881,Autosomal_recessive]
chr16	30198693	30198832	trio	139	6	25	0.00000	0.166	0.000	16p11.2 microduplication syndrome [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/78],16p11.2-p12.2 microdeletion syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/68]	CORO1A	CORO1A (oe_lof=0.10 region=exonic/splicing)	CORO1A [HI=Gene associated with autosomal recessive phenotype PMIDS=]	1172563 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],1176676 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1176677 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1180509 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],1199403 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146013 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146122 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146284 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146482 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146730 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148372 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148442 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148545 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149487 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150136 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150206 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150388 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150389 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151177 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151637 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151764 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152315 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153216 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],153220 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153631 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],154862 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155297 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155318 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155319 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155364 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],161090 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252974 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],32436 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],33185 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396210 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396305 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396558 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396907 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442090 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442408 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442780 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442896 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443067 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443076 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443147 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],564317 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564320 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564322 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564323 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564326 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57462 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58735 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60447 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60464 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60467 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625602 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625603 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625604 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625606 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625607 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Chromosome 16p11.2 duplication syndrome"],625650 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],625688 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],666439 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="16p11.2 deletion syndrome"],929398 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],983165 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="See cases"],992652 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605000_[GENE=CORO1A_PHENOS=Immunodeficiency_8,615401,Autosomal_recessive]
chr16	31202274	31202441	trio	167	3	4	0.04681	0.217	0.000		FUS	FUS (oe_lof=0.10 region=exonic/splicing)		144329 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146013 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151637 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	137070_[GENE=FUS_PHENOS=Amyotrophic_lateral_sclerosis_6,with_or_without_frontotemporal_dementia,608030/Essential_tremor,hereditary,4,614782,Autosomal_dominant]
chr16	53674935	53675038	trio	103	3	3	0.09294	0.127	0.000		RPGRIP1L	RPGRIP1L (oe_lof=0.77 region=exonic/splicing)		59490 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610937_[GENE=RPGRIP1L_PHENOS=Joubert_syndrome_7,611560,Autosomal_recessive/Meckel_syndrome_5,611561,Autosomal_recessive/COACH_syndrome_3,619113]
chr16	66503495	66503778	trio	283	1	4	0.03272	0.032	0.000		BEAN1	BEAN1 (oe_lof=0.97 region=exonic/splicing)		145310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59493 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815823 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	612051_[GENE=BEAN1_PHENOS=Spinocerebellar_ataxia_31,117210,Autosomal_dominant]
chr16	66551029	66551128	trio	99	4	12	0.00182	0.191	0.000		TK2	TK2 (oe_lof=0.73 region=exonic/splicing)		145310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59493 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815823 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	188250_[GENE=TK2_PHENOS=Mitochondrial_DNA_depletion_syndrome_2_(myopathic_type),609560,Autosomal_recessive/Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_recessive_3,617069,Autosomal_recessive]
chr16	66583831	66584325	trio	494	3	7	0.01571	0.096	0.000		TK2,CKLF,CKLF-CMTM1	TK2 (oe_lof=0.73 region=exonic/splicing),CKLF (oe_lof=0.68 region=intronic/intergenic),CKLF-CMTM1 (oe_lof=0.78 region=intronic/intergenic)		145310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59493 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815823 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	188250_[GENE=TK2_PHENOS=Mitochondrial_DNA_depletion_syndrome_2_(myopathic_type),609560,Autosomal_recessive/Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_recessive_3,617069,Autosomal_recessive]
chr16	70288514	70288647	trio	133	1	6	0.01571	0.083	0.000		EXOSC6,AARS1	EXOSC6 (oe_lof=0.00 region=intronic/intergenic),AARS1 (oe_lof=0.43 region=exonic/splicing)			601065_[GENE=AARS1_PHENOS=Developmental_and_epileptic_encephalopathy_29,616339,Autosomal_recessive/Charcot-Marie-Tooth_disease,axonal,type_2N,613287,Autosomal_dominant]
chr16	70323314	70323422	trio	108	3	3	0.06894	0.178	0.000		AARS1,DDX19B	AARS1 (oe_lof=0.43 region=intronic/intergenic),DDX19B (oe_lof=0.58 region=intronic/intergenic)			601065_[GENE=AARS1_PHENOS=Developmental_and_epileptic_encephalopathy_29,616339,Autosomal_recessive/Charcot-Marie-Tooth_disease,axonal,type_2N,613287,Autosomal_dominant]
chr16	89251571	89254703	trio	3132	3	7	0.03700	0.089	0.000		CDH15	CDH15 (oe_lof=0.79 region=exonic/splicing)		149103 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],150862 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155557 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394211 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="See cases"],442336 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442884 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442917 [CN_TYPE=gain CN=4 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57288 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58651 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59520 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59521 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59538 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59539 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59540 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],686714 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	114019_[GENE=CDH15_PHENOS=Mental_retardation,autosomal_dominant_3,612580]
chr17	3539752	3540135	trio	383	3	9	0.00856	0.115	0.000		SHPK,CTNS	SHPK (oe_lof=0.90 region=intronic/intergenic),CTNS (oe_lof=0.46 region=intronic/intergenic)	CTNS [HI=Gene associated with autosomal recessive phenotype PMIDS=]	1179166 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Ocular cystinosis;Nephropathic cystinosis;Juvenile nephropathic cystinosis"],1180511 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],144239 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146594 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150948 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153060 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154373 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253507 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395799 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442031 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443023 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58677 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59563 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],602683 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],602738 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],615261 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685111 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685247 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686361 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686861 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686989 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687075 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687094 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687631 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687856 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687869 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687982 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688152 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688556 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688746 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689076 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689154 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689234 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],689298 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605060_[GENE=SHPK_PHENOS=Sedoheptulokinase_deficiency,617213,Autosomal_recessive],606272_[GENE=CTNS_PHENOS=Cystinosis,nephropathic,219800,Autosomal_recessive/Cystinosis,ocular_nonnephropathic,219750,Autosomal_recessive/Cystinosis,late-onset_juvenile_or_adolescent_nephropathic,219900,Autosomal_recessive/Cystinosis,atypical_nephropathic,219800,Autosomal_recessive]
chr17	7124233	7124387	trio	154	3	7	0.01192	0.102	0.000		DLG4,ACADVL,MIR324,DVL2	DLG4 (oe_lof=0.11 region=intronic/intergenic),ACADVL (oe_lof=0.76 region=exonic/splicing),MIR324 (oe_lof=n/a region=intronic/intergenic),DVL2 (oe_lof=0.42 region=intronic/intergenic)	ACADVL [HI=Gene associated with autosomal recessive phenotype PMIDS=]	149166 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442228 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57356 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59582 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815900 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980123 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980124 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	602887_[GENE=DLG4_PHENOS=Intellectual_developmental_disorder_62,618793,Autosomal_dominant],609575_[GENE=ACADVL_PHENOS=VLCAD_deficiency,201475,Autosomal_recessive]
chr17	7348396	7348514	trio	118	4	7	0.01118	0.166	0.000		FGF11,CHRNB1	FGF11 (oe_lof=0.68 region=intronic/intergenic),CHRNB1 (oe_lof=0.65 region=exonic/splicing)		149166 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396380 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442228 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57356 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59582 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980123 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	100710_[GENE=CHRNB1_PHENOS=Myasthenic_syndrome,congenital,2C,associated_with_acetylcholine_receptor_deficiency,616314,Autosomal_recessive/Myasthenic_syndrome,congenital,2A,slow-channel,616313,Autosomal_dominant]
chr17	7359103	7359270	trio	167	3	6	0.01378	0.134	0.000		CHRNB1,ZBTB4	CHRNB1 (oe_lof=0.65 region=exonic/splicing),ZBTB4 (oe_lof=0.00 region=intronic/intergenic)		149166 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396380 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442228 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57356 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59582 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],980123 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	100710_[GENE=CHRNB1_PHENOS=Myasthenic_syndrome,congenital,2C,associated_with_acetylcholine_receptor_deficiency,616314,Autosomal_recessive/Myasthenic_syndrome,congenital,2A,slow-channel,616313,Autosomal_dominant]
chr17	10297556	10297779	trio	223	3	3	0.02682	0.096	0.000		MYH8	MYH8 (oe_lof=0.86 region=exonic/splicing)		150528 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	160741_[GENE=MYH8_PHENOS=Carney_complex_variant,608837/Trismus-pseudocamptodactyly_syndrome,158300,Autosomal_dominant]
chr17	10600542	10600895	trio	353	3	6	0.01854	0.159	0.000		SCO1,ADPRM	SCO1 (oe_lof=0.55 region=exonic/splicing),ADPRM (oe_lof=0.59 region=intronic/intergenic)		150528 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	603644_[GENE=SCO1_PHENOS=Mitochondrial_complex_IV_deficiency,nuclear_type_4,619048,Autosomal_recessive]
chr17	19552054	19552447	trio	393	3	10	0.00331	0.127	0.000	Potocki-Lupski syndrome (17p11.2 duplication syndrome) [TYPE=Heterozygous duplication SOURCE=https://decipher.sanger.ac.uk/syndrome/19],Smith-Magenis Syndrome [TYPE=Heterozygous deletion SOURCE=https://decipher.sanger.ac.uk/syndrome/8]	ALDH3A2	ALDH3A2 (oe_lof=0.51 region=exonic/splicing)		1047863 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Smith-Magenis syndrome"],1047866 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Potocki-Lupski syndrome"],144213 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144242 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145065 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146614 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146753 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146754 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146755 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147756 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147821 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148912 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148929 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149203 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150319 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150379 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150691 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150743 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151506 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152261 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152568 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153671 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153822 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155110 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155114 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155143 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155314 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155350 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155418 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155529 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155583 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155648 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253426 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253611 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253648 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393812 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],393895 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394152 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394560 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395659 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395778 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396303 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396356 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396637 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396881 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396894 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396949 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441841 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441875 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441899 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442167 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442368 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442542 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442795 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442859 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442905 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442933 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443131 [CN_TYPE=loss CN=0 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443148 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443760 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],523256 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="10 conditions"],523257 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Long face;Delayed speech and language development;Delayed gross motor development;Proximal placement of thumb"],564408 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564411 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564412 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],564413 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57018 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57034 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57035 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58108 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58110 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58113 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58115 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58126 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58127 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58128 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58131 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58132 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58134 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],602781 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],602787 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],60430 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60437 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60455 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60456 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60457 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],615305 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625730 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Smith-Magenis syndrome"],916447 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980114 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],980115 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	609523_[GENE=ALDH3A2_PHENOS=Sjogren-Larsson_syndrome,270200,Autosomal_recessive]
chr17	33904905	33905666	trio	761	3	4	0.01463	0.134	0.000		SNHG30,SNORD7,PEX12	SNHG30 (oe_lof=n/a region=intronic/intergenic),SNORD7 (oe_lof=n/a region=intronic/intergenic),PEX12 (oe_lof=1.34 region=exonic/splicing)			601758_[GENE=PEX12_PHENOS=Peroxisome_biogenesis_disorder_3B,266510,Autosomal_recessive/Peroxisome_biogenesis_disorder_3A_(Zellweger),614859,Autosomal_recessive]
chr17	38804015	38804113	trio	98	5	8	0.03019	0.274	0.000		SMARCE1,KRT222	SMARCE1 (oe_lof=0.04 region=intronic/intergenic),KRT222 (oe_lof=0.62 region=intronic/intergenic)			603111_[GENE=SMARCE1_PHENOS=Meningioma,familial,susceptibility_to,607174,Autosomal_dominant/Coffin-Siris_syndrome_5,616938,Autosomal_dominant]
chr17	40474290	40474522	trio	232	1	6	0.01240	0.083	0.000		STAT3	STAT3 (oe_lof=0.02 region=exonic/splicing)			102582_[GENE=STAT3_PHENOS=Hyper-IgE_recurrent_infection_syndrome,147060,Autosomal_dominant/Autoimmune_disease,multisystem,infantile-onset,1,615952,Autosomal_dominant]
chr17	40475012	40475171	trio	159	3	8	0.00810	0.064	0.000		STAT3	STAT3 (oe_lof=0.02 region=exonic/splicing)			102582_[GENE=STAT3_PHENOS=Hyper-IgE_recurrent_infection_syndrome,147060,Autosomal_dominant/Autoimmune_disease,multisystem,infantile-onset,1,615952,Autosomal_dominant]
chr17	46023217	46023365	trio	148	3	3	0.07435	0.102	0.000		PNPO	PNPO (oe_lof=0.90 region=exonic/splicing)			603287_[GENE=PNPO_PHENOS=Pyridoxamine_5'-phosphate_oxidase_deficiency,610090,Autosomal_recessive]
chr17	48673913	48674017	trio	104	1	3	0.10470	0.172	0.000		CACNA1G	CACNA1G (oe_lof=0.13 region=exonic/splicing)		444852 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],59589 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604065_[GENE=CACNA1G_PHENOS=Spinocerebellar_ataxia_42,616795,Autosomal_dominant/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087,Autosomal_dominant]
chr17	48681506	48683394	trio	1888	1	7	0.05167	0.025	0.000		CACNA1G	CACNA1G (oe_lof=0.13 region=exonic/splicing)		444852 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],59589 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	604065_[GENE=CACNA1G_PHENOS=Spinocerebellar_ataxia_42,616795,Autosomal_dominant/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087,Autosomal_dominant]
chr17	56296502	56296976	trio	474	3	10	0.00337	0.178	0.000		MKS1,LPO	MKS1 (oe_lof=0.76 region=exonic/splicing),LPO (oe_lof=0.84 region=intronic/intergenic)	MKS1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	151500 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253345 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	609883_[GENE=MKS1_PHENOS=Bardet-Biedl_syndrome_13,615990,Autosomal_recessive/Meckel_syndrome_1,249000,Autosomal_recessive/Joubert_syndrome_28,617121,Autosomal_recessive]
chr17	57078949	57079085	trio	136	3	4	0.05220	0.223	0.000		TRIM37	TRIM37 (oe_lof=0.47 region=exonic/splicing)	TRIM37 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	151500 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443558 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],929382 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	605073_[GENE=TRIM37_PHENOS=Mulibrey_nanism,253250,Autosomal_recessive]
chr17	62009545	62009714	trio	169	4	15	0.00026	0.083	0.000		CD79B	CD79B (oe_lof=0.08 region=exonic/splicing)			147245_[GENE=CD79B_PHENOS=Agammaglobulinemia_6,612692,Autosomal_recessive]
chr17	62488774	62493194	trio	4420	3	10	0.00700	0.102	0.000		POLG2,DDX5,MIR3064,MIR5047	POLG2 (oe_lof=0.72 region=exonic/splicing),DDX5 (oe_lof=0.00 region=intronic/intergenic),MIR3064 (oe_lof=n/a region=intronic/intergenic),MIR5047 (oe_lof=n/a region=intronic/intergenic)			604983_[GENE=POLG2_PHENOS=Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,autosomal_dominant_4,610131,Autosomal_dominant/Mitochondrial_DNA_depletion_syndrome_16_(hepatic_type),618528,Autosomal_recessive/Mitochondrial_DNA_depletion_syndrome_16B_(neuroophthalmic_type),619425,Autosomal_recessive]
chr17	75372155	75372490	trio	335	3	5	0.02667	0.102	0.000		SEPTIN9	SEPTIN9 (oe_lof=0.08 region=intronic/intergenic)			604061_[GENE=SEPTIN9_PHENOS=Amyotrophy,hereditary_neuralgic,162100,Autosomal_dominant]
chr17	76115042	76115137	trio	95	1	6	0.01843	0.076	0.000		TMC6	TMC6 (oe_lof=0.53 region=exonic/splicing)	TMC6 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	57076 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	605828_[GENE=TMC6_PHENOS=Epidermodysplasia_verruciformis,226400,Autosomal_recessive]
chr17	76129924	76130091	trio	167	3	6	0.01920	0.057	0.000		TMC6,TMC8	TMC6 (oe_lof=0.53 region=intronic/intergenic),TMC8 (oe_lof=0.81 region=exonic/splicing)	TMC8 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	57076 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	605828_[GENE=TMC6_PHENOS=Epidermodysplasia_verruciformis,226400,Autosomal_recessive],605829_[GENE=TMC8_PHENOS=Epidermodysplasia_verruciformis_2,618231,Autosomal_recessive]
chr17	76130941	76131100	trio	159	1	6	0.01920	0.057	0.000		TMC6,TMC8	TMC6 (oe_lof=0.53 region=intronic/intergenic),TMC8 (oe_lof=0.81 region=exonic/splicing)	TMC8 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	57076 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	605828_[GENE=TMC6_PHENOS=Epidermodysplasia_verruciformis,226400,Autosomal_recessive],605829_[GENE=TMC8_PHENOS=Epidermodysplasia_verruciformis_2,618231,Autosomal_recessive]
chr17	78082079	78082416	trio	337	1	5	0.01920	0.083	0.000		GAA	GAA (oe_lof=0.74 region=exonic/splicing)		564476 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57076 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57263 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58714 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	606800_[GENE=GAA_PHENOS=Glycogen_storage_disease_II,232300,Autosomal_recessive]
chr17	80038236	80038476	trio	240	3	4	0.03483	0.115	0.000		FASN	FASN (oe_lof=0.09 region=exonic/splicing)		148281 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149717 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153720 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564476 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57076 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57263 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58714 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],615597 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687727 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	
chr17	80045820	80046762	trio	942	1	7	0.06827	0.102	0.000		FASN	FASN (oe_lof=0.09 region=exonic/splicing)		148281 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],149717 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153720 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],396411 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564476 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],57076 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57263 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58714 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],615597 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],687727 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	
chr18	2931244	2931451	trio	207	3	7	0.02458	0.057	0.000		LPIN2	LPIN2 (oe_lof=0.34 region=exonic/splicing)	LPIN2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146636 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148659 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],151983 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152369 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153999 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155594 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395913 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397425 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442363 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564552 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58747 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59616 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59912 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59917 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815964 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979685 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605519_[GENE=LPIN2_PHENOS=Majeed_syndrome,609628]
chr18	2960637	2960857	trio	220	3	8	0.00636	0.115	0.000		LPIN2	LPIN2 (oe_lof=0.34 region=exonic/splicing)	LPIN2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146636 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148659 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],151983 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152369 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153999 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155594 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395913 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397425 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442363 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564552 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58747 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59616 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59912 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59917 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815964 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979685 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	605519_[GENE=LPIN2_PHENOS=Majeed_syndrome,609628]
chr18	3447598	3453864	trio	6266	3	33	0.00000	0.121	0.000		TGIF1	TGIF1 (oe_lof=0.43 region=exonic/splicing)	TGIF1 [HI=Sufficient evidence for dosage pathogenicity PMIDS=16962354,12522553,22125506]	146636 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148659 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],151983 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153999 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155594 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396923 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397425 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442363 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564552 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58322 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58747 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59917 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],815964 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],929359 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	602630_[GENE=TGIF1_PHENOS=Holoprosencephaly_4,142946,Autosomal_dominant]
chr18	6999434	7002394	trio	2960	3	4	0.05377	0.121	0.000		LAMA1	LAMA1 (oe_lof=0.51 region=exonic/splicing)	LAMA1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		150320_[GENE=LAMA1_PHENOS=Poretti-Boltshauser_syndrome,615960,Autosomal_recessive]
chr18	9117826	9119598	trio	1772	3	5	0.02968	0.019	0.000		NDUFV2	NDUFV2 (oe_lof=0.42 region=exonic/splicing)	NDUFV2 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	58752 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59957 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600532_[GENE=NDUFV2_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_7,618229,Autosomal_recessive]
chr18	21119309	21119444	trio	135	3	13	0.00156	0.057	0.000		NPC1	NPC1 (oe_lof=0.34 region=exonic/splicing)		58761 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	607623_[GENE=NPC1_PHENOS=Niemann-Pick_disease,type_C1,257220,Autosomal_recessive/Niemann-Pick_disease,type_D,257220,Autosomal_recessive]
chr18	21120402	21121182	trio	780	3	18	0.00004	0.076	0.000		NPC1	NPC1 (oe_lof=0.34 region=exonic/splicing)		58761 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	607623_[GENE=NPC1_PHENOS=Niemann-Pick_disease,type_C1,257220,Autosomal_recessive/Niemann-Pick_disease,type_D,257220,Autosomal_recessive]
chr18	21363977	21364131	trio	154	3	3	0.05999	0.306	0.000		LAMA3	LAMA3 (oe_lof=0.59 region=exonic/splicing)		58761 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600805_[GENE=LAMA3_PHENOS=Laryngoonychocutaneous_syndrome,245660,Autosomal_recessive/Epidermolysis_bullosa,junctional,Herlitz_type,226700,Autosomal_recessive/Epidermolysis_bullosa,generalized_atrophic_benign,226650,Autosomal_recessive]
chr18	21396342	21396461	trio	119	3	4	0.05332	0.236	0.000		LAMA3	LAMA3 (oe_lof=0.59 region=exonic/splicing)		58761 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600805_[GENE=LAMA3_PHENOS=Laryngoonychocutaneous_syndrome,245660,Autosomal_recessive/Epidermolysis_bullosa,junctional,Herlitz_type,226700,Autosomal_recessive/Epidermolysis_bullosa,generalized_atrophic_benign,226650,Autosomal_recessive]
chr18	21416935	21417063	trio	128	3	3	0.03429	0.064	0.000		LAMA3	LAMA3 (oe_lof=0.59 region=exonic/splicing)		58761 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600805_[GENE=LAMA3_PHENOS=Laryngoonychocutaneous_syndrome,245660,Autosomal_recessive/Epidermolysis_bullosa,junctional,Herlitz_type,226700,Autosomal_recessive/Epidermolysis_bullosa,generalized_atrophic_benign,226650,Autosomal_recessive]
chr18	21422349	21422495	trio	146	3	3	0.02988	0.025	0.000		LAMA3	LAMA3 (oe_lof=0.59 region=exonic/splicing)		58761 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600805_[GENE=LAMA3_PHENOS=Laryngoonychocutaneous_syndrome,245660,Autosomal_recessive/Epidermolysis_bullosa,junctional,Herlitz_type,226700,Autosomal_recessive/Epidermolysis_bullosa,generalized_atrophic_benign,226650,Autosomal_recessive]
chr18	21479242	21481297	trio	2055	3	3	0.23784	0.255	0.000		LAMA3	LAMA3 (oe_lof=0.59 region=exonic/splicing)		58761 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600805_[GENE=LAMA3_PHENOS=Laryngoonychocutaneous_syndrome,245660,Autosomal_recessive/Epidermolysis_bullosa,junctional,Herlitz_type,226700,Autosomal_recessive/Epidermolysis_bullosa,generalized_atrophic_benign,226650,Autosomal_recessive]
chr18	21526098	21529898	trio	3800	3	3	0.08114	0.172	0.000		LAMA3	LAMA3 (oe_lof=0.59 region=exonic/splicing)		58761 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	600805_[GENE=LAMA3_PHENOS=Laryngoonychocutaneous_syndrome,245660,Autosomal_recessive/Epidermolysis_bullosa,junctional,Herlitz_type,226700,Autosomal_recessive/Epidermolysis_bullosa,generalized_atrophic_benign,226650,Autosomal_recessive]
chr18	33709827	33710044	trio	217	4	14	0.00044	0.204	0.000		SLC39A6,ELP2	SLC39A6 (oe_lof=0.52 region=intronic/intergenic),ELP2 (oe_lof=0.68 region=exonic/splicing)		149244 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58779 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625733 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	616054_[GENE=ELP2_PHENOS=Mental_retardation,autosomal_recessive_58,617270,Autosomal_recessive]
chr18	33722234	33722320	trio	86	3	4	0.01920	0.076	0.000		ELP2	ELP2 (oe_lof=0.68 region=exonic/splicing)		149244 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58779 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625733 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	616054_[GENE=ELP2_PHENOS=Mental_retardation,autosomal_recessive_58,617270,Autosomal_recessive]
chr18	33747054	33747195	trio	141	1	3	0.02682	0.032	0.000		ELP2	ELP2 (oe_lof=0.68 region=exonic/splicing)		149244 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58779 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625733 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	616054_[GENE=ELP2_PHENOS=Mental_retardation,autosomal_recessive_58,617270,Autosomal_recessive]
chr18	53255259	53257055	trio	1796	3	6	0.04579	0.255	0.000		TCF4	TCF4 (oe_lof=0.09 region=exonic/splicing)	TCF4 [HI=Sufficient evidence for dosage pathogenicity PMIDS=17478476,29604340,22045651]	148226 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396087 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57286 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59964 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59998 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60000 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	602272_[GENE=TCF4_PHENOS=Pitt-Hopkins_syndrome,610954,Autosomal_dominant/Corneal_dystrophy,Fuchs_endothelial,3,613267,Autosomal_dominant]
chr19	853252	853413	trio	161	1	4	0.05220	0.197	0.000		ELANE	ELANE (oe_lof=0.57 region=exonic/splicing)		145089 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145542 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],146110 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147565 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152851 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],252977 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253623 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442900 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],444854 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],523266 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="Global developmental delay;Seizures;Muscular hypotonia"],564605 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57357 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58787 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59078 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59080 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60038 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],686280 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816059 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816518 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	130130_[GENE=ELANE_PHENOS=Neutropenia,cyclic,162800,Autosomal_dominant/Neutropenia,severe_congenital_1,autosomal_dominant,202700,Autosomal_dominant]
chr19	4095376	4095457	trio	81	1	5	0.02518	0.083	0.000		MAP2K2	MAP2K2 (oe_lof=0.10 region=exonic/splicing)	MAP2K2 [HI=Little evidence for dosage pathogenicity PMIDS=]	1047892 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Obesity;Global developmental delay"],145080 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],145414 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148645 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],155547 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],58787 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59081 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59083 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60071 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625734 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"],686280 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816518 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	601263_[GENE=MAP2K2_PHENOS=Cardiofaciocutaneous_syndrome_4,615280,Autosomal_dominant]
chr19	6693413	6693508	trio	95	1	4	0.02518	0.013	0.000		C3	C3 (oe_lof=0.21 region=exonic/splicing)			120700_[GENE=C3_PHENOS=C3_deficiency,613779,Autosomal_recessive/Hemolytic_uremic_syndrome,atypical,susceptibility_to,5,612925,Autosomal_dominant/Macular_degeneration,age-related,9,611378]
chr19	7598635	7598905	trio	270	3	4	0.02876	0.217	0.000		MCOLN1,PNPLA6	MCOLN1 (oe_lof=0.37 region=exonic/splicing),PNPLA6 (oe_lof=0.48 region=intronic/intergenic)			603197_[GENE=PNPLA6_PHENOS=Spastic_paraplegia_39,autosomal_recessive,612020,Autosomal_recessive/Oliver-McFarlane_syndrome,275400,Autosomal_recessive/Laurence-Moon_syndrome,245800,Autosomal_recessive/Boucher-Neuhauser_syndrome,215470,Autosomal_recessive],605248_[GENE=MCOLN1_PHENOS=Mucolipidosis_IV,252650,Autosomal_recessive]
chr19	7706581	7706749	trio	168	4	7	0.01780	0.242	0.000		STXBP2	STXBP2 (oe_lof=0.56 region=exonic/splicing)			601717_[GENE=STXBP2_PHENOS=Hemophagocytic_lymphohistiocytosis,familial,5,with_or_without_microvillus_inclusion_disease,613101]
chr19	7707859	7708141	trio	282	1	2	0.15485	0.172	0.000		STXBP2	STXBP2 (oe_lof=0.56 region=exonic/splicing)			601717_[GENE=STXBP2_PHENOS=Hemophagocytic_lymphohistiocytosis,familial,5,with_or_without_microvillus_inclusion_disease,613101]
chr19	7711125	7711240	trio	115	1	4	0.03000	0.032	0.000		STXBP2	STXBP2 (oe_lof=0.56 region=exonic/splicing)			601717_[GENE=STXBP2_PHENOS=Hemophagocytic_lymphohistiocytosis,familial,5,with_or_without_microvillus_inclusion_disease,613101]
chr19	10252694	10252906	trio	212	3	6	0.01571	0.038	0.000		DNMT1	DNMT1 (oe_lof=0.08 region=exonic/splicing)		146077 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59110 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	126375_[GENE=DNMT1_PHENOS=Neuropathy,hereditary_sensory,type_IE,614116,Autosomal_dominant/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121,Autosomal_dominant]
chr19	10260119	10260343	trio	224	3	6	0.01843	0.076	0.000		DNMT1	DNMT1 (oe_lof=0.08 region=exonic/splicing)		146077 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59110 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"]	126375_[GENE=DNMT1_PHENOS=Neuropathy,hereditary_sensory,type_IE,614116,Autosomal_dominant/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121,Autosomal_dominant]
chr19	11151964	11152246	trio	282	1	3	0.03195	0.032	0.000		SMARCA4	SMARCA4 (oe_lof=0.01 region=exonic/splicing)	SMARCA4 [HI=Some evidence for dosage pathogenicity PMIDS=20137775,23775540]	146077 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153069 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59110 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59111 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],983187 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	603254_[GENE=SMARCA4_PHENOS=Coffin-Siris_syndrome_4,614609,Autosomal_dominant/Rhabdoid_tumor_predisposition_syndrome_2,613325,Autosomal_dominant]
chr19	12758037	12758422	trio	385	3	3	0.04069	0.025	0.000		MAN2B1	MAN2B1 (oe_lof=0.75 region=exonic/splicing)	MAN2B1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147761 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153069 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395272 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59110 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59111 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59112 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60073 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685830 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	609458_[GENE=MAN2B1_PHENOS=Mannosidosis,alpha-,types_I_and_II,248500,Autosomal_recessive]
chr19	12767375	12767880	trio	505	3	9	0.00423	0.057	0.000		MAN2B1	MAN2B1 (oe_lof=0.75 region=exonic/splicing)	MAN2B1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147761 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153069 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395272 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59110 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59111 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59112 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60073 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685830 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	609458_[GENE=MAN2B1_PHENOS=Mannosidosis,alpha-,types_I_and_II,248500,Autosomal_recessive]
chr19	12776156	12917903	trio	141747	3	23	0.00198	0.025	0.000		MAN2B1,WDR83,WDR83OS,DHPS,FBXW9,TNPO2,SNORD41,TRIR,GET3,BEST2,HOOK2,MIR5684,JUNB,PRDX2,RNASEH2A	MAN2B1 (oe_lof=0.75 region=exonic/splicing),WDR83 (oe_lof=1.02 region=exonic/splicing),WDR83OS (oe_lof=0.77 region=exonic/splicing),DHPS (oe_lof=0.50 region=complete),FBXW9 (oe_lof=0.67 region=complete),TNPO2 (oe_lof=0.04 region=complete),SNORD41 (oe_lof=n/a region=complete),TRIR (oe_lof=0.17 region=complete),GET3 (oe_lof=0.07 region=complete),BEST2 (oe_lof=0.91 region=complete),HOOK2 (oe_lof=0.70 region=complete),MIR5684 (oe_lof=n/a region=complete),JUNB (oe_lof=0.00 region=complete),PRDX2 (oe_lof=0.35 region=complete),RNASEH2A (oe_lof=0.45 region=exonic/splicing)	MAN2B1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	146686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147761 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153069 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395272 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59110 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59111 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59112 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60073 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685830 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	600944_[GENE=DHPS_PHENOS=Neurodevelopmental_disorder_with_seizures_and_speech_and_walking_impairment,618480,Autosomal_recessive],603002_[GENE=TNPO2_PHENOS=Intellectual_developmental_disorder_with_hypotonia,impaired_speech,and_dysmorphic_facies,619556],606034_[GENE=RNASEH2A_PHENOS=Aicardi-Goutieres_syndrome_4,610333,Autosomal_recessive],609458_[GENE=MAN2B1_PHENOS=Mannosidosis,alpha-,types_I_and_II,248500,Autosomal_recessive]
chr19	13215704	13215905	trio	201	3	9	0.00794	0.096	0.000		LYL1,TRMT1	LYL1 (oe_lof=0.00 region=intronic/intergenic),TRMT1 (oe_lof=0.67 region=exonic/splicing)		146026 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147761 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],149139 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153069 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394960 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],395272 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59110 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59111 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59112 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59113 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60073 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685830 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	151440_[GENE=LYL1_PHENOS=Leukemia,T-cell_acute_lymphoblastoid,151440],611669_[GENE=TRMT1_PHENOS=Mental_retardation,autosomal_recessive_68,618302,Autosomal_recessive]
chr19	13616736	13617284	trio	548	1	3	0.09919	0.229	0.000		CACNA1A	CACNA1A (oe_lof=0.08 region=exonic/splicing)	CACNA1A [HI=Sufficient evidence for dosage pathogenicity PMIDS=19586927,21927611,25735478]	146686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147761 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153069 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442731 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59111 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59112 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],808659 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	601011_[GENE=CACNA1A_PHENOS=Developemental_and_epileptic_encephalopathy_42,617106,Autosomal_dominant/Spinocerebellar_ataxia_6,183086,Autosomal_dominant/Episodic_ataxia,type_2,108500,Autosomal_dominant/Migraine,familial_hemiplegic,1,with_progressive_cerebellar_ataxia,141500,Autosomal_dominant/Migraine,familial_hemiplegic,1,141500,Autosomal_dominant]
chr19	14023971	14029017	trio	5046	3	6	0.02602	0.127	0.000		CC2D1A	CC2D1A (oe_lof=0.27 region=exonic/splicing)		146686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147284 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147761 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442731 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59111 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59112 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610055_[GENE=CC2D1A_PHENOS=Mental_retardation,autosomal_recessive_3,608443,Autosomal_recessive]
chr19	14037320	14037413	trio	93	3	5	0.01940	0.051	0.000		CC2D1A,PODNL1	CC2D1A (oe_lof=0.27 region=exonic/splicing),PODNL1 (oe_lof=1.10 region=intronic/intergenic)		146686 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147284 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147761 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442731 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],443137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59111 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59112 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	610055_[GENE=CC2D1A_PHENOS=Mental_retardation,autosomal_recessive_3,608443,Autosomal_recessive]
chr19	15298682	15299169	trio	487	3	6	0.04967	0.185	0.000		NOTCH3	NOTCH3 (oe_lof=0.23 region=exonic/splicing)		144765 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147284 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396159 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442476 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],816068 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	600276_[GENE=NOTCH3_PHENOS=Lateral_meningocele_syndrome,130720,Autosomal_dominant/Myofibromatosis,infantile_2,615293,Autosomal_dominant/Cerebral_arteriopathy_with_subcortical_infarcts_and_leukoencephalopathy_1,125310,Autosomal_dominant]
chr19	17942473	17942617	trio	144	3	5	0.03882	0.172	0.000		JAK3	JAK3 (oe_lof=0.36 region=exonic/splicing)			600173_[GENE=JAK3_PHENOS=SCID,autosomal_recessive,T-negative/B-positive_type,600802,Autosomal_recessive]
chr19	17954576	17955249	trio	673	3	3	0.07702	0.166	0.000		JAK3	JAK3 (oe_lof=0.36 region=exonic/splicing)			600173_[GENE=JAK3_PHENOS=SCID,autosomal_recessive,T-negative/B-positive_type,600802,Autosomal_recessive]
chr19	18001685	18001820	trio	135	3	5	0.02459	0.045	0.000		SLC5A5	SLC5A5 (oe_lof=0.33 region=exonic/splicing)			601843_[GENE=SLC5A5_PHENOS=Thyroid_dyshormonogenesis_1,274400,Autosomal_recessive]
chr19	19307762	19308070	trio	308	3	6	0.01768	0.057	0.000		BORCS8-MEF2B,MEF2B,BORCS8,RFXANK,NR2C2AP	BORCS8-MEF2B (oe_lof=0.45 region=intronic/intergenic),MEF2B (oe_lof=0.50 region=intronic/intergenic),BORCS8 (oe_lof=0.80 region=intronic/intergenic),RFXANK (oe_lof=0.66 region=exonic/splicing),NR2C2AP (oe_lof=0.27 region=intronic/intergenic)			603200_[GENE=RFXANK_PHENOS=MHC_class_II_deficiency,complementation_group_B,209920,Autosomal_recessive]
chr19	33991834	34002071	trio	10237	1	10	0.02334	0.032	0.000		PEPD	PEPD (oe_lof=0.89 region=exonic/splicing)		153499 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	613230_[GENE=PEPD_PHENOS=Prolidase_deficiency,170100,Autosomal_recessive]
chr19	34868398	34868501	trio	103	3	5	0.03898	0.076	0.000		GPI	GPI (oe_lof=0.45 region=exonic/splicing)		153499 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	172400_[GENE=GPI_PHENOS=Hemolytic_anemia,nonspherocytic,due_to_glucose_phosphate_isomerase_deficiency,613470,Autosomal_recessive]
chr19	36139115	36139315	trio	200	1	4	0.02459	0.019	0.000		ETV2,COX6B1	ETV2 (oe_lof=0.91 region=intronic/intergenic),COX6B1 (oe_lof=0.37 region=intronic/intergenic)	COX6B1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	625760 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized epilepsy with febrile seizures plus, type 1"],625761 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	124089_[GENE=COX6B1_PHENOS=Mitochondrial_complex_IV_deficiency,nuclear_type_7,619051,Autosomal_recessive]
chr19	36339868	36340565	trio	697	3	7	0.02387	0.070	0.000		NPHS1	NPHS1 (oe_lof=0.52 region=exonic/splicing)	NPHS1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	625760 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized epilepsy with febrile seizures plus, type 1"]	602716_[GENE=NPHS1_PHENOS=Nephrotic_syndrome,type_1,256300,Autosomal_recessive]
chr19	36486080	36487230	trio	1150	3	3	0.06827	0.185	0.000		SDHAF1	SDHAF1 (oe_lof=1.11 region=exonic/splicing)	SDHAF1 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	625760 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized epilepsy with febrile seizures plus, type 1"]	612848_[GENE=SDHAF1_PHENOS=Mitochondrial_complex_II_deficiency,nuclear_type_2,619166,Autosomal_recessive]
chr19	36592106	36592229	trio	123	1	4	0.02551	0.076	0.000		WDR62	WDR62 (oe_lof=0.67 region=exonic/splicing)		625760 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Generalized epilepsy with febrile seizures plus, type 1"]	613583_[GENE=WDR62_PHENOS=Microcephaly_2,primary,autosomal_recessive,with_or_without_cortical_malformations,604317,Autosomal_recessive]
chr19	38955269	38955372	trio	103	1	4	0.02112	0.019	0.000		RYR1	RYR1 (oe_lof=0.38 region=exonic/splicing)		253452 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	180901_[GENE=RYR1_PHENOS=Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000,Autosomal_dominant,Autosomal_recessive/Central_core_disease,117000,Autosomal_dominant,Autosomal_recessive/King-Denborough_syndrome,619542,Autosomal_dominant/Malignant_hyperthermia_susceptibility_1,145600,Autosomal_dominant/Minicore_myopathy_with_external_ophthalmoplegia,255320,Autosomal_recessive]
chr19	38965948	38966100	trio	152	3	4	0.04132	0.089	0.000		RYR1	RYR1 (oe_lof=0.38 region=exonic/splicing)		253452 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685595 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	180901_[GENE=RYR1_PHENOS=Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000,Autosomal_dominant,Autosomal_recessive/Central_core_disease,117000,Autosomal_dominant,Autosomal_recessive/King-Denborough_syndrome,619542,Autosomal_dominant/Malignant_hyperthermia_susceptibility_1,145600,Autosomal_dominant/Minicore_myopathy_with_external_ophthalmoplegia,255320,Autosomal_recessive]
chr19	38980706	38980926	trio	220	3	7	0.03312	0.083	0.000		RYR1	RYR1 (oe_lof=0.38 region=exonic/splicing)		253452 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685595 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	180901_[GENE=RYR1_PHENOS=Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000,Autosomal_dominant,Autosomal_recessive/Central_core_disease,117000,Autosomal_dominant,Autosomal_recessive/King-Denborough_syndrome,619542,Autosomal_dominant/Malignant_hyperthermia_susceptibility_1,145600,Autosomal_dominant/Minicore_myopathy_with_external_ophthalmoplegia,255320,Autosomal_recessive]
chr19	38984982	38985275	trio	293	3	3	0.05775	0.210	0.000		RYR1	RYR1 (oe_lof=0.38 region=exonic/splicing)		253452 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685595 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	180901_[GENE=RYR1_PHENOS=Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000,Autosomal_dominant,Autosomal_recessive/Central_core_disease,117000,Autosomal_dominant,Autosomal_recessive/King-Denborough_syndrome,619542,Autosomal_dominant/Malignant_hyperthermia_susceptibility_1,145600,Autosomal_dominant/Minicore_myopathy_with_external_ophthalmoplegia,255320,Autosomal_recessive]
chr19	39037075	39037176	trio	101	1	3	0.01900	0.045	0.000		RYR1	RYR1 (oe_lof=0.38 region=exonic/splicing)		253452 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],685595 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	180901_[GENE=RYR1_PHENOS=Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000,Autosomal_dominant,Autosomal_recessive/Central_core_disease,117000,Autosomal_dominant,Autosomal_recessive/King-Denborough_syndrome,619542,Autosomal_dominant/Malignant_hyperthermia_susceptibility_1,145600,Autosomal_dominant/Minicore_myopathy_with_external_ophthalmoplegia,255320,Autosomal_recessive]
chr19	41903684	41903850	trio	166	5	8	0.01429	0.274	0.000		BCKDHA,EXOSC5	BCKDHA (oe_lof=0.68 region=exonic/splicing),EXOSC5 (oe_lof=0.54 region=intronic/intergenic)			608348_[GENE=BCKDHA_PHENOS=Maple_syrup_urine_disease,type_Ia,248600,Autosomal_recessive]
chr19	42383050	42383369	trio	319	1	6	0.01843	0.083	0.000		CD79A,ARHGEF1	CD79A (oe_lof=0.16 region=exonic/splicing),ARHGEF1 (oe_lof=0.21 region=intronic/intergenic)			112205_[GENE=CD79A_PHENOS=Agammaglobulinemia_3,613501,Autosomal_recessive],601855_[GENE=ARHGEF1_PHENOS=Immunodeficiency_62,618459,Autosomal_recessive]
chr19	44010861	44012222	trio	1361	1	13	0.00016	0.051	0.000		PHLDB3,ETHE1	PHLDB3 (oe_lof=0.92 region=intronic/intergenic),ETHE1 (oe_lof=0.84 region=exonic/splicing)		253540 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608451_[GENE=ETHE1_PHENOS=Ethylmalonic_encephalopathy,602473,Autosomal_recessive]
chr19	44015579	44030821	trio	15242	4	20	0.00500	0.166	0.000		ETHE1,ZNF575	ETHE1 (oe_lof=0.84 region=exonic/splicing),ZNF575 (oe_lof=0.38 region=exonic/splicing)		253540 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],915988 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Ethylmalonic encephalopathy"]	608451_[GENE=ETHE1_PHENOS=Ethylmalonic_encephalopathy,602473,Autosomal_recessive]
chr19	45924426	45927187	trio	2761	4	6	0.00491	0.210	0.000		ERCC1	ERCC1 (oe_lof=0.80 region=exonic/splicing)		147383 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148766 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253540 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	126380_[GENE=ERCC1_PHENOS=Cerebrooculofacioskeletal_syndrome_4,610758,Autosomal_recessive]
chr19	45992096	45992821	trio	725	3	10	0.00874	0.083	0.000		RTN2,PPM1N	RTN2 (oe_lof=0.22 region=exonic/splicing),PPM1N (oe_lof=0.82 region=intronic/intergenic)		147383 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148766 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253540 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	603183_[GENE=RTN2_PHENOS=Spastic_paraplegia_12,autosomal_dominant,604805,Autosomal_dominant]
chr19	47251274	47251984	trio	710	3	3	0.04135	0.115	0.000		STRN4,FKRP	STRN4 (oe_lof=0.12 region=intronic/intergenic),FKRP (oe_lof=0.76 region=intronic/intergenic)		147383 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148766 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],441540 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],59115 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],60103 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],625762 [CN_TYPE=gain CN=n/a CLNSIG="Pathogenic" PHENOTYPE="n/a"]	606596_[GENE=FKRP_PHENOS=Muscular_dystrophy-dystroglycanopathy_(congenital_with_or_without_mental_retardation),type_B,5,606612,Autosomal_recessive/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,5,607155,Autosomal_recessive/Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,5,613153,Autosomal_recessive]
chr19	50365432	50365548	trio	116	3	3	0.05144	0.096	0.000		PTOV1,PNKP	PTOV1 (oe_lof=0.18 region=intronic/intergenic),PNKP (oe_lof=0.85 region=exonic/splicing)			605610_[GENE=PNKP_PHENOS=Charcot-Marie-Tooth_disease,type_2B2,605589,Autosomal_recessive/Ataxia-oculomotor_apraxia_4,616267,Autosomal_recessive/Microcephaly,seizures,and_developmental_delay,613402,Autosomal_recessive]
chr19	51869514	51869682	trio	168	6	35	0.00000	0.172	0.000		ETFB,CLDND2	ETFB (oe_lof=0.39 region=exonic/splicing),CLDND2 (oe_lof=1.07 region=intronic/intergenic)	ETFB [HI=Gene associated with autosomal recessive phenotype PMIDS=]		130410_[GENE=ETFB_PHENOS=Glutaric_acidemia_IIB,231680,Autosomal_recessive]
chr19	54392882	54393281	trio	399	3	6	0.01378	0.210	0.000		PRKCG	PRKCG (oe_lof=0.08 region=exonic/splicing)		253434 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397292 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564606 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	176980_[GENE=PRKCG_PHENOS=Spinocerebellar_ataxia_14,605361,Autosomal_dominant]
chr20	3869476	3870589	trio	1113	4	7	0.00737	0.159	0.000		PANK2	PANK2 (oe_lof=0.61 region=exonic/splicing)		395878 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396106 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59194 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	606157_[GENE=PANK2_PHENOS=HARP_syndrome,607236,Autosomal_recessive/Neurodegeneration_with_brain_iron_accumulation_1,234200,Autosomal_recessive]
chr20	13765662	13765946	trio	284	4	3	0.08602	0.363	0.000		ESF1,NDUFAF5	ESF1 (oe_lof=0.28 region=intronic/intergenic),NDUFAF5 (oe_lof=0.80 region=exonic/splicing)	NDUFAF5 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		612360_[GENE=NDUFAF5_PHENOS=Mitochondrial_complex_I_deficiency,nuclear_type_16,618238,Autosomal_recessive]
chr20	25287459	25288691	trio	1232	1	3	0.02862	0.045	0.000		ABHD12	ABHD12 (oe_lof=0.47 region=exonic/splicing)	ABHD12 [HI=Gene associated with autosomal recessive phenotype PMIDS=]		613599_[GENE=ABHD12_PHENOS=Polyneuropathy,hearing_loss,ataxia,retinitis_pigmentosa,and_cataract,612674,Autosomal_recessive]
chr20	33539517	33543611	trio	4094	3	3	0.08631	0.242	0.000		GSS	GSS (oe_lof=0.50 region=exonic/splicing)		146117 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153447 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	601002_[GENE=GSS_PHENOS=Hemolytic_anemia_due_to_glutathione_synthetase_deficiency,231900,Autosomal_recessive/Glutathione_synthetase_deficiency,266130,Autosomal_recessive]
chr20	35555575	35559288	trio	3713	3	9	0.00557	0.070	0.000		SAMHD1	SAMHD1 (oe_lof=0.67 region=exonic/splicing)			606754_[GENE=SAMHD1_PHENOS=Chilblain_lupus_2,614415,Autosomal_dominant/Aicardi-Goutieres_syndrome_5,612952,Autosomal_recessive]
chr20	35569432	35580256	trio	10824	3	8	0.02602	0.076	0.000		SAMHD1	SAMHD1 (oe_lof=0.67 region=exonic/splicing)		1180534 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	606754_[GENE=SAMHD1_PHENOS=Chilblain_lupus_2,614415,Autosomal_dominant/Aicardi-Goutieres_syndrome_5,612952,Autosomal_recessive]
chr20	44520545	44520676	trio	131	3	3	0.07702	0.197	0.000		SPATA25,NEURL2,CTSA	SPATA25 (oe_lof=0.70 region=intronic/intergenic),NEURL2 (oe_lof=0.93 region=intronic/intergenic),CTSA (oe_lof=0.59 region=exonic/splicing)			613111_[GENE=CTSA_PHENOS=Galactosialidosis,256540,Autosomal_recessive]
chr20	57478717	57480545	trio	1828	3	12	0.00005	0.038	0.000		GNAS	GNAS (oe_lof=0.21 region=exonic/splicing)	GNAS [HI=Sufficient evidence for dosage pathogenicity PMIDS=9876352,11095461,11600516]		139320_[GENE=GNAS_PHENOS=ACTH-independent_macronodular_adrenal_hyperplasia,219080,Somatic_mutation/Pituitary_adenoma_3,multiple_types,somatic,617686/Pseudohypoparathyroidism_Ic,612462,Autosomal_dominant/Pseudohypoparathyroidism_Ia,103580,Autosomal_dominant/Osseous_heteroplasia,progressive,166350,Autosomal_dominant/Pseudohypoparathyroidism_Ib,603233,Autosomal_dominant/McCune-Albright_syndrome,somatic,mosaic,174800/Pseudopseudohypoparathyroidism,612463,Autosomal_dominant]
chr20	57485379	57485466	trio	87	3	4	0.03967	0.076	0.000		GNAS	GNAS (oe_lof=0.21 region=exonic/splicing)	GNAS [HI=Sufficient evidence for dosage pathogenicity PMIDS=9876352,11095461,11600516]		139320_[GENE=GNAS_PHENOS=ACTH-independent_macronodular_adrenal_hyperplasia,219080,Somatic_mutation/Pituitary_adenoma_3,multiple_types,somatic,617686/Pseudohypoparathyroidism_Ic,612462,Autosomal_dominant/Pseudohypoparathyroidism_Ia,103580,Autosomal_dominant/Osseous_heteroplasia,progressive,166350,Autosomal_dominant/Pseudohypoparathyroidism_Ib,603233,Autosomal_dominant/McCune-Albright_syndrome,somatic,mosaic,174800/Pseudopseudohypoparathyroidism,612463,Autosomal_dominant]
chr20	61987299	61991061	trio	3762	1	4	0.07625	0.064	0.000		CHRNA4	CHRNA4 (oe_lof=0.48 region=exonic/splicing)		1047899 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Epileptic spasms"],144360 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146197 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150212 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153207 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160985 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253445 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253462 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253468 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395261 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],425532 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],442701 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564629 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],58974 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58975 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58977 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],604692 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],604693 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979738 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	118504_[GENE=CHRNA4_PHENOS=Nicotine_addiction,susceptibility_to,188890/Epilepsy,nocturnal_frontal_lobe,1,600513,Autosomal_dominant]
chr20	62073749	62073894	trio	145	1	4	0.03047	0.045	0.000		KCNQ2	KCNQ2 (oe_lof=0.05 region=exonic/splicing)	KCNQ2 [HI=Sufficient evidence for dosage pathogenicity PMIDS=17675531,14534157]	1047899 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="Epileptic spasms"],144360 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146197 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],148310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150212 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153207 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],153305 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],160985 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253418 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253445 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253462 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253468 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395261 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],425532 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],442701 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564629 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],564637 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],58974 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58975 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],58977 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],604692 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],604693 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],872799 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979738 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	602235_[GENE=KCNQ2_PHENOS=Developmental_and_epileptic_encephalopathy_7,613720,Autosomal_dominant/Seizures,benign_neonatal,1,121200,Autosomal_dominant/Myokymia,121200,Autosomal_dominant]
chr21	46915262	46915356	trio	94	1	4	0.02698	0.025	0.000		COL18A1,SLC19A1	COL18A1 (oe_lof=0.40 region=exonic/splicing),SLC19A1 (oe_lof=0.69 region=intronic/intergenic)		144193 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148266 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154533 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155268 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253347 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253527 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396341 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396958 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397136 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397326 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443167 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564674 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57115 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59045 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59046 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59068 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],604997 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686963 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816172 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816179 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],816184 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120328_[GENE=COL18A1_PHENOS=Knobloch_syndrome,type_1,267750,Autosomal_recessive/Glaucoma,primary_closed-angle,618880,Autosomal_dominant],600424_[GENE=SLC19A1_PHENOS=Megaloblastic_anemia,folate-responsive,601775,Autosomal_recessive]
chr21	46925742	46925890	trio	148	3	3	0.04534	0.083	0.000		COL18A1,SLC19A1	COL18A1 (oe_lof=0.40 region=exonic/splicing),SLC19A1 (oe_lof=0.69 region=intronic/intergenic)		144193 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148266 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154533 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155268 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253347 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253527 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396341 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396958 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397136 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397326 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443167 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564674 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57115 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59045 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59046 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59068 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],604997 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686963 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816172 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816179 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],816184 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120328_[GENE=COL18A1_PHENOS=Knobloch_syndrome,type_1,267750,Autosomal_recessive/Glaucoma,primary_closed-angle,618880,Autosomal_dominant],600424_[GENE=SLC19A1_PHENOS=Megaloblastic_anemia,folate-responsive,601775,Autosomal_recessive]
chr21	47421157	47421310	trio	153	1	5	0.02602	0.032	0.000		COL6A1	COL6A1 (oe_lof=0.13 region=exonic/splicing)		144193 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148266 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154533 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155268 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253347 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253527 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394602 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],395947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396958 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397136 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397326 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443167 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564674 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57115 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59045 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59046 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59068 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59069 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],686963 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816172 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816179 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],816184 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	120220_[GENE=COL6A1_PHENOS=Bethlem_myopathy_1,158810,Autosomal_dominant,Autosomal_recessive/Ullrich_congenital_muscular_dystrophy_1,254090,Autosomal_dominant,Autosomal_recessive]
chr21	47832741	47832916	trio	175	1	4	0.04646	0.096	0.000		PCNT	PCNT (oe_lof=0.70 region=exonic/splicing)		144193 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148266 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154533 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155268 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253347 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253363 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253527 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],394602 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],395947 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396958 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397136 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397326 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443167 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],564674 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57115 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59045 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59046 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59068 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],59069 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],605013 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816172 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816179 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],816184 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	605925_[GENE=PCNT_PHENOS=Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720,Autosomal_recessive]
chr22	24916345	24919751	trio	3406	3	3	0.06827	0.051	0.000		UPB1	UPB1 (oe_lof=0.86 region=exonic/splicing)		219016 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],253435 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253485 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253500 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395052 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396589 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],397033 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],565019 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],565029 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565031 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],625627 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="n/a"],635766 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="Global developmental delay"],684901 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],684928 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],685920 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],686931 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688543 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688980 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816203 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816209 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816211 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979598 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979600 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	606673_[GENE=UPB1_PHENOS=Beta-ureidopropionase_deficiency,613161,Autosomal_recessive]
chr22	37257020	37260181	trio	3161	3	3	0.08142	0.197	0.000		NCF4-AS1,NCF4	NCF4-AS1 (oe_lof=n/a region=intronic/intergenic),NCF4 (oe_lof=0.75 region=exonic/splicing)		221996 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],442145 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443342 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57629 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57630 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57941 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	601488_[GENE=NCF4_PHENOS=Chronic_granulomatous_disease_3,autosomal_recessive,613960,Autosomal_recessive]
chr22	38577661	38577771	trio	110	5	32	0.00000	0.146	0.000		PLA2G6	PLA2G6 (oe_lof=0.60 region=intronic/intergenic)		153362 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395465 [CN_TYPE=gain CN=n/a CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],442777 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443342 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],57629 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57632 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57943 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],816479 [CN_TYPE=loss CN=1 CLNSIG="Likely pathogenic" PHENOTYPE="See cases"],816564 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	603604_[GENE=PLA2G6_PHENOS=Parkinson_disease_14,autosomal_recessive,612953,Autosomal_recessive/Neurodegeneration_with_brain_iron_accumulation_2B,610217,Autosomal_recessive/Infantile_neuroaxonal_dystrophy_1,256600,Autosomal_recessive]
chr22	40754858	40755049	trio	191	3	9	0.00331	0.025	0.000		ADSL	ADSL (oe_lof=0.74 region=exonic/splicing)	ADSL [HI=Gene associated with autosomal recessive phenotype PMIDS=]	57943 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	608222_[GENE=ADSL_PHENOS=Adenylosuccinase_deficiency,103050,Autosomal_recessive]
chr22	41253075	41256807	trio	3732	3	12	0.01920	0.261	0.000		ST13,XPNPEP3,DNAJB7	ST13 (oe_lof=0.20 region=intronic/intergenic),XPNPEP3 (oe_lof=0.59 region=exonic/splicing),DNAJB7 (oe_lof=1.28 region=intronic/intergenic)	XPNPEP3 [HI=Gene associated with autosomal recessive phenotype PMIDS=]	57634 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57943 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"]	613553_[GENE=XPNPEP3_PHENOS=Nephronophthisis-like_nephropathy_1,613159,Autosomal_recessive]
chr22	42466276	42466856	trio	580	3	6	0.01707	0.210	0.000		NAGA,PHETA2	NAGA (oe_lof=0.88 region=exonic/splicing),PHETA2 (oe_lof=1.08 region=intronic/intergenic)		147621 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],565011 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	104170_[GENE=NAGA_PHENOS=Schindler_disease,type_I,609241,Autosomal_recessive/Kanzaki_disease,609242,Autosomal_recessive/Schindler_disease,type_III,609241,Autosomal_recessive]
chr22	42523439	42526893	trio	3454	1	26	0.00223	0.045	1.000 (0.97,0.97,0.97,0.97,0.97)		NDUFA6-DT,CYP2D6	NDUFA6-DT (oe_lof=n/a region=intronic/intergenic),CYP2D6 (oe_lof=1.64 region=exonic/splicing)		147621 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="See cases"],565011 [CN_TYPE=gain CN=3 CLNSIG="Likely pathogenic" PHENOTYPE="n/a"]	124030_[GENE=CYP2D6_PHENOS=Codeine_sensitivity,608902,Autosomal_recessive/Debrisoquine_sensitivity,608902,Autosomal_recessive]
chr22	50965584	50967049	trio	1465	3	3	0.05999	0.076	0.000		NCAPH2,SCO2,TYMP,ODF3B	NCAPH2 (oe_lof=0.35 region=intronic/intergenic),SCO2 (oe_lof=1.08 region=intronic/intergenic),TYMP (oe_lof=0.52 region=exonic/splicing),ODF3B (oe_lof=0.53 region=intronic/intergenic)		1180542 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],144225 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],144377 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146310 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],146391 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],147807 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],148302 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],150859 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],151373 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],152137 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154200 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],154522 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155420 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],155641 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],253555 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],395399 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],396138 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],397184 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],441538 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443408 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443409 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443450 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],443889 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],565004 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565012 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565013 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565047 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565048 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],565049 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],57193 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57398 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57674 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57675 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57701 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57703 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],57704 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="See cases"],605425 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],605426 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],605435 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],605461 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],625663 [CN_TYPE=loss CN=n/a CLNSIG="Pathogenic" PHENOTYPE="22q13.3 deletion syndrome"],685951 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],688513 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816237 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816569 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816570 [CN_TYPE=gain CN=3 CLNSIG="Pathogenic" PHENOTYPE="n/a"],816571 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"],979615 [CN_TYPE=loss CN=1 CLNSIG="Pathogenic" PHENOTYPE="n/a"]	131222_[GENE=TYMP_PHENOS=Mitochondrial_DNA_depletion_syndrome_1_(MNGIE_type),603041,Autosomal_recessive],604272_[GENE=SCO2_PHENOS=Myopia_6,608908,Autosomal_dominant/Mitochondrial_complex_IV_deficiency,nuclear_type_2,604377,Autosomal_recessive]
